
<html lang="en"     class="pb-page"  data-request-id="18e28a0c-3af6-42ea-83de-bfe930dfc306"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm401094t;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2013.56.issue-20"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3" /></meta><meta name="dc.Creator" content="Val S.  Goodfellow" /></meta><meta name="dc.Creator" content="Colin J.  Loweth" /></meta><meta name="dc.Creator" content="Satheesh B.  Ravula" /></meta><meta name="dc.Creator" content="Torsten  Wiemann" /></meta><meta name="dc.Creator" content="Thong  Nguyen" /></meta><meta name="dc.Creator" content="Yang  Xu" /></meta><meta name="dc.Creator" content="Daniel E.  Todd" /></meta><meta name="dc.Creator" content="David  Sheppard" /></meta><meta name="dc.Creator" content="Scott  Pollack" /></meta><meta name="dc.Creator" content="Oksana  Polesskaya" /></meta><meta name="dc.Creator" content="Daniel F.  Marker" /></meta><meta name="dc.Creator" content="Stephen  Dewhurst" /></meta><meta name="dc.Creator" content="Harris A.  Gelbard" /></meta><meta name="dc.Description" content="Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson’s disease and HIV-1 associated neurocognitive disorders (HAND), requiring an inhibitor that can achiev..." /></meta><meta name="Description" content="Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson’s disease and HIV-1 associated neurocognitive disorders (HAND), requiring an inhibitor that can achiev..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 3, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401094t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401094t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401094t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401094t" /></link>
        
    
    

<title>Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401094t" /></meta><meta property="og:title" content="Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0012.jpeg" /></meta><meta property="og:description" content="Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson’s disease and HIV-1 associated neurocognitive disorders (HAND), requiring an inhibitor that can achieve significant brain concentration levels. We report here URMC-099 (1) an orally bioavailable (F = 41%), potent (IC50 = 14 nM) MLK3 inhibitor with excellent brain exposure in mouse PK models and minimal interference with key human CYP450 enzymes or hERG channels. The compound inhibits LPS-induced TNFα release in microglial cells, HIV-1 Tat-induced release of cytokines in human monocytes and up-regulation of phospho-JNK in Tat-injected brains of mice. Compound 1 likely functions in HAND preclinical models by inhibiting multiple kinase pathways, including MLK3 and LRRK2 (IC50 = 11 nM). We compare the kinase specificity and BBB penetration of 1 with CEP-1347 (2). Compound 1 is well tolerated, with excellent in vivo activity in HAND models, and is under investigation for further development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401094t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401094t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401094t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401094t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401094t&amp;href=/doi/10.1021/jm401094t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8032-8048</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4010829" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401101p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Val+S.++Goodfellow">Val S. Goodfellow</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colin+J.++Loweth">Colin J. Loweth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Satheesh+B.++Ravula">Satheesh B. Ravula</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Torsten++Wiemann">Torsten Wiemann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thong++Nguyen">Thong Nguyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Xu">Yang Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+E.++Todd">Daniel E. Todd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Sheppard">David Sheppard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Pollack">Scott Pollack</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oksana++Polesskaya">Oksana Polesskaya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+F.++Marker">Daniel F. Marker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Dewhurst">Stephen Dewhurst</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harris+A.++Gelbard">Harris A. Gelbard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Califia Bio Inc., 11575 Sorrento Valley Road, San Diego 92121, California, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">University of Rochester Medical Center, School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">BioFocus, Chesterford Research Park, Saffron Walden, Essex CB10 1XL, U.K.</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Biofocus DPI, 9640 Towne Centre Drive, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 858-720-1948. E-mail: <a href="/cdn-cgi/l/email-protection#5e282d3931313a383b323231291e3d3f323738373f3c3731703d3133"><span class="__cf_email__" data-cfemail="bec8cdd9d1d1dad8dbd2d2d1c9fedddfd2d7d8d7dfdcd7d190ddd1d3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401094t&amp;href=/doi/10.1021%2Fjm401094t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8032–8048</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 17, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 July 2013</li><li><span class="item_label"><b>Published</b> online</span>3 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401094t" title="DOI URL">https://doi.org/10.1021/jm401094t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8032%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVal%2BS.%2BGoodfellow%252C%2BColin%2BJ.%2BLoweth%252C%2BSatheesh%2BB.%2BRavula%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D20%26contentID%3Djm401094t%26title%3DDiscovery%252C%2BSynthesis%252C%2Band%2BCharacterization%2Bof%2Ban%2BOrally%2BBioavailable%252C%2BBrain%2BPenetrant%2BInhibitor%2Bof%2BMixed%2BLineage%2BKinase%2B3%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8048%26publicationDate%3DOctober%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401094t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3866</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">42</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401094t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Val&quot;,&quot;last_name&quot;:&quot;S. Goodfellow&quot;},{&quot;first_name&quot;:&quot;Colin&quot;,&quot;last_name&quot;:&quot;J. Loweth&quot;},{&quot;first_name&quot;:&quot;Satheesh&quot;,&quot;last_name&quot;:&quot;B. Ravula&quot;},{&quot;first_name&quot;:&quot;Torsten&quot;,&quot;last_name&quot;:&quot;Wiemann&quot;},{&quot;first_name&quot;:&quot;Thong&quot;,&quot;last_name&quot;:&quot;Nguyen&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;E. Todd&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Sheppard&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Pollack&quot;},{&quot;first_name&quot;:&quot;Oksana&quot;,&quot;last_name&quot;:&quot;Polesskaya&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;F. Marker&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Dewhurst&quot;},{&quot;first_name&quot;:&quot;Harris&quot;,&quot;last_name&quot;:&quot;A. Gelbard&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;8032-8048&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401094t&quot;},&quot;abstract&quot;:&quot;Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson’s disease and HIV-1 associated neurocognitive disorders (HAND), requiring an inhibitor that can achieve significant brain concentration levels. We report here URMC-099 (1) an orally bioavailable (F = 41%), potent (IC50 = 14 nM) MLK3 inhibitor with excellent brain exposure in mouse PK models and minimal interference with key human CYP450 enzymes or hERG channels. The compound inhibits LPS-induced TNFα release in microglial cells, HIV-1 Tat-induced release of cytokines in human monocytes and up-regulation of phospho-JNK in Tat-injected brains of mice. Compound 1 likely functions in HAND preclinical models by inhibiting multiple kinase pathways, including MLK3 and LRRK2 (IC50 = 11 nM). We compare the kinase specificity and BBB penetration of 1 with CEP-1347 (2). Compound 1 is well tolerated, with excellent in vivo activity in HAND models, and is under investigation for further development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401094t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401094t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401094t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401094t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401094t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401094t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401094t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401094t&amp;href=/doi/10.1021/jm401094t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401094t" /></input><a href="/doi/pdf/10.1021/jm401094t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401094t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401094t%26sid%3Dliteratum%253Aachs%26pmid%3D24044867%26genre%3Darticle%26aulast%3DGoodfellow%26date%3D2013%26atitle%3DDiscovery%252C%2BSynthesis%252C%2Band%2BCharacterization%2Bof%2Ban%2BOrally%2BBioavailable%252C%2BBrain%2BPenetrant%2BInhibitor%2Bof%2BMixed%2BLineage%2BKinase%2B3%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D20%26spage%3D8032%26epage%3D8048%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jmcmar.2013.56.issue-20/production/jmcmar.2013.56.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson’s disease and HIV-1 associated neurocognitive disorders (HAND), requiring an inhibitor that can achieve significant brain concentration levels. We report here URMC-099 (<b>1</b>) an orally bioavailable (<i>F</i> = 41%), potent (IC<sub>50</sub> = 14 nM) MLK3 inhibitor with excellent brain exposure in mouse PK models and minimal interference with key human CYP450 enzymes or hERG channels. The compound inhibits LPS-induced TNFα release in microglial cells, HIV-1 Tat-induced release of cytokines in human monocytes and up-regulation of phospho-JNK in Tat-injected brains of mice. Compound <b>1</b> likely functions in HAND preclinical models by inhibiting multiple kinase pathways, including MLK3 and LRRK2 (IC<sub>50</sub> = 11 nM). We compare the kinase specificity and BBB penetration of <b>1</b> with CEP-1347 (<b>2</b>). Compound <b>1</b> is well tolerated, with excellent in vivo activity in HAND models, and is under investigation for further development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We report here the discovery, synthesis, and characterization of URMC-099 (<b>1</b>), a new inhibitor of mixed lineage kinase type 3 (MLK3) with excellent blood–brain barrier penetration properties, which has shown neuroprotective and antineuroinflammatory properties in in vitro and in vivo models of HIV-1 associated neurocognitive disorders (HAND).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Combination antiretroviral therapy (cART) has greatly increased both the life expectancy and quality of life for HIV-1 seropositive individuals and is one of the greatest success stories of modern drug development. However, as the population of AIDS patients has aged, it has become apparent that neurological impairments resulting from HIV infection are not controlled by cART and may indeed be exacerbated by some CNS penetrating antiretroviral agents used in HIV therapy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> HAND encompasses a broad range of neurologic deficits that range from mild cognitive impairment to frank dementia and is the result of damage to normal synaptic architecture that is likely mediated by dysregulation of immune cells in the CNS. In the U.S., greater than 50% of AIDS patients experience some symptoms of HAND, with a significant percentage (15%) exhibiting neurologic morbidity severe enough to preclude normal activities of daily living with substantial economic impact for their healthcare.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The hallmarks of HAND include: (1) a dysregulation of inflammatory cytokines and chemokines, (2) the recruitment of monocytes to the CNS, (3) viral infection of microglia leading to interruption of their normal function, and (4) extensive synaptodendritic damage, which ultimately impacts polysynaptic pathways that are the substrate for HAND in affected regions of the brain. A host of inflammatory mediators have been implicated in cellular models of HAND, where TNF-α release and signaling likely play a major central role. A more limited subset of mediators has been identified as being up-regulated in the cerebrospinal fluid (CSF) and post-mortem brain tissues of HAND patients. These mediators/effectors include TNFα, the chemokine monocyte chemoattractant protein (MCP-1), and from preclinical models, mixed-lineage kinase 3 (MLK3), an important control point in MAPK kinase regulated inflammation pathways.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Mixed lineage kinases are mitogen activated protein kinase kinase kinases (MAPKKKs) with features of both serine–threonine and tyrosine kinases that regulate the c-Jun N-terminal kinase (JNK) mitogen activated protein kinase (MAPK) signaling cascade and also regulate p38 and extracellular signal-regulated kinase (ERK).<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> MLK3 (MAP3K11) is the most widely expressed MLK family member<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> and is expressed in neurons<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (as well as other cell types).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> At the cellular level, MLK3 is activated by stress, including reactive oxygen species, ceramide, and TNFα.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> At the molecular level, it is activated by Cdc42 and Rac, which interact with MLK3, and can cause it to dimerize via a leucine zipper interface, resulting in autophosphorylation at Thr277 and Ser281 within the protein activation loop and enzyme activation.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> HIV-1 Tat also leads to phosphorylation at these same residues in primary rat neurons<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and to activation of glycogen synthase kinase (GSK-3ß) in neurons.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> This is important because MLK3 can be activated as a result of direct phosphorylation by GSK-3β.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Previously published MLK3 inhibitors, CEP-1347<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (<b>2</b>), K252a<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (<b>3</b>), CEP-701<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (<b>4</b>), CEP-11004<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (<b>5</b>), and compound <b>6</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), have been based largely on the protein kinase-promiscuous staurosporine scaffold. Compound <b>2</b> has been used as a tool compound to explore the effects of MLK3 inhibition for HAND and Parkinson’s disease<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> in cellular and animal models, although the compound is in no way specific for MLK3. Compound <b>2</b> has also been a central player in the target validation of mixed lineage kinases for HAND. Compound <b>2</b> protected primary rat hippocampal neurons as well as dorsal root ganglion neurons from the otherwise lethal effects of exposure to HIV-1 coat protein gp120.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Tat and gp120 induce autophosphorylation of MLK3 in primary rat neurons, which was abolished by the addition of <b>2</b>. Compound <b>2</b> also enhanced survival of both rat and human neurons and inhibited the activation of human monocytes after exposure to Tat and gp120.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compound <b>2</b> is neuroprotective in an in vivo model of HIV-1 infection, reversing microglial activation and restoring normal synaptic architecture, as well as restoring macrophage secretory profiles to a trophic vs toxic phenotype in response to HIV-1 infection.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of known potent MLK3 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Unfortunately, <b>2</b> failed to show efficacy in a large phase II clinical trial for early stage Parkinson’s disease.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound <b>2</b> has a high molecular weight (MW = 615) with a large polar surface area (PSA = 95 Å<sup>2</sup>), properties which are not conducive to blood–brain barrier (BBB) penetration. There are additional reasons to suspect that <b>2</b> likely did not maintain therapeutic levels in the brains of significant numbers of patients. No published data for CNS penetration is available for this compound, however, <b>2</b> is known to interact with and inhibit CYP450 enzymes.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Plasma PK concentration data for human subjects receiving <b>2</b> and antiviral therapy showed very large patient to patient variation in blood levels of <b>2</b>, which may be indicative of induction of metabolic liver enzymes. In silico assessment using Optibrium<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> software suggested poor CNS penetration of <b>2</b>, confirmed by blood–brain barrier studies reported here, as well as the likelihood of interaction with liver enzymes, which could lead to further degradation of CNS exposure over time. Therefore our goal was to identify a new potent MLK3 inhibitor with improved pharmacokinetics and significant CNS penetration, which might serve as a first-in-class treatment, adjunctive to cART, for HAND.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have identified a 7-azaindole based MLK3 inhibitor <b>1</b>, with potent in vitro activity against HIV-1 Tat mediated release of cytokines in human and mouse immune cells, including cultured mouse microglial BV-2 cells; it is also neuroprotective in mice exposed to HIV-1 Tat.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In mouse brain imaging experiments, compound <b>1</b> has demonstrated its in vivo efficacy for preservation of normal synaptic architecture and reversal of neuroinflammation following CNS exposure to HIV-1 Tat.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Because of a compelling profile of central anti-inflammatory effects and neuroprotection, compound <b>1</b> is being evaluated for adjunctive therapy with or without cART in humanized mice engrafted with human CD34 cells that can sustain peripheral and central infection with HIV-1.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">A proprietary focused library of kinase inhibitors from BioFocus Ltd. containing approximately 15000 unique compounds was screened against MLK3 in a radiometric filter plate assay format. A large number of active compounds with consistent structure activity themes were identified from structurally distinct chemical libraries. We focused our initial hit-to-lead development on the imidazopyrazinone series based around screening hit (<b>7</b>) (see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This compound gave variable potency in enzyme inhibition assays (MLK3 IC<sub>50</sub> ranged between 40–120 nM); we believed this variability was due to solubility issues. Cellular assays also suggested poor ability to penetrate cells (LPS-stimulated TNF-α release in BV-2 mouse microglial cells, IC<sub>50</sub> = 23.6 μM). However, the simple structure, well-developed SAR from screening hits, ease of synthesis, and potential for scaffold hopping from this series of compounds more than compensated for its initial drawbacks. During the modification of this scaffold, the design of compounds for optimization focused on low molecular weight compounds (<450 MW) with small numbers of hydrogen bond donors (<3) and low polar surface area to maximize chances of CNS penetration. Analysis of virtual libraries of potential synthetic targets with Stardrop (Optibrium Ltd.) guided us toward the 7-azaindole type scaffold and compounds related to the indole containing (<b>8</b>), a direct analogue of <b>7</b>. Compound <b>8</b> (see figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) was much more potent against MLK3 and showed significant inhibition of the release of TNFα in BV-2 cells stimulated with LPS. We rapidly synthesized a number of potent analogues around this structure type with the goal of simultaneously optimizing (1) high potency in a biochemical MLK3 inhibition assay, (2) inhibitory activity in macrophages/microglia to prevent HIV-1 Tat-induced stimulation of a relevant panel of cytokines of validated importance in HAND, (3) metabolic stability, (4) CNS penetration, and (5) high brain and plasma concentrations upon oral dosing. Ultimately, compound <b>1</b> emerged as an attractive candidate in a small focused library of very active compounds and was designed through a strategy to introduce solubilizing groups known to be effective in marketed kinase inhibitors. Our goal was to replace the trimethoxy aryl residue, with a group that could exhibit very low polar surface area in order to increase the potential for CNS penetration. The benzyl-linked <i>N</i>-methyl piperazine moiety met these criteria and yielded compound <b>1</b>, both highly potent against MLK3 and with very low polar surface area.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Potent and drug-like 7-azaindole MLK3 inhibitors selected for initial profiling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Optimization design path to compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Inhibition of LPS-Induced TNFα Release in Murine BV-2 Microglial Cells</h3><div class="NLM_p last">After obtaining potent MLK3 inhibition data, we used an ELISA-based assay to gauge if our potent MLK3 inhibitor compounds were affecting the MAPK kinase pathway, which regulates TNFα release in microglial cells, one of the key cytokines responsible for inflammatory effects in HAND.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35">(32-35)</a> This secondary assay allowed us to identify chemotypes that readily penetrated relevant immune cells and elicited functional activity in reduction of this key pro-inflamatory cytokine. We profiled 132 potent compounds for activity in MLK3 inhibition, TNFα release inhibition assays, as well as drug-like properties (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and selected six compounds (<b>1</b>, <b>8</b>, <b>9</b>, <b>10</b>, <b>11</b>, <b>12</b>) for preliminary pharmacokinetic screening in mice (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Screening Phamacokinetics Studies and Blood–Brain Barrier Penetration</h3><div class="NLM_p">It is a widely held belief that few potent protein kinase inhibitors penetrate the CNS, although published data are scant regarding CNS exposure for these mostly anticancer drugs. Recent strategies in kinase drug development have skewed the propensity for these drugs to have properties unfavorable for BBB penetration.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Our strategy for finding CNS penetrant compounds for proof-of-concept studies was to keep structures as simple as possible, with nonlinear shapes, few hydrogen bond donors, Log <i>D</i> between 2 and 5, and low polar surface area. We tested the most promising compounds in screening PK studies for BBB penetration in mice. Test compounds were dosed iv in C57BL/6 male mice, through the tail vein, for a total dose of 10 mg/kg per animal, and standard pharmacokinetic parameters were determined (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Both <b>1</b> and <b>8</b> exhibited significant brain concentrations (brain AUC (μg/kg·h) = 5130 and 1535, respectively) over the time course of the experiment with excellent brain/plasma ratios. The brain concentrations of <b>1</b> remained well above the in vitro MLK3 inhibition IC<sub>50</sub> for over 6 h after injection. The volume of distribution for <b>1</b> is within acceptable bounds and does not indicate that the compound will accumulate in tissues. The brain and plasma concentrations for <b>8</b> were very closely matched, giving B/P ratios of ∼1 throughout the entire experiment. A B/P ratio of 1 suggests that the compound partitions fairly freely across the BBB, indicating few issues with PGP efflux pumps or accumulation of compound in brain tissue. However, compound <b>8</b> was rapidly metabolized in mice. In our experience with the 7-azaindole based inhibitors, polar surface area, molecular weight, and number of hydrogen bond donors were most important in determining whether a compound would exhibit good CNS exposure. Thus compounds such as <b>12</b> with high polar surface area or <b>10</b> with large number of hydrogen bond donors, exhibited poor BBB penetration in this preliminary study (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.)</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Screening PK Study (iv, 10 mg/kg, C57 BL/6 Mice)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>8</b></th><th class="colsep0 rowsep0" align="center"><b>9</b></th><th class="colsep0 rowsep0" align="center"><b>10</b></th><th class="colsep0 rowsep0" align="center"><b>11</b></th><th class="colsep0 rowsep0" align="center"><b>12</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μg/L·h)</td><td class="colsep0 rowsep0" align="left">3410</td><td class="colsep0 rowsep0" align="left">1560</td><td class="colsep0 rowsep0" align="left">1400</td><td class="colsep0 rowsep0" align="left">1630</td><td class="colsep0 rowsep0" align="left">3150</td><td class="colsep0 rowsep0" align="left">1840</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.72</td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">1.13</td><td class="colsep0 rowsep0" align="left">1.21</td><td class="colsep0 rowsep0" align="left">1.95</td><td class="colsep0 rowsep0" align="left">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>z</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (L/kg)</td><td class="colsep0 rowsep0" align="left">11.5</td><td class="colsep0 rowsep0" align="left">6.43</td><td class="colsep0 rowsep0" align="left">11.7</td><td class="colsep0 rowsep0" align="left">10.7</td><td class="colsep0 rowsep0" align="left">8.92</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>z</sub> (L/h/kg)</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">6.42</td><td class="colsep0 rowsep0" align="left">7.1</td><td class="colsep0 rowsep0" align="left">6.2</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/L)</td><td class="colsep0 rowsep0" align="left">1848</td><td class="colsep0 rowsep0" align="left">2744</td><td class="colsep0 rowsep0" align="left">4742</td><td class="colsep0 rowsep0" align="left">4823</td><td class="colsep0 rowsep0" align="left">9788</td><td class="colsep0 rowsep0" align="left">4250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain AUC (μg/kg·h)</td><td class="colsep0 rowsep0" align="left">5130</td><td class="colsep0 rowsep0" align="left">1535</td><td class="colsep0 rowsep0" align="left">213</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">693</td><td class="colsep0 rowsep0" align="left">136</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain <i>C</i><sub>max</sub> (μg/kg)</td><td class="colsep0 rowsep0" align="left">4685</td><td class="colsep0 rowsep0" align="left">3736</td><td class="colsep0 rowsep0" align="left">530</td><td class="colsep0 rowsep0" align="left">314.5</td><td class="colsep0 rowsep0" align="left">834</td><td class="colsep0 rowsep0" align="left">283</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain/plasma ratio @ 1 h</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">0.99</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">BQL<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1.02</td><td class="colsep0 rowsep0" align="left">0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Below quantification level.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Apparent volume of distribution during terminal phase.</p></div></div></div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Oral PK Study with Compound <b>1</b></h4><div class="NLM_p">To gauge the potential of compound <b>1</b> to function as a drug and to establish that oral dosing would be allowed in animal models, we initiated an oral PK study where compound <b>1</b> was dosed at 10 mg/kg in C57BL/6 mice (see Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). To determine %<i>F</i>, iv dosing was repeated at a lower concentration (2.5 mg/kg) to ensure that metabolic mechanisms would not be saturated by a high dose of test article dissolved in DMSO/PEG400. Using iv (2.5 mg/kg) and PO (10 mg/kg) dosing in C57Bl/6 mice, analysis of plasma concentrations of compound <b>1</b> yielded standard pharmacokinetic parameters, confirming proportionally similar exposures as measured by AUC levels at lower doses and similar half-life (terminal half-life iv = 2.14 h, oral = 1.92 h) and good oral bioavailability (%<i>F</i> = 41) using a simple standard oral dosing vehicle containing 0.4% Tween-80 and 0.5% hydroxypropylmethyl cellulose in pH 7.4 buffered saline.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Low Dose iv Administration of Compound <b>1</b> in C57 BL/6 Mice (2.5 mg/kg)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>1</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μg/L·h)</td><td class="colsep0 rowsep0" align="left">1400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">2.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>z</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>z</sub> (L/h/kg)</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/L)</td><td class="colsep0 rowsep0" align="left">570</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Oral Dosing of Compound <b>1</b> in C57 BL/6 Mice (10 mg/kg)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>1</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μg/L·h)</td><td class="colsep0 rowsep0" align="left">2300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/L)</td><td class="colsep0 rowsep0" align="left">2670</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">%<i>F</i></td><td class="colsep0 rowsep0" align="left">41</td></tr></tbody></table></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Blood–Brain Barrier Penetration of <b>2</b></h4><div class="NLM_p">Our stated goal was to identify a compound with significantly improved CNS penetration over <b>2</b>. To rapidly assess and compare the ability of a large number of compounds to penetrate the CNS, we adopted a simple screening model utilizing C57 BL/6 mice which were also employed in our imaging efficacy assays.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the screening BBB penetration assay, mice were dosed iv at 10 mg/kg and brain and plasma levels are measured at three time points utilizing averages from three mice per time point (see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In this assay format, <b>1</b> again achieved significant brain levels (e.g., at 3 h, the whole brain concentration was 950 ng/g, with a B/P ratio of 0.81). We utilized this rapid assessment of BBB penetration to compare <b>2</b> with our compounds. In this iv dosing assay, <b>2</b> showed significantly lower plasma and brain levels at all time points, with poor B/P ratios. For example, by three hours after iv dosing at the same starting dose (10 mg/kg), the brain concentration of compound <b>1</b> (ng/g) was measured as 14 times higher than that observed for <b>2</b>. While these numbers may not necessarily translate into high free fraction concentrations in human brain, taken together with human microsomal and hepatocyte stability data, they suggest that compound <b>1</b> is much more likely to achieve significant CNS levels. Our method does not determine free brain/free plasma fraction concentration ratios. This determination may be important when drugs are very tightly protein bound in the brain (>99%). With very high protein binding, the drug may be present in the brain but may not engage the therapeutic target. Compounds showing weaker protein binding (<99%) obviously are in equilibrium with an apparent binding constant that is usually much weaker than the highly potent <i>K</i><sub>d</sub> or <i>K</i><sub>m</sub> of drugs with significantly increased activity for the target kinase MLK3. It is well-known that for such drugs, the protein bound fraction represents a reservoir of displaceable drug in equilibrium with free drug. We have provided data (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) to rank order compounds for protein binding in human plasma. This data shows that protein binding for compound <b>1</b> is approximately 98%, and we expect the reservoir of drug in the brain to be in free equilibrium and available to bind to the MLK 3 target enzyme with high affinity (<i>K</i><sub>i</sub> ∼ 10 nM). This conclusion is supported by the fact that the terminal half-life for brain concentrations for compound <b>1</b> has been measured in mice at between 1.5 and 2 h, very close to the plasma half-life, suggesting that compound <b>1</b> in mice is not highly protein bound in the brain and is available to be metabolized by systemic CYP450 enzymes with modest <i>K</i><sub>m</sub> affinity and is also available for target engagement with high affinity for MLK3.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Blood–Brain Barrier Penetration Comparison (iv Dosing, 10 mg/kg)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">sample</th><th class="colsep0 rowsep0" align="center">30 min</th><th class="colsep0 rowsep0" align="center">60 min</th><th class="colsep0 rowsep0" align="center">180 min</th><th class="colsep0 rowsep0" align="center">B/P ratio <br /></br>30 min</th><th class="colsep0 rowsep0" align="center">B/P ratio <br /></br>60 min</th><th class="colsep0 rowsep0" align="center">B/P ratio <br /></br>180 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">plasma<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">4163</td><td class="colsep0 rowsep0" align="left">2920</td><td class="colsep0 rowsep0" align="left">1167</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">brain<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2833</td><td class="colsep0 rowsep0" align="left">2249</td><td class="colsep0 rowsep0" align="left">950</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.68</td><td class="colsep0 rowsep0" align="left">0.77</td><td class="colsep0 rowsep0" align="left">0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">plasma<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">3613</td><td class="colsep0 rowsep0" align="left">2566</td><td class="colsep0 rowsep0" align="left">936</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">brain<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">164</td><td class="colsep0 rowsep0" align="left">179</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">0.07</td><td class="colsep0 rowsep0" align="left">0.138</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">plasma<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">2403</td><td class="colsep0 rowsep0" align="left">1716</td><td class="colsep0 rowsep0" align="left">326</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">brain<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">594</td><td class="colsep0 rowsep0" align="left">463</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">0.21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">ng/mL.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">ng/g.</p></div></div></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> A Direct Control Analogue of Compound <b>1</b> with Poor CNS Penetration</h4><div class="NLM_p last">We have also identified a very closely related analogue (<b>13</b>) of compound <b>1</b> with very limited CNS penetration. While compound <b>13</b> had similar MLK3 potency and activity compared to compound <b>1</b> in simple kinase specificity screens, it had good systemic exposure but much lower brain levels when administered iv to C57Bl/6 mice, with B/P ratios of 0.04, 0.07, and 0.13 at 0.5, 1, and 3 h, respectively. This result was not fully anticipated based on in silico predictions or results with similar analogues. The formal replacement of carbon by nitrogen provides both a new basic center and a site for hydrogen bonding. It may be that the side chain azaindole pyridine nitrogen alters the preferred solution conformation compared to compound <b>1</b>, allowing better exposure to hydrogen bond interactions with that side chain with proteins or water. Such increased H-bonding could impede BBB penetration.</div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Metabolic Stability, CYP450 Inhibition, hERG Inhibition</h4><div class="NLM_p">When <b>1</b> was tested in vivo in mice, the terminal half-life after oral and iv administration was measured as 2.1 and 1.9 h, respectively. Data were obtained for the stability of <b>1</b> in the presence of human microsomes (45%) as well as human (55%), monkey (55%), and mouse hepatocytes (73%), where the data is expressed as “% remaining after 1 h”. The human microsome and hepatocyte stability data are similar to several marketed drugs used as standards in the assays, suggesting that while the half-life is not ideal for once a day dosing, it likely would be acceptable for a first-in-class drug for HAND where no known treatment currently exists. There were no significant CYP450 inhibition issues for <b>1</b> identified from the three most common isoforms of interest for drug/drug interactions (see Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Kinase inhibitors possessing amine-solubilizing groups such as the piperazine present potential risk for inhibition of hERG channels, with associated risks of QT prolongation. The automated Cerep whole cell patch-clamp technique<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (Qpatch 16, Sophion Biosciences) was used to record outward potassium currents from single cells transfected with the hERG channel. The IC<sub>50</sub> for <b>1</b> was determined as 21 μM and was rated as low cardiac toxicity risk by the CEREP compound evaluation criteria.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. CYP450 Inhibition (IC<sub>50</sub>, μM)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">CYP450</th><th class="colsep0 rowsep0" align="center" char="."><b>1</b></th><th class="colsep0 rowsep0" align="center" char="."><b>8</b></th><th class="colsep0 rowsep0" align="center" char="."><b>9</b></th><th class="colsep0 rowsep0" align="center" char="."><b>10</b></th><th class="colsep0 rowsep0" align="center" char="."><b>11</b></th><th class="colsep0 rowsep0" align="center" char="."><b>12</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2D6</b></td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">13.2</td><td class="colsep0 rowsep0" align="char" char=".">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3A4</b></td><td class="colsep0 rowsep0" align="char" char=".">16.2</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">21.8</td><td class="colsep0 rowsep0" align="char" char=".">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2C9</b></td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">13.7</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">>30</td></tr></tbody></table></div></div></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Inhibition of Tat-Induced Pro-inflammatory Cytokine Release by Primary Human Monocytes</h4><div class="NLM_p">We tested whether <b>1</b> could regulate the HIV-1 Tat-induced release of a set of pro-inflammatory cytokines from primary human monocytes. We focused on TNF-α, MCP-1, IL-6, and IL-8 because these are believed to be of importance of the pathogenesis of HAND.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35 ref36 ref37 ref38 ref39 ref40">(32-40)</a></div><div class="NLM_p">Compound <b>1</b> potently inhibited all of the mediators in a dose dependent fashion. Statistically significant inhibition, compared to Tat-only treatment, was achieved at the lowest drug concentration tested (100 nM) for TNFα and IL-6 and at 300 nM for MCP1; in the case of IL-8, more than 50% inhibition of chemokine release was attained by 300 nM of drug, although this did not achieve statistical significance due to high variation in the Tat-only control samples (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Similar findings were observed in human monocyte-derived macrophages (MDM, data not shown) with the most potent inhibition of our inhibitors against MCP-1 and TNF-α release from MDM.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of HIV Tat stimulated cytokine release in human monocytes with compound <b>1</b> at 100, 300, and 1000 nM concentrations (NT = no treatment).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> In Vivo Inhibition of HIV-1 Tat Induced JNK Signaling with Compound <b>1</b></h4><div class="NLM_p">HIV-1 Tat activates JNK in neurons and other cell types, via an MLK-dependent pathway.<a onclick="showRef(event, 'ref14 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref14 ref41 ref42 ref43 ref44">(14, 41-44)</a> JNKs are major regulators of mammalian apoptotic cell death pathways and have also been proposed to have an important role in neurodegeneration.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> However, direct inhibition of JNK may not be an acceptable strategy for disease modification because the role of JNK in cell death is so ubiquitous in different cell types, tissues, and organs. Further, there is significant JNK phosphorylation and activity in neurons from healthy brain tissue, indicating that JNK plays multiple roles in the healthy CNS. A selective strategy of interfering with HIV-induced signaling upstream of JNK, such as MLK signaling, may provide an opportunity to develop a more selective treatment for HAND with less risk of side effects and undesired toxicity as well as a potential treatment for other neurodegenerative diseases.</div><div class="NLM_p">To verify in vivo inhibition of the HIV-1 Tat-induced JNK pathway activation by compound <b>1</b>, C57BL/6 mice were injected intracerebrally with saline or HIV Tat<sub>1–72</sub>, 700 μm deep in somatosensory cortex by stereotactic injection. This paradigm reproducibly results in sustained in vivo neuroinflammation after Tat injection.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Half of the mice received ip pretreatment/treatment with 10 mg/kg of compound <b>1</b>, every 12 h, which continued until sacrifice, with a total of three doses before Tat injection and two doses post injection while the other half were untreated (<i>n</i> = 3 for each of the four groups). Mice received the Tat injection at 4–6 h after the third ip injection of compound <b>1</b>. In separate single dose PK experiments, plasma levels measured at 4 h post injection of drug were 500 nM and brain levels were also at 500 nM. At 6 h post drug injection, plasma levels were at 275 nM and brain levels were at 233 nM. Mice were anesthetized and sacrificed 24 h after Tat injection. Levels of phosphorylated JNK (pJNK) were measured by Western blotting from whole brain lysates collected directly adjacent to the Tat injection site (the caudal medial quadrant of the left hemisphere). To control for variations in protein loading between experimental replicates, levels of pJNK were normalized to the expression of total α-tubulin (see Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). The untreated Tat exposed animals had a 75% increase in the levels of phosphorylated JNK compared to the saline control animals (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). Compound <b>1</b> treatment in the Tat exposed animals normalized phosphorylated JNK levels to those observed in saline controls (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B) (*, <i>p</i> < 0.05). We analyzed data depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A,B by one-way ANOVA with Newman–Keuls post hoc test. Error bars indicate SEM, but the compound had no effect on pJNK levels in saline-treated animals.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Intraperitoneal (ip) compound <b>1</b> treatment prevents HIV-1 Tat mediated increase in JNK phosphorylation in vivo in brain tissue ipsilateral to stereotactically injected Tat. (A) Immunoblots of the expression of pJNK and α-tubulin in brain tissue of mice stereotactically injected with saline (Sa) vehicle and no treatment or Sa+ systemic administration of <b>1</b> or stereotaxic injection of HIV-1 Tat and no treatment or stereotaxic injection of Tat with systemic administration of <b>1</b>. (B) Densitometric analyses of the optical density of bands in (A), normalized to the expression of α tubulin in each experimental replicate. * = <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Molecular Modeling Studies with Compound <b>1</b></h4><div class="NLM_p">Analysis of the potential binding modes of compound <b>1</b> were based on known SAR as well as crystal structures of similar 7-azaindole based inhibitors cocrystallized in kinase active sites. Docking studies of compound <b>1</b> in the MLK1 ATP binding site were performed using the automated docking utilities contained within the molecular modeling suite MOE<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> as well as manual dockings and minimizations, allowing complete flexibility of the protein and ligand (refer to Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). MLK1 is an excellent model for MLK3 binding, and <b>1</b> potently inhibits MLK1 (IC<sub>50</sub> = 19 nM). In aggregate, these analyses suggested that the compound is likely a type 1 kinase inhibitor forming two hydrogen bonds to the hinge. The indole is likely positioned so that it may make potential key interactions with neighboring lysine, aspartic acid, asparagine, or phenylalanine residues. In these models, the piperazine moiety interacts with a critical arginine residue and is also partially solvent exposed.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Potential binding site interactions analysis for MLK1 and compound <b>1</b> based on manual docking and minimization studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To the best of our knowledge, no X-ray crystal structure for MLK3 has yet been published. Cephalon has released an X-ray crystal structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DTC">3DTC</a>) of one of their inhibitors <b>6</b> cocrystallized in MLK1.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> All but one of the significant residues in the MLK1 ATP binding site are identical to MLK3 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Phe<sub>222</sub>, present in the hinge region of MLK1, is a tyrosine in MLK3, however, the side chain is outwardly facing and its impact is minimal on ligand binding. In our SAR studies, we observed that the pyrrolo NH and the pyridine nitrogen of the scaffold were required for potency. In addition, for the side chains, having an aromatic group such as an indole, aniline, or phenol was associated with high in vitro enzyme inhibition potency as they provided a hydrogen bond donor from the <i>para</i> position of an aromatic ring.</div><div class="NLM_p">In studying the sequences of related kinases, only MLK1, MLK3, and ZAP70 contained the Gly<sub>225</sub>-Gly<sub>226</sub>-Pro<sub>227</sub> motif, positioned at the top of the hinge, however 10 kinases contained a proline residue at the position equivalent to Pro<sub>227</sub>. One such kinase was spleen tyrosine kinase, SYK, which had been crystallized with the Rigel compound, R406.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In this structure, the 3,4,5-trimethoxyphenyl group extended into the solvent exposed region where it was observed to buttress the proline and also interact with a lysine residue in the equivalent position to Arg<sub>203</sub>. (MLK3 numbering) This group was recognized within our SAR in early compounds such as <b>7</b> and <b>8</b>, and it was proposed that a similar interaction could take place with this group extending into the solvent exposed region.</div><div class="NLM_p">The 7-azaindole scaffold, in recent years, has been demonstrated to be a privileged structure for forming interactions with the hinge region of ATP binding sites of several kinases, and these compounds are the subject of several patents and studies of binding fragments for several protein kinases including AKT1, IKKB, JAK3, SGK1, and ABL1 mutants.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> A binding mode analysis performed against kinase X-ray structures containing ligands with an azaindole scaffold revealed consistency with our binding mode hypothesis identified through docking studies with homology models and PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DTC">3DTC</a>.</div><div class="NLM_p">Of particular interest to us were 7-azaindole ligands bound in PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ETA">3ETA</a> (insulin-like growth factor-1 receptor (IGF-1R)) tyrosine kinase and 2Z60 (T315I mutant of ABL1), which exhibited a binding mode we had originally focused on from docking studies with homology models. In these structures, the pyrrolo hydrogen of the inhibitor donates a hydrogen bond to the carbonyl of the Hinge +1 residue, and the pyridine nitrogen accepts a hydrogen bond from the hinge +3 N–H moiety. 3-Position substituents would likely interact with Phe<sub>155</sub> in MLK1 and Asn<sub>273</sub>. 5-Position substituents on the 7-azaindole scaffold may interact with Arg<sub>230</sub> and may be largely solvent exposed, allowing the incorporation of solubilizing groups. This model is consistent with all structure–activity data.</div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> Protein Kinase Specificity</h5><div class="NLM_p">Previously, little protein kinase specificity data has been published for MLK3 inhibitors. Compound <b>3</b> is a fairly promiscuous inhibitor.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compound <b>4</b> was originally identified as a potent inhibitor of FLT3 or JAK isoforms but is also a fairly potent inhibitor of MLK kinases and a close analogue of <b>2</b>.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compound <b>6</b> was reported to be a potent inhibitor of MLK1 and a weak inhibitor of TrkA and Fyn.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Compound <b>1</b> (MLK<sub>3</sub> IC<sub>50</sub> = 14 nM) inhibits both MLK1 (IC<sub>50</sub> = 19 nM) as well as MLK2 (IC<sub>50</sub> = 42 nM) and the related MLK family member DLK (IC<sub>50</sub> = 150 nM), as expected from the analysis of the active sites of these enzymes.</div><div class="NLM_p">We initially utilized a screen of nine protein kinases to profile potential compounds (AMPK, CDK1, ERK2, GSK3B, LCK, P38a, SRK, SYK, JNK1, and ZAP70; see Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). In this panel of important diverse kinases from TK and AGC families, only LCK, a fairly promiscuous kinase, yielded an IC<sub>50</sub> potency below 500 nM. As interest in this compound progressed with uniformly superior activity in cellular and in vivo models of HAND, we began to explore reasons for the unique activity. Using a bioinformatics approach, we identified six kinases which have known high affinity for closely related azaindole structures for further screening of the inhibition profile of <b>1</b>. Two of these kinases had crystal structures of bound 7-azaindole inhibitors available to allow us to explore modeling of kinase specificity based on the observed subsite interactions.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. IC<sub>50</sub>s (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> Determined for Selected Protein Kinases for Compound <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub></th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMPK</td><td class="colsep0 rowsep0" align="left">1512</td><td class="colsep0 rowsep0" align="left">LCK</td><td class="colsep0 rowsep0" align="char" char=".">333</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AurA</td><td class="colsep0 rowsep0" align="left">108</td><td class="colsep0 rowsep0" align="left">MEKK2</td><td class="colsep0 rowsep0" align="char" char=".">661</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AurB</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">P38a</td><td class="colsep0 rowsep0" align="char" char=".">12050</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AurC</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">ROCK1</td><td class="colsep0 rowsep0" align="char" char=".">1030</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK1</td><td class="colsep0 rowsep0" align="left">1125</td><td class="colsep0 rowsep0" align="left">ROCK2</td><td class="colsep0 rowsep0" align="char" char=".">111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="left">1180</td><td class="colsep0 rowsep0" align="left">SGK</td><td class="colsep0 rowsep0" align="char" char=".">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c-MET</td><td class="colsep0 rowsep0" align="left">177</td><td class="colsep0 rowsep0" align="left">SGK1</td><td class="colsep0 rowsep0" align="char" char=".">201</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK2</td><td class="colsep0 rowsep0" align="left">6290</td><td class="colsep0 rowsep0" align="left">SRC</td><td class="colsep0 rowsep0" align="char" char=".">4330</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT1</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">SYK</td><td class="colsep0 rowsep0" align="char" char=".">731</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3B</td><td class="colsep0 rowsep0" align="left">>10,000</td><td class="colsep0 rowsep0" align="left">TRKA</td><td class="colsep0 rowsep0" align="char" char=".">85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IGF1R</td><td class="colsep0 rowsep0" align="left">307</td><td class="colsep0 rowsep0" align="left">TRKB</td><td class="colsep0 rowsep0" align="char" char=".">217</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IR</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">ZAP70</td><td class="colsep0 rowsep0" align="char" char=".">5050</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JNK1</td><td class="colsep0 rowsep0" align="left">3280</td><td class="colsep0 rowsep0" align="left">ABL1</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Average of two determinations (nanomolar). IC<sub>50</sub>s for various kinases in specificity screens were conducted by Reaction Biology, Inc. (Malvern, Pennsylvania) as described in ref <a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">51</a>.</p></div></div></div><div class="NLM_p">Although compound <b>1</b> had initially appeared fairly selective on the original screening panel, on these six selected kinases compound <b>1</b> exhibited significant potency for several of the kinases in these biochemical assays for inhibition of phosphorylation of substrates (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). We expanded our investigation of specificity using the binding kinome scan ScanMax assay from DiscoverRx (originally conducted at Ambit Biosciences), so comparison could be made with compounds described in the literature.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. IC<sub>50</sub> Values<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> for Kinase Panel Selected by Bioinformatics Analysis of Kinase Ligands</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">compounds</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase/assay</th><th class="colsep0 rowsep0" align="center" char="."><b>1</b></th><th class="colsep0 rowsep0" align="center" char="."><b>13</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ABL1 (T315I)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">285</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="char" char=".">1180</td><td class="colsep0 rowsep0" align="char" char=".">720</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT3</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IKKa</td><td class="colsep0 rowsep0" align="char" char=".">591</td><td class="colsep0 rowsep0" align="char" char=".">330</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IKKb</td><td class="colsep0 rowsep0" align="char" char=".">257</td><td class="colsep0 rowsep0" align="char" char=".">288</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IR</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">1290</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT3(MEF Cells)</td><td class="colsep0 rowsep0" align="char" char=".">560</td><td class="colsep0 rowsep0" align="char" char=".">730</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Average of two determinations (nanomolar). IC<sub>50</sub>s for various kinases in specificity screens were conducted by Reaction Biology, Inc. (Malvern, Pennsylvania) as described in ref <a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">51</a>. MEF cell experiments described in <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div><div class="NLM_p">In this assay, compound <b>1</b> was screened against a panel of 442 kinases and showed greater than 90% inhibition against 111 wild-type human protein kinases at 1 μM (data in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>). The ScanMax assay from DiscoverRx<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> is widely used to compare kinase inhibitor specificity based on extrapolated kinase/inhibitor binding and to produce thermodynamic binding constants, <i>K</i><sub>d</sub>. The assay measures the ability of significantly modified kinases to bind to a solid support immobilized ligand and utilizes conditions not present in living cells, such as the absence of ATP. To confirm the results obtained with this assay, we therefore also conducted a scan of 342 human wild-type kinases for inhibition of substrate phosphorylation using a high throughput ATP-P<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> radiolabeled assay from Reaction Biology Corp. at a dose of 1 μM in the presence of 10 μM ATP (data in <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> We followed up with individual radioligand binding data for ATP uptake to determine IC<sub>50</sub> values for some of the more interesting kinases (see Tables <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). In the ScanMax binding format assay, at a concentration of 1 μM, compound <b>1</b> exhibited greater than 50% inhibition of binding for 265 kinases and showed greater than 99% inhibition of binding for 36 kinases. In the Reaction Biology format in a screen of 342 human wild-type kinases, compound <b>1</b> exhibited 50% or greater inhibition of 202 kinases, with 15 showing greater than 99% inhibition (see <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p last">A large number of kinases showed very significant affinity for compound <b>1</b> in the ScanMax binding assay. These included the following important kinases that showed >90% inhibition at 1 μM: ABL1, CDK11, CDK4, CDKL2, CLK1, CLK2, CLK4, DYRK1B, FLT3, KIT, MELK, PDGFRB, SRPK2, ALK, ARK5, AXL, IKKalpha, IKKbeta, ROCK1, TYK2. Additionally, several kinases that are potential targets for antineurodegenerative kinase inhibitor programs showed substantial inhibition: DLK (88%, <i>K</i><sub>d</sub> = 70 nM, IC<sub>50</sub> = 150 nM), LRRK2 (92%, IC<sub>50</sub> = 11 nM), LRRK2 (G2019S mutant, 96%), MARK1 (92%), MARK2 (49%), IGF1R (48%), and SGK1 (70%). Compound <b>1</b> is essentially inactive against two kinases known to interact with MLK3 (GSK3β IC<sub>50</sub> > 10 μM, as well as AKT1) and several other pathway-related or interesting kinases including AKT2, AKT3, ERK1, ERK2, p38 (all isoforms), BRAF, and EGFR. It is also noteworthy that <b>1</b> inhibited binding of JNK kinases potently in the ScanMax format, but that high JNK1, -2, and -3 activity was not confirmed in the biochemical assay measuring inhibition of substrate phosphorylation. For example, JNK1 showed 99% binding inhibition at 1 μM in the ScanMax assay, but the IC<sub>50</sub> for phosphorylation inhibition was 3.2 μM.</div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Comparison Kinome Scan of Compound <b>2</b></h5><div class="NLM_p">To define the specificity of <b>2</b> and to compare and contrast activity at potential control nodes for anti-inflammatory and neuroprotective pathways, we synthesized <b>2</b><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> as a standard and conducted kinase inhibition scans using the ScanMax assay to examine activity on 456 kinases, including most known human kinases and important mutants thereof. Compound <b>2</b> was characterized by <sup>1</sup>H NMR, LC-MS, and high-resolution mass spectrometry, and the activity was confirmed in enzyme inhibition assays. As expected, <b>2</b> was a very potent inhibitor of the three major MLK enzymes with IC<sub>50</sub>s (average of two determinations) for MLK3 = 6 nM, MLK2 = 2 nM, MLK1 < 1 nM (refer to <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a>, method B).</div><div class="NLM_p">In the ScanMax binding format assay, at a concentration of 1 μM, <b>2</b> exhibited greater than 50% inhibition of binding of 185 kinases and showed greater than 99% inhibition of binding of 28 kinases including LRRK2, FLT3, CAMK1D, KIT, MLK1, and Aurora kinases A and C (see Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a> and <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>). Overall, both compound <b>1</b> and <b>2</b> showed only modest kinase specificity with notable differences in selectivity. Compound <b>1</b> showed potent activity on the ABL1 family and important mutants, whereas <b>2</b> lacked potent activity in this family. In contrast, <b>2</b> showed high activity against certain CAMK family kinases, unlike compound <b>1</b>. Activity against CAMK2A (84% inhibition for 2) and CAMK2D (87% inhibition for <b>2</b>) is highly correlated with positive activity in micronucleus screening models for kinase induced chromosome damage, as are BRSK2 (94% inhibition) and AMPK-alpha2 (98% inhibition).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Unlike <b>1</b>, compound <b>2</b> also strongly interacted with a subset of AGC family kinases, inhibiting RSK1 and RSK4 and related kinases.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Percent inhibition profiles in the DiscoverRx ScanMax kinome scan for compounds <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Both compounds <b>1</b> and <b>2</b>, as well as other MLK3 inhibitors not reported here, strongly interact with members of the STE family kinases (MAP4K4, TNIK, and MINK) involved in MAPK pathways. Our working hypothesis is that the remarkable effects observed in in vivo efficacy studies<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> of <b>1</b> may be the result of compound <b>1</b> being a “selectively non-selective kinase inhibitor.” Indeed, recent strategies in kinase drug discovery now recognize that the most efficacious drugs modulate multiple kinase pathways, but a key issue remains in finding safe compounds with multiple activities.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Two kinases, FLT3 and LRRK2, are both very potently inhibited by both compounds <b>1</b> and <b>2</b> and seem potentially interesting with regard to off-target and neuroprotective effects.</div></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> FLT3 Inhibition</h5><div class="NLM_p">To date, every compound showing potent activity in our human monocyte assay for inhibition of cytokine induction by HIV-1 Tat have been potent inhibitors of FLT3 and MLK3. Moreover, a literature survey revealed that most previously described MLK3 inhibitors also potently inhibit FLT3 (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Kinase Inhibitors with High Affinity for MLK3 and FLT3<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase inhibitor</th><th class="colsep0 rowsep0" align="center" char=".">FLT3<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MLK3<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIBF-1120</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CEP-701</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EXEL-2880</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">340</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KW-2449</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">230</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pazopanib</td><td class="colsep0 rowsep0" align="char" char=".">1100</td><td class="colsep0 rowsep0" align="char" char=".">740</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PD-173955</td><td class="colsep0 rowsep0" align="char" char=".">150</td><td class="colsep0 rowsep0" align="char" char=".">550</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC-412</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R406</td><td class="colsep0 rowsep0" align="char" char=".">0.71</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Staurosporine</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAE-684</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">420</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VX-680</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">680</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">ScanMax Binding <i>K</i><sub>d</sub>, nM.</p></div></div></div><div class="NLM_p">FLT3 is a cytokine/growth factor receptor tyrosine kinase and is important for survival, proliferation, and differentiation of hematopoietic cells in bone marrow. Inhibitors of FLT3 are being developed for the treatment of acute myeloid leukemia (AML)<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and are also of interest for chronic neuroinflammatory and neurodegenerative conditions such as multiple sclerosis.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> It is therefore notable that all of the azaindole MLK3 inhibitors disclosed here exhibited significant FLT3 activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. IC<sub>50</sub> (Nanomolar) or Percent Inhibition at 1 μmol for FLT3 and LRRK2<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">FLT3</th><th class="colsep0 rowsep0" align="center">LRRK2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">88%</td><td class="colsep0 rowsep0" align="center">2970</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">4.0</td><td class="colsep0 rowsep0" align="center">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">98%</td><td class="colsep0 rowsep0" align="center">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">98%</td><td class="colsep0 rowsep0" align="center">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">99%</td><td class="colsep0 rowsep0" align="center">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">97%</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">98%</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">9.5</td><td class="colsep0 rowsep0" align="center">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Average of two determinations.</p></div></div></div><div class="NLM_p last">Global suppression of FLT3 is not expected to be benign, and potent FLT3 inhibitors such as compound <b>4</b> have caused suppression of platelet production.<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58, 59)</a> However, in practice it is difficult to achieve cellular and in vivo inhibition of FLT3. We explored the cellular activity of our inhibitors in a cell-based FLT3 phosphorylation assay, using a murine embryonal fibroblast (MEF) cell line that expresses a high level of exogenous full-length human FLT3-wt. Stimulation of these cells with human FLT3-ligand results in FLT3 autophosphorylation. The IC<sub>50</sub> for compound <b>1</b> against purified FLT3 was 4 nM, but in this cell-based assay, compound <b>1</b>’s IC<sub>50</sub> against FLT3 was 140-fold less (560 nM). The activity of compound <b>13</b> was similar (730 nM). These findings suggest that our azaindole MLK3 inhibitors exhibit only modest levels of activity against FLT3 in cells and that FLT3 inhibition may not make a dominant contribution to the in vivo efficacy of compound <b>1</b>.</div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> LRRK2 Inhibition</h4><div class="NLM_p">Leucine-rich repeat kinase 2 (LRRK2) represents another interesting kinase implicated in neurodegenerative and inflammatory diseases, including familial Parkinson’s disease (which has been associated with the G2019S mutation in LRRK2) and Crohn’s disease.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> LRRK2 is potently inhibited by compound <b>1</b> (IC<sub>50</sub> = 11 nM), and <b>2</b> also showed 100% inhibition of LRRK2 binding and 98% inhibition of the LRRK2 (G2019S) mutant binding in the ScanMax assay at a concentration of 1 μM.</div><div class="NLM_p">Interestingly, exposure of murine BV2 microglial cells to HIV-1 Tat results in phosphorylation of serine 935 on LRRK2 as well as release of pro-inflammatory cytokines and an increase in phagocytic activity. LRRK2 kinase inhibition attenuated Tat-induced cytokine release and phagocytosis, suggesting that LRRK2 may be a novel regulator of microglial inflammation in HAND.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_p">The role that kinases other than MLK3 play in the potent in vivo and in vitro activity of compound <b>1</b> in models of HAND is the subject of current investigation. Our hypothesis is that strong neuroprotective and antineuroinflammatory efficacy of compound <b>1</b> in our in vivo models for HAND are attributable to its ability to safely interfere with multiple kinase pathways that act cooperatively (or synergistically) to drive the pathogenesis of HAND. This has important implications for our understanding of HAND and suggests that cooperative kinase-regulated gene networks may play a critical and previously underappreciated role in this disease.</div><div class="NLM_p last">The knowledge we have gained from the structure–activity relationships and requirements for metabolic stability and blood–brain barrier penetration have allowed us to design second-generation compounds not based on the 7-azaindole core that are much more selective for MLK3 and are potently neuroprotective in rodent cells, but the details of biological activity deviate surprisingly from those exhibited by <b>2</b> and compound <b>1</b>; the details of these studies will be published in due course.</div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Using potent and drug-like screening hits as a starting point, we employed a strategy to find CNS penetrant compounds based on low molecular weight, low polar surface area, limited number of hydrogen bond donors, and well-defined log <i>D</i>. By doing so, we identified a potent, orally bioavailable MLK3 inhibitor with excellent pharmacokinetic properties and improved CNS penetration over previously developed MLK3 inhibitors. This compound has excellent activity in preclinical models for HIV associated neurocognitive disease<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and is undergoing safety testing for potential development. Compound <b>1</b> potently inhibits several key kinases involved in multiple inflammatory and neurodegenerative pathways, including MLK3 and LRRK2, and is likely a ”selectively nonselective” kinase inhibitor which modulates cooperative kinase-regulated gene networks involved in the pathogenesis of HAND.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds were efficiently synthesized using sequential Suzuki couplings utilizing key intermediate <b>16</b>. For routine synthesis of diverse analogues, best yields and purity were obtained by protecting the azaindole nitrogen as a tosyl group. The synthesis of compound <b>1</b> is illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. 5-Bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine <b>14</b> was iodinated with NIS to afford <b>15</b>. The N–H was protected using TsCl, and the resulting tosylate <b>16</b> was subjected to regioselective Suzuki coupling reaction using indole-5-boronic acid at room temperature to yield intermediate <b>17</b>. The second Suzuki coupling with 4-formyl boronic acid with intermediate <b>17</b> gave the benzaldehyde <b>18</b>. Reductive amination reaction with 1-methyl piperazine followed by hydrolysis of the tosyl group resulted in the desired product <b>1</b> in an overall efficient synthesis. Compounds <b>8</b>, <b>9</b>, <b>10</b>, <b>11</b>, and <b>12</b> were produced using the same synthetic approach.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NIS, acetone; (b) NaH, <i>p</i>-TSA, THF; (c) indole-5-boronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, MeCN, aq 2 M Na<sub>2</sub>CO<sub>3</sub>; (d) 4-formylphenyl boronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, MeCN, aq 2 M Na<sub>2</sub>CO<sub>3</sub>; (e) 1-methylpiperazine, Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>; (f) aq 5N NaOH, CH<sub>2</sub>Cl<sub>2</sub>, acetone.</p></p></figure><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 7-azaindole-5-boronic acid pinacol ester, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, MeCN, aq 1 M Na<sub>2</sub>CO<sub>3</sub>; (b) NaH, <i>p</i>-toluene sulfonyl chloride, DMF; (c) 4-formylphenyl boronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, MeCN, aq 1 M Na<sub>2</sub>CO<sub>3</sub>; (d) 1-methyl piperazine, Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>; (e) NaOH, MeOH.</p></p></figure><div class="NLM_p">Synthesis of compound <b>13</b> proceeded by similar sequential Suzuki couplings but required the protection of the side chain azaindole nitrogen to achieve best yields and purity (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Suzuki coupling intermediate <b>16</b> with 7-aza-1<i>H</i>-indol-5-ylboronic acid provided <b>20</b>, which was then tosylated to yield <b>21</b>. The second Suzuki coupling produced intermediate aldehyde <b>22</b>, which was reductively aminated and deprotected to yield compound <b>13</b>.</div><div id="sec2_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Resynthesis of Screening Hit <b>7</b></h3><div class="NLM_p">Aminopyrazine <b>24</b> was brominated with NBS, and the resulting dibromo compound <b>25</b> underwent regioselective substitution with 5-aminoindole. Cyclization of <b>26</b> was accomplished by heating with carbonyl diimidazole. Suzuki coupling of <b>27</b>, using standard conditions with the 3,4,5-trimethoxy substituted boronic acid, provided compound <b>7</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Screening Hit <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (b) EtOH, DIEA, 80 °C; (c) CDI, THF, 65 °C; (d) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CH<sub>3</sub>CN, H<sub>2</sub>O, 150 °C.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The structures of compounds synthesized in the examples below were confirmed using the following procedures. LC-MS/UV/ELS analysis was performed on instrumentation consisting of Shimadzu LC-10AD vp series HPLC pumps and dual wavelength UV detector, a Gilson 215 autosampler, a Sedex 75c evaporative light scattering (ELS) detector, and a PE/Sciex API 150EX mass spectrometer. Then 5.0 μL injections were performed for each sample on a Phenomenex Gemini 5 μm C18 column. Mobile phases consisted of 0.05% formic acid in both HPLC grade water (A) and HPLC grade acetonitrile (B). Then 5.0 μL injections were performed for each sample, using gradient elution from 5% B to 100% B in 4 min at a flow rate of 2.0 mL/min with a final hold at 100% B of 1.8 min. UV (220 and 254 nm) and ELS data was collected for 4.5 min. All final compounds exhibited >95% purity. Routine one-dimensional NMR spectroscopy was performed on a 300 MHz Varian Mercury-Plus spectrometer. The samples were dissolved in deuterated solvents obtained from Cambridge Isotope Laboratories, Inc. and transferred to 5 mm ID NMR tubes. The spectra were acquired at 293 K. C, H, N, Pd combustion analysis provided by Robertson Mircrolit Laboratories, and high resolution mass spectra were obtained by the UCSD Department of Chemistry Agilent 6230 ESI-TOF mass spectrometer service.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-(1<i>H</i>-Indol-5-yl)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>1</b>)</h3><div class="NLM_p last">In a round-bottom flask, <b>19</b> (12.4 g, 21.5 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (105 mL) and MeOH (105 mL), then 5N NaOH (210 mL) added. The resulting mixture was heated at 50 °C for 60 min. After completion of the reaction, the product was extracted using EtOAc and purified on silica gel chromatography. After the purification, all combined batches were again dissolved in DCM (250 mL), MeOH (250 mL), and THF (250 mL) and added quadra pure TU thiourea resin (10 g) and stirred overnight on rotary evaporator. After filtration, the solvents were removed and redissolved in EtOH (450 mL) then heated to 55 °C. After 2 h, HPLC grade water was added and the resulting mixture kept in a freezer to afford white solid was collected by filtration to afford 3-(1<i>H</i>-indol-5-yl)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine <b>1</b> (6.4 g, 70%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.82 (bs, 1H), 11.07 (bs, 1H), 8.54 (d, <i>J</i> = 1.2 Hz, 1H), 8.41 (d, <i>J</i> = 1.2 Hz, 1H), 7.89 (s, 1H), 7.76 (d, <i>J</i> = 1.5 Hz, 1H), 7.69 (d, <i>J</i> = 5.1 Hz, 2H), 7.48 (m, 2H), 7.39 (d, <i>J</i> = 4.8 Hz, 2H), 7.35 (m, 1H), 6.49 (dd, <i>J</i> = 2.7, 1.2 Hz, 1H), 3.48 (s, 2H), 2.50 (m, 3H), 2.38 (m, 5H). ESI (<i>m</i>/<i>z</i>) 422 (M + H), calcd 421. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>28</sub>N<sub>5</sub> (M + H)<sup>+</sup> 422.2341, found 423.2329. CHN.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (9<i>S</i>,10<i>R</i>,12<i>R</i>)-9,12-Epoxy-1<i>H</i>-diindolo[1,2,3-<i>fg</i>:3′,2′,1′-<i>kl</i>]pyrrolo[3,4-<i>i</i>][1,6]benzodiazocine-10-carboxylic Acid, 5,16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo Methyl Ester (<b>2</b>)</h3><div class="NLM_p last"><b>2</b> was synthesized from K252a (LC Laboratories, Woburn, MA) according to the method of Kaneko.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 9.13 (s, 1H), 8.63 (s, 1H), 7.95 (s, 1H), 7.88 (d, <i>J</i> = 5.1 Hz, 1H), 7.84 (d, <i>J</i> = 5.1 Hz, 1H), 7.46–7.44 (m, 2H), 7.10 (dd, <i>J</i> = 3.0, 4.2 Hz, 1H), 6.33 (s, 1H), 5.02 (d, <i>J</i> = 10.2 Hz, 1H), 4.95 (d, <i>J</i> = 10.2 Hz, 1H), 3.98 (s, 2H), 3.94 (s, 2H), 3.92 (s, 3H), 3.38–3.35 (m, 1H), 2.50–2.46 (m, 4H), 2.13 (s, 3H), 1.99 (dd, <i>J</i> = 3.0, 8.4 Hz, 1H), 1.23 (t, <i>J</i> = 2.4 Hz, 6H). MS ESI (<i>m</i>/<i>z</i>): 616.3 (M + H)<sup>+</sup>, calcd 616.2. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>33</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>Na (M + Na)<sup>+</sup> 638.1754, found 638.1755.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(1<i>H</i>-Indol-5-yl)-6-(3,4,5-trimethoxyphenyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyrazin-2(3<i>H</i>)-one (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>24</b> (27 mg, 0.08 mmol) in CH<sub>3</sub>CN (1 mL) in a Personal Chemistry microwave reaction vial was added 3,4,5-trimethoxyphenylboronic acid (17 mg, 0.08 mmol), bis(triphenylphosphine)-palladium(II) dichloride (6.0 mg, 0.008 mmol), and 1 M Na<sub>2</sub>CO<sub>3</sub> (1 mL). The resulting mixture was degassed with Ar for 10 min, after which it was heated at 150 °C for 10 min in a Personal Chemistry Optimizer. The organic layer was separated, filtered, and concentrated in vacuo. The residue was purified by preparatory HPLC to yield <b>7</b> (6.5 mg, 19%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 12.18 (s, 1H), 11.28 (s, 1H), 8.57 (s, 1H), 7.83 (d, <i>J</i> = 1.8 Hz, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 7.42 (m, 1H), 7.37 (dd, <i>J</i> = 1.8, 8.4 Hz, 1H), 7.20 (s, 2H), 6.51 (m, 1H), 3.78 (s, 6H), 3.66 (s, 3H). HPLC retention time: 2.30 min. HR-MS (ESI-TOFMS) 418.1511 (M + H), calcd 418.1511.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-(1<i>H</i>-Indol-5-yl)-5-(3,4,5-trimethoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>8</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.78 (s, 1H), 11.03 (s, 1 H), 8.51 (d, <i>J</i> = 2.1 Hz, 1H), 8.36 (d, <i>J</i> = 1.8 Hz, 1H), 7.86 (s, 1H), 7.72 (d, <i>J</i> = 2.4 Hz, 1H), 7.45 (s, 2H), 7.32 (m, 1H), 6.92 (s, 2H), 6.45 (m, 1 H), 3.85 (s, 6H), 3.70 (s, 3H). MS ESI (<i>m</i>/<i>z</i>): 400.4 (M + H)<sup>+</sup>, calcd 399. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>Na (M + Na)<sup>+</sup> 422.1475, found 422.1476.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-(3-(1<i>H</i>-Indol-5-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)pyridin-2-amine (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.73 (d, <i>J</i> = 1.8 Hz, 1H), 11.05 (s, 1 H), 8.43 (d, <i>J</i> = 2.4 Hz, 1H), 8.29 (d, <i>J</i> = 1.8 Hz, 1H), 8.27 (d, <i>J</i> = 2.1 Hz, 1H), 7.88 (s, 1H), 7.76 (dd, <i>J</i> = 2.4, 8.4 Hz, 1H), 7.46 (s, 2H), 7.33 (m, 1H), 6.55 (dd, <i>J</i> = 0.6, 8.7 Hz, 1H), 6.46 (m, 1 H), 5.99 (s, 2 H). HPLC retention time: 1.10 min. MS ESI (<i>m</i>/<i>z</i>): 326.2 (M + H)<sup>+</sup>, calcd 325. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>16</sub>N<sub>5</sub> (M + H)<sup>+</sup> 326.1400, found 326.1401.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-(5-(3,4,5-Trimethoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)pyridin-2-amine (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.82 (s, 1H), 8.53 (d, <i>J</i> = 1.8 Hz, 1H), 8.31 (d, <i>J</i> = 1.8, 1 H), 8.28 (d, <i>J</i> = 1.5 Hz), 7.76 (dd, <i>J</i> = 2.1, 8.4 Hz, 1 H), 7.70 (d, <i>J</i> = 2.4 Hz, 1H), 6.95 (s, 2H), 6.54 (d, <i>J</i> = 8.4 Hz, 1 H), 5.87 (s, 2H), 3.86 (s, 6H), 3.68 (s, 3H). MS ESI (<i>m</i>/<i>z</i>): 377.4 (M + H), calcd 376. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>21</sub>N<sub>4</sub>O<sub>3</sub> (M + H)<sup>+</sup> 377.1608, found 377.1607.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-(3-(1<i>H</i>-Indol-5-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)pyrimidin-2-amine (<b>11</b>)</h3><div class="NLM_p last">MS ESI (<i>m</i>/<i>z</i>): 327.2 (M + H), calcd 326. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>15</sub>N<sub>6</sub> (M + H)<sup>+</sup> 327.1353, found 327.1354.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-(5-(3,4,5-Trimethoxyphenyl)-1<i>H</i>-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine (<b>12</b>)</h3><div class="NLM_p last">MS ESI (<i>m</i>/<i>z</i>): 378.4 (M + H), calcd 377. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup> 378.1561, found 378.1563.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-(5-(4-((4-Methylpiperazin-1-yl)methyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>13</b>)</h3><div class="NLM_p last">To a solution of <b>23</b> (4.00 g, 5.46 mmol) in MeOH (20 mL) was added NaOH (723 mg, 16.4 mmol). The resulting mixture was heated at 50 °C for 60 min. After completion of the reaction, the product was extracted using 250 mL of IPA:CHCl<sub>3</sub> (1:3) and water. The organic portions were dried and concentrated in vacuo. The crude product was purified on a silica gel column to afford <b>13</b> (1.57 g, 68%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.96 (s, 1H), 11.63 (s, 1H), 8.61 (d, <i>J</i> = 1.5 Hz, 1H), 8.56 (d, <i>J</i> = 1.2 Hz, 1H), 8.41 (d, <i>J</i> = 0.9 Hz, 1H), 8.31 (d, <i>J</i> = 1.2 Hz, 1H), 7.89 (d, <i>J</i> = 1.5 Hz, 1H), 7.73 (d, <i>J</i> = 4.8 Hz, 2H), 7.49–7.48 (m, 1H), 7.40 (d, <i>J</i> = 4.8 Hz, 2H), 6.51–6.49 (m, 1H), 3.49 (s, 2H), 2.38–2.36 (m, 4H), 2.21 (s, 3H). ESI (<i>m</i>/<i>z</i>) 423.4 (M + H)<sup>+</sup>, calcd 422. HRMS (EI) <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>27</sub>N<sub>6</sub> (M + H)<sup>+</sup> 423.2292, found 423.2295.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-Bromo-3-iodo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>15</b>)</h3><div class="NLM_p last">In a 3 L round-bottom flask, 5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (63g, 319 mmol) was dissolved in 1500 mL of acetone. To the stirred mixture was added NIS (79.1g, 351 mmol), and the resulting mixture was stirred for 1.5 h; the precipitated solid was collected by filtration and washed with cold acetone (400 mL) to afford <b>15</b> (89.8 g, 88% yield) as white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 12.35 (bs, 1H), 8.31 (d, <i>J</i> = 1.5 Hz, 1H), 7.86 (dd, <i>J</i> = 1.2 Hz, 0.3 Hz, 1 H), 7.80 (d, <i>J</i> = 1.5 Hz, 1H). MS ESI (<i>m</i>/<i>z</i>): 322/324 (M + H)<sup>+</sup>, calcd 323.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-Bromo-3-iodo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>16</b>)</h3><div class="NLM_p last">To a stirred solution of <b>15</b> (45.0g, 139 mmol) in 700 mL of anhydrous THF cooled to 0 °C with an ice bath was added NaH [60% dispersion in mineral oil] (8.3 g, 208 mmol). The reaction mixture was stirred for 20 min at 0 °C, after which <i>p</i>-toluenesulfonyl chloride (29.1 g, 153 mmol) was added. The resulting mixture was stirred at 0 °C for 1.5 h, after confirmation of completion by LCMS and TLC, the reaction mixture was warmed to room temperature, evaporated to dryness, and quenched with water. The crude product was mixed with EtOAc (1000 mL) refluxed for 1 h, and then hexane (500 mL) was added to precipitate the product <b>16</b> (60 g, 90% yield) as a light-yellow powder. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 8.50 (d, <i>J</i> = 1.5 Hz, 1H), 8.21 (s, 1H), 8.00 (d, <i>J</i> = 4.8 Hz, 0.3 Hz, 2H), 7.98 (d, <i>J</i> = 1.5 Hz, 1H), 7.44 (dd, <i>J</i> = 4.8 Hz, 0.3 Hz, 2H), 2.34 (s, 3H). MS ESI (<i>m</i>/<i>z</i>): 477.0/479.0 (M + 1)<sup>+</sup>, calcd 477.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-Bromo-3-(1<i>H</i>-indol-5-yl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>17</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>16</b> (60 g, 125 mmol) and 1<i>H</i>-indol-5-ylboronic acid (22.2 g, 138 mmol) in CH<sub>3</sub>CN (625 mL) was added 1 M Na<sub>2</sub>CO<sub>3</sub> (312 mL) followed by bis(triphenylphosphine)palladium(II) dichloride (4.4 g, 6.2 mmol). The resulting mixture was stirred at room temperature for 1 h. After complete consumption of starting materials, the mixture was extracted with EtOAc and evaporated to dryness in vacuo, it was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), absorbed onto Celite, and dried. The residue was purified via silica gel chromatography using CH<sub>2</sub>Cl<sub>2</sub> as the eluent to obtain <b>17</b> (38.6 g, 65% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.21 (bs, 1H), 8.52 (d, <i>J</i> = 1.2 Hz, 1H), 8.47 (d, <i>J</i> = 1.5 Hz, 1H), 8.13 (s, 1H), 8.05 (d, <i>J</i> = 5.1 Hz, 2H), 7.92 (s, 1H), 7.51 (d, <i>J</i> = 4.8 Hz, 1H), 7.46 (dd, <i>J</i> = 5.1, 1.2 Hz, 1H), 7.43 (d, <i>J</i> = 5.1 Hz, 1H), 7.40 (dd, <i>J</i> = 3.9, 1.8 Hz, 2H), 6.52 (dd, <i>J</i> = 2.7, 1.2 Hz,1 H), 2.33 (s, 3H). MS ESI (<i>m</i>/<i>z</i>): 466.2/468.2 (M + H)<sup>+</sup>, calcd 466.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(3-(1<i>H</i>-Indol-5-yl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)benzaldehyde (<b>18</b>)</h3><div class="NLM_p last">To a solution of <b>17</b> (29.5 g, 63.3 mmol) in CH<sub>3</sub>CN (315 mL) in a round-bottom flask was added 4-formylphenylboronic acid (11.4 g, 76 mmol), bis(triphenylphosphine)-palladium(II) dichloride (4.4 g, 6.3 mmol), and 1 M Na<sub>2</sub>CO<sub>3</sub> (160 mL). The resulting mixture was heated to reflux for 2.5 h. The reaction was cooled to room temperature; the precipitated product was filtered and dried. The organic layer was extracted with EtOAc and washed with brine and evaporated to dryness to afford more crude material. The filtered solid and crude and material from evaporation were redissolved in CH<sub>2</sub>Cl<sub>2</sub>, absorbed on Celite, and purified via silica gel chromatography using CH<sub>2</sub>Cl<sub>2</sub> as the eluent to afford <b>18</b> (38.6 g, 65% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.21 (bs, 1H), 10.07 (s, 1H), 8.81 (d, <i>J</i> = 1.2 Hz, 1H), 8.53 (d, <i>J</i> = 1.2 Hz, 1H), 8.13 (s, 1H), 8.08 (d, <i>J</i> = 5.1 Hz, 2H), 8.02 (m, 5H), 7.53 (dd, <i>J</i> = 5.1 Hz, 2H), 7.45 (d, <i>J</i> = 5.1 Hz, 2H), 7.46 (dd, <i>J</i> = 3.0, 1.5 Hz, 1H), 6.52 (dd, <i>J</i> = 2.7, 1.2 Hz,1 H), 2.34 (s, 3H). MS ESI (<i>m</i>/<i>z</i>): 492 (M + H)<sup>+</sup>, calcd 491.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-(1-Tosyl-1<i>H</i>-indol-5-yl)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>19</b>)</h3><div class="NLM_p last">To a solution of <b>18</b> (22 g, 44.8 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (448 mL) was added 1-methylpiperazine (8.9 g, 89 mmol) and sodium triacetoxyborohydride (14.2 g, 67.2 mmol). The reaction mixture was stirred for 1 h at room temperature, after which it was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and brine. The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The crude product was purified on silica gel column to give <b>15</b> (17 g, 68% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.23 (bs, 1H), 8.70 (d, <i>J</i> = 1.2 Hz, 1H), 8.40 (d, <i>J</i> = 1.5 Hz, 1H), 8.09 (d, <i>J</i> = 0.9 Hz, 2H), 8.07 (s, 1H), 7. 98 (s, 1H), 7.71 (d, <i>J</i> = 5.1 Hz, 2H), 7.52 (s, 2H), 7.41 (m, 5H), 7.24 (d, <i>J</i> = 4.5 Hz, 1H), 7.16 (dd, <i>J</i> = 10.8, 4.5 Hz, 2H), 6.52 (dd, <i>J</i> = 2.7, 1.2 Hz, 1H), 3.53 (s, 2H), 2.57 (m, 3H), 2.34 (m, 5H) 2.29 (s, 3H). MS ESI (<i>m</i>/<i>z</i>): 576 (M + H)<sup>+</sup>, calcd 575.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-(5-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>20</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>16</b> (60 g, 125 mmol) and 7-aza-1<i>H</i>-indol-5-ylboronic acid (22.2 g, 138 mmol) in CH<sub>3</sub>CN (625 mL) was added 1 M Na<sub>2</sub>CO<sub>3</sub> (312 mL) followed by bis(triphenylphosphine)palladium(II) dichloride (4.4 g, 6.2 mmol). The resulting mixture was stirred at room temperature for 1 h. After complete consumption of starting materials, the mixture was extracted with EtOAc and evaporated to dryness in vacuo and it was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (50 mL), absorbed onto Celite, and dried. The residue was purified via silica gel chromatography using CH<sub>2</sub>Cl<sub>2</sub> as the eluent to obtain <b>20</b> (38.6 g, 65% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 11.21 (bs, 1H), 8.52 (d, <i>J</i> = 1.2 Hz, 1H), 8.47 (d, <i>J</i> = 1.5 Hz, 1H), 8.13 (s, 1H), 8.05 (d, <i>J</i> = 5.1 Hz, 2H), 7.92 (s, 1H), 7.51 (d, <i>J</i> = 4.8 Hz, 1H), 7.46 (dd, <i>J</i> = 5.1, 1.2 Hz, 1H), 7.43 (d, <i>J</i> = 5.1 Hz, 1H), 7.40 (dd, <i>J</i> = 3.9, 1.8 Hz, 2H), 6.52 (dd, <i>J</i> = 2.7, 1.2 Hz,1 H), 2.33 (s, 3H). MS ESI (<i>m</i>/<i>z</i>): 466.2/468.2 (M + H)<sup>+</sup>, calcd 466.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-(5-Bromo-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>21</b>)</h3><div class="NLM_p last">To a stirred solution of <b>20</b> (1.01 g, 2.17 mmol) in 20 mL of anhydrous DMF was added NaH [60% dispersion in mineral oil] (130 mg, 3.25 mmol). The reaction mixture was stirred for 20 min at room temperature, after which <i>p</i>-toluene sulfonyl chloride (538 mg, 2.82 mmol) was added. The resulting mixture was stirred at room temperature for 2 h. The mixture was evaporated to dryness and quenched with water. The crude product was mixed with EtOAc (100 mL) and extracted. The organic solution was dried and evaporated in vacuo. The residue was purified via silica gel chromatography eluting with 20% EtOAc in hexanes to obtain <b>21</b> as a white solid (1.21 g, 90%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz) δ 8.76 (d, <i>J</i> = 1.2 Hz, 1H), 8.56 (d, <i>J</i> = 1.2 Hz, 1H), 8.54 (d, <i>J</i> = 1.2 Hz, 1H), 8.45 (d, <i>J</i> = 1.5 Hz, 1H), 8.39 (s, 1H), 8.04 – 8.01 (m, 4H), 7.96 (d, <i>J</i> = 2.4 Hz, 1H), 7.43 (d, <i>J</i> = 4.5 Hz, 4H), 6.87 (d, <i>J</i> = 2.4 Hz, 1H), 2.34 (s, 6H). MS ESI (<i>m</i>/<i>z</i>): 622.4/624.1 (M + 1)<sup>+</sup>, calcd 621.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 4-(1-Tosyl-3-(1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)benzaldehyde (<b>22</b>),</h3><div class="NLM_p last">To a solution of <b>21</b> (1.32 g, 2.12 mmol) in CH<sub>3</sub>CN (20 mL) in a round-bottom flask was added 4-formylphenylboronic acid (349 mg, 2.33 mmol), bis(triphenylphosphine)-palladium(II) dichloride (149 mg, 0.212 mmol), and 1 M Na<sub>2</sub>CO<sub>3</sub> (20 mL). The resulting mixture was heated to reflux for 3 h and then cooled to room temperature. The precipitated product was filtered and dried. The organic layer was extracted with EtOAc and washed with brine and evaporated to dryness to afford more crude material. The filtered solid and crude material from evaporation were redissolved in CH<sub>2</sub>Cl<sub>2</sub>, absorbed on Celite, and purified on silica gel column chromatography to yield <b>22</b> as a white solid (822 mg, 60% yield). MS ESI (<i>m</i>/<i>z</i>): 647.2 (M + H)<sup>+</sup>, calcd 646.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-(5-(4-((4-Methylpiperazin-1-yl)methyl)phenyl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)-1-tosyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>23</b>)</h3><div class="NLM_p last">To a solution of <b>22</b> (3.35 g, 5.18 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) was added 1-methylpiperazine (1.15 mL, 10.4 mmol) and sodium triacetoxyborohydride (2.19 g, 10.4 mmol). The reaction mixture was stirred for 1 h at room temperature, after which it was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and brine. The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The crude product was purified on silica gel column to afford <b>23</b> (2.65 g, 70% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 8.83 (d, <i>J</i> = 1.2 Hz, 1H), 8.71 (d, <i>J</i> = 1.2 Hz, 1H), 8.52 (d, <i>J</i> = 1.5 Hz, 1H), 8.44 (d, <i>J</i> = 1.2 Hz, 1H), 8.36 (s, 1H), 8.07 (d, <i>J</i> = 5.1 Hz, 2H), 8.02 (d, <i>J</i> = 5.1 Hz, 2H), 7.96 (d, <i>J</i> = 2.4 Hz, 1H), 7.71 (d, <i>J</i> = 4.8 Hz, 2H), 7.43 (d, <i>J</i> = 5.1 Hz, 4H), 7.38 (d, <i>J</i> = 4.8 Hz, 2H), 6.87 (d, <i>J</i> = 2.4 Hz, 1H), 3.48 (s, 2H), 2.40 – 2.25 (m, 8H), 2.14 (s, 3H). MS ESI (<i>m</i>/<i>z</i>): 731.4 (M + H)<sup>+</sup>, calcd 730.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3,5-Dibromopyrazin-2-amine (<b>25</b>)</h3><div class="NLM_p last">To a stirred solution of aminopyrazine <b>24</b> (8.21 g, 86.4 mmol) in anhydrous methylene chloride (215 mL) cooled to 0 °C was added <i>N</i>-bromosuccinimide (32.3 g, 181 mmol) in portions over a 6 h period, during which time the temperature of the reaction was kept below 0 °C. The resulting mixture was stored at 4 °C overnight, after which it was stirred vigorously and quenched with H<sub>2</sub>O (100 mL). The organic layer was separated, after which it was washed with saturated aqueous NaHCO<sub>3</sub>, washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated in vacuo to yield a residue that was triturated with 20% EtOAc in hexanes to yield <b>25</b> (10.3 g, 47%) as a yellow–brown powder. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz) δ 8.02 (s, 1H), 5.05 (bs, 2H). HPLC retention time: 1.99 min. MS ESI (<i>m</i>/<i>z</i>): 252.0/254.0/256.2 (M + 1)<sup>+</sup>, calcd 251.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 6-Bromo-<i>N</i><sup><i>2</i></sup>-(1<i>H</i>-indol-5-yl)pyrazine-2,3-diamine (<b>26</b>)</h3><div class="NLM_p last">To a stirred suspension of <b>25</b> (3.48 g, 13.7 mmol) and 1<i>H</i>-indol-5-amine (2.00 g, 15.0 mmol) in EtOH (3.5 mL) was added diisopropylethylamine (2.60 mL, 15.0 mmol). The resulting mixture was stirred for 48 h at 80 °C, after which it was partitioned between EtOAc and H<sub>2</sub>O. The organic layer was separated, after which it was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated in vacuo to yield a residue that was purified via silica gel chromatography eluting with 1:1 EtOAc:hexanes to yield <b>26</b> (1.75 g, 42%) as a red–brown solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 300 MHz): δ 10.98 (s, 1H), 8.22 (s, 1H), 7.83 (s, 1H), 7.31–7.28 (m, 3H), 7.19 (d, <i>J</i> = 8.7 Hz, 1H), 6.43 (s, 2H), 6.36 (s, 1H). HPLC retention time: 2.07 min. MS ESI (<i>m</i>/<i>z</i>): 304.2/306.2 (M + H)<sup>+</sup>, calcd 303.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 6-Bromo-1-(1<i>H</i>-indol-5-yl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyrazin-2(3<i>H</i>)-one (<b>27</b>)</h3><div class="NLM_p last">To a solution of <b>26</b> (0.450 g, 1.48 mmol) in THF (5 mL) was added carbonyldiimidazole (1.20 g, 7.40 mmol). The resulting mixture was heated at 65 °C for 48 h, after which it was concentrated in vacuo and partitioned between EtOAc and H<sub>2</sub>O. The organic layer was separated, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to yield a residue that was purified via silica gel chromatography eluting with EtOAc to yield <b>27</b> (0.20 g, 41%). HPLC retention time: 2.07 min. MS ESI (<i>m</i>/<i>z</i>): 330.2/332.2 (M + 1) <sup>+</sup>, calcd 329.</div></div><div id="sec3_21_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> LPS-Induced TNFα Release from Microglial BV2 Cells</h3><div class="NLM_p last">A TNFα release assay in LPS-stimulated BV-2 cells was performed essentially as described.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Briefly, mouse microglial BV-2 cells were treated with test compounds followed by LPS (100 ng/mL final concentration), and culture supernatants were harvested 8 h thereafter for TNFα ELISA.</div></div><div id="sec3_21_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Screening PK (iv Dosing) in Mice</h3><div class="NLM_p">Three mice were used for each time point. Male C57/BL/6 mice were dosed iv (10 mg/mL) by tail vein injection of a solution of 2 mg/mL in solutions containing the indicated compound and vehicles (compounds <b>1</b>, <b>9</b>, <b>10</b>, <b>11</b> and <b>13</b>, 5% DMSO, 40% PEG-400, 55% saline; compounds <b>8</b> and <b>12</b>, 5% DMSO, 40% PEG-400, 55% H<sub>2</sub>O containing 20% HP-βCD). Blood samples of approximately 0.30 μL were collected from each mouse (<i>n</i> = 3 mice per time point) by retro-orbital bleed while the animals were anesthetized with isoflurane. Blood samples were collected in tubes containing sodium heparin as the anticoagulant, predose and at 0.083, 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h postdose. Samples were centrifuged within 1 h of collection and plasma was collected and stored at −20 °C until analysis. Total concentrations of the compound were determined by liquid chromatography–tandem mass spectrometry (LC-MS/MS), following plasma protein precipitation with acetonitrile and injection of the supernatant onto the column (XTerraMS C18, 5 μm, 4.6 mm × 50 mm). The LC system comprised an Agilent (Agilent Technologies Inc., USA) 1100 series liquid chromatography equipped with G1379A degasser, G1311A Quantpump, G1313A autosampler, and G1316A column oven. Mass spectrometric analysis was performed using an API4000 (triple-quadrupole) instrument from AB Inc. (Canada) with an ESI interface.</div><div class="NLM_p last">The aqueous mobile phase was water with 0.1% formic acid, and the organic mobile phase was methanol with 0.1% formic acid. The lower and upper limits of quantitation of the assay were 2.5 and 5000 ng/mL based on known standards, respectively. Brains were collected from three different animals at each time point, rinsed with ice-cold saline, weighed, and stored at −80 °C until analysis. For compound quantitation, mouse brains were homogenized in 5 volumes of water. The homogenates were extracted by protein precipitation with acetonitrile. LC-MS/MS analysis was conducted as described for the plasma. Brain homogenate concentrations were converted to brain concentrations for the calculations of brain to plasma ratios.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Brain Penetration Comparison for Compounds <b>1</b>, <b>2</b>, and <b>13</b></h3><div class="NLM_p last">Compounds were dissolved in 5% DMSO, 40% PEG-400, and 55% saline to yield a nominal concentration of 2 mg/mL (pH = 8) and were dosed at 10 mg/kg in C57BL/6 mice by tail vein injection. Samples were collected as described above at 30, 60, and 180 min postdose. Mice were anesthetized, sacrificed and blood collected by retro-orbital bleeds, and brains collected (3 time points over 24 h, 3 mice per time point). Concentration of compounds was determined in plasma and brain samples as described above.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Detailed Oral PK Study for Compound <b>1</b> in C57/Bl/6 Mice</h3><div class="NLM_p">Intravenous dosing for %<i>F</i> determination: Male C57/BL/6 mice were dosed iv (2.5 mg/kg) by tail vein injection of a solution of 2 mg/mL of compound <b>1</b> dissolved in 5% DMSO, 40% PEG-400, and 55% saline. Blood samples of approximately 0.30 μL were collected from each mouse (<i>n</i> = 3 mice per time point) by retro-orbital bleed while the animals were anesthetized with isoflurane. Blood samples were collected in tubes containing sodium heparin as the anticoagulant, predose and at 0.083, 0.25, 0.5, 1, 2, 4, 7, and 24 h postdose. Samples were centrifuged within 1 h of collection and plasma was collected and stored at −80 °C until analysis.</div><div class="NLM_p">Oral Dosing for %<i>F</i> determination: Compound was dosed by oral gavage (10 mg/kg) as a suspension of 1 mg/mL of <b>1</b> in a solution of 0.5% hydroxypropyl methylcellulose and 0.4% Tween-80 in pH 7.4 PBS buffer. Blood samples were collected in tubes containing sodium heparin as the anticoagulant, predose and at 0.25, 0.5, 1, 2, 4 6, 8, and 24 h post dose. Total concentrations of the compound were determined by liquid chromatography–tandem mass spectrometry (LC-MS/MS) as described above.</div><div id="sec3_23_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Stability in Human Liver Microsomes</h4><div class="NLM_p last">Stability of the test compound was determined in human liver microsomes by Cerep Inc., using standard assay conditions of 1 μM concentration of the test compound. Compound concentration was determined by HPLC, and reported values are the average of duplicate values.</div></div><div id="sec3_23_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Stability in Hepatocytes</h4><div class="NLM_p last">Stability of the test compound was determined in cryopreserved human, cynomolgus monkey, and CD-1 mice hepatocytes, by Cerep Inc., using standard assay conditions of 1 μM concentration of the test compound. Compound concentration was determined by HPLC, and reported values are the average of tripicate values.</div></div><div id="sec3_23_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> CYP2C9, 2D6, and 3A4 Inhibition</h4><div class="NLM_p">Test compound was incubated with pooled human liver microsomes at 37 °C in 0.1 M Tris buffer, pH 7.4, and its effect on the metabolism of probe substrates for CYP enzymes determined (2D6, diclofenac; 3A4, dextromethorphan; 2C9, midazolam). The compound was tested at six concentrations ranging from 0.12 to 30 μM. Conditions of incubation in this assay have been optimized to maintain first-order reaction conditions and to minimize the potential for nonspecific binding of probe or study compound.</div><div class="NLM_p last">Reactions were terminated with acetonitrile containing analytical internal standard (carbamazepine), and samples were centrifuged to remove microsomal protein and analyzed using optimized HPLC and MS conditions. The MS responses for the solvent control samples were taken as the 100% reference values against which the inhibition of metabolism was measured. IC<sub>50</sub> values were calculated using a sigmoidal dose–response equation within GraphPad Prism.</div></div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Inhibition of HIV Tat-Induced Cytokine Release in Primary Human Monocytes</h3><div class="NLM_p">This assay was performed essentially as described.<a onclick="showRef(event, 'ref14 ref63'); return false;" href="javascript:void(0);" class="ref ref14 ref63">(14, 63)</a> Briefly, human monocytes were isolated from freshly collected whole blood using CD14 immunomagnetic beads (Miltenyi-Biotec), plated in 24-well plates and incubated with the specified compounds at the indicated concentrations (100, 3000, 1000 nM); in control wells, no compound was added. Then 30 min later, HIV-1 Tat was added to a final concentration of 50 nM; the cells were incubated for 8 h (in control wells, nothing was added [NT]). Cell supernatants were then collected, centrifuged to remove debris, transferred to new microcentrifuge tubes, and frozen at −20 °C. A Luminex bead array assay was then performed to quantitate the indicated chemokines and cytokines. Results were measured in triplicate or quadruplicate, and data are presented as mean values; error bars denote the standard deviation. Note that similar results were obtained with monocytes derived from multiple (<i>n</i> > 5) different donors, as well as in terminally differentiated monocyte-derived macrophages (data not shown). * = <i>p</i> < 0.05; one-way ANOVA with Bonferroni’s correction (when compared to Tat only control).</div><div id="sec3_24_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Inhibition of JNK Phosphorylation in HIV-Tat Treated Mice</h4><div class="NLM_p">Wild-type C57BL/6 mice were either pretreated with three doses of 10 mg/kg Compound 1 spaced 12 h apart (<i>n</i> = 6) or were left untreated (<i>n</i> = 6). Treatment with compound <b>1</b> continued every 12 h throughout the duration of the experiment. Half of the mice (three pretreated with compound <b>1</b>, three untreated) received a stereotactic injection of 3 μL of 3 μg/μL HIV-1 Tat<sub>1–72</sub> in PBS into the somatosensory cortex at the coordinates 1.0 mm posterior to Bregma, 1.0 mm lateral left of Bregma, and 0.7 mm ventral to the pial surface. The remaining mice received an injection of 3 μL of sterile PBS at the same coordinates. A 35 gauge needle with a 10 μL Hamilton syringe controlled by a microsyringe pump (Micro4 World Precision Instruments) was used to perform the injections, which were delivered at a flow rate of 80 nL/min to minimize brain injury occurring as a result of injection pressure. The needle and syringes were coated with Sigmacote (Sigma SL-2) to prevent the Tat from sticking to the inside of the syringe. Then 24 hours after injection, the mice were sacrificed by pentobarbital overdose; animals were then briefly transcardially perfused with ice-cold saline, and the brains were removed, sectioned, and flash frozen on dry ice.</div><div class="NLM_p last">The brain tissue of interest was homogenized in a glass homogenizer in a solution of 1X Tris-buffered saline pH 7.4 with 0.05% Tween and protease and phosphatase inhibitors (no. 161280; Thermo Fisher Scientific). The homogenate was spun down at 13000 rcf for 15 min to remove insoluble debris, and the lysis supernatant was collected. The protein concentrations were measured and normalized using a Bradford assay. Then 12 μg of protein sample was then mixed with loading dye, boiled for 5 min, and run on a 4% to 15% SDS-PAGE gel (BioRad 456–1086) at 100 V. The gel was transferred onto a nitrocellulose membrane at 100 V for 66 min on ice. The membranes were blocked in 5% milk in 1× Tris-buffered saline with 0.05% Tween (TBS-T) for 1 h at room temperature with shaking. The membranes were washed three times in TBS-T for 10 min a wash. The primary antibody against phosphorylated JNK (Cell Signaling 4668P) was applied overnight at 4 °C at a concentration of 1:2000 in TBS-T with 5% milk. The next day, the membranes were washed three times in TBS-T for 10 min a wash. The horseradish peroxidase (HRP)-conjugated secondary antibody (BioRad 170–6515) was applied at a concentration of 1:11000 in 5% milk TBS-T for 45 min at room temperature with shaking. The membranes were washed three times in TBS-T and enhanced chemiluminescence (ECL) substrate (Thermo 34076, Thermo 34080) was applied for 3 min. The membranes were developed on film (Thermo 34091). To control for variations in protein loading, the membranes were stripped (Millipore 2504) and then blocked in 5% milk TBS-T for 30 min. The mouse anti-α-tubulin (Sigma T5168) was applied in 5% milk TBS-T overnight with shaking. The process of washing, secondary application, and developing was repeated in order to obtain the α-tubulin loading control blot. The optical density measurements used for quantification were obtained using ImageJ. * = <i>p</i> < 0.05; one-way ANOVA with Bonferroni’s correction.</div></div><div id="sec3_24_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Discover RX ScanMax Kinome Binding Scan</h4><div class="NLM_p last">Compounds that bind the kinase active site directly (sterically) or indirectly (allosterically) prevent kinase binding to the immobilized ligand, and will reduce the amount of kinase captured on a solid support. Conversely, test molecules that do not bind the kinase have no effect on the amount of kinase captured on the solid support. Screening “hits” are identified by measuring the amount of kinase captured in test versus control samples by using a quantitative qPCR method that detects the associated DNA label to determine a <i>K</i><sub>d</sub> for ligand binding. Compounds <b>1</b> and <b>2</b> were tested at 1 μM concentration against a panel of 442 known protein kinases. Data are presented as percent of control activity remaining. (0% indicates very tight binders, 100% indicates no binding). Complete data are presented in the <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec3_24_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Reaction Biology Wild-Type Human Kinome Inhibition Scan</h4><div class="NLM_p last">Compound <b>1</b> was tested against 342 wild-type human kinases for inhibition of protein phosphorylation using the Reaction Biology Inc. Hot Spot P33 radio binding assay.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The compound was tested in single dose duplicate mode at a concentration of 1 μM . Control Compound was tested in 10 dose IC<sub>50</sub> mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out at 10 μM ATP. Complete data are available in the <a class="ref internalNav" href="#notes-4" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec3_24_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Kinase Specificity Inhibition Data</h4><div class="NLM_p last">Kinase inhibition IC<sub>50</sub> values were determined from 10 point curves. IC<sub>50</sub>s for various kinases in specificity screens were conducted by Reaction Biology, Inc. (Malvern, Pennsylvania) as described.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Radiometric Filter Plate MLK3 Assay (Method A)</h3><div class="NLM_p last">MLK3 (200 ng (130 nM), Dundee, DU8313) was incubated with 1 μM inactive MKK7b (Dundee, DU703) in the presence of 2 μM cold ATP (<i>K</i><sub>m</sub>) and 0.5 μCi/assay <sup>33</sup>P ATP and appropriate concentrations of compounds. After a 20 min incubation, the reactions were washed through filter plates and read on a scintillation counter.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Biochemical Assay for the Inhibition of Kinase Activity for MLK3 (Method B)</h3><div class="NLM_p last">Myelin basic protein (20 μM final concentration) was dissolved in 20 mM Hepes (pH 7.5) containing 10 μM MgCl<sub>2</sub>, 1 μM EGTA, 0.02% Brij35, 0.02 mg/mL BSA, 0.1 μM Na3VO4, 2 mM DTT, and 1% DMSO. Activated MLK3 was added and mixed (20 nM final concentration), and inhibitors were added in DMSO. <sup>33</sup>P-ATP (specific activity 500 μCi/μL) was delivered into the reaction mixture to initiate the reaction (ATP concentration: 10 μM), and the mixture was incubated at room temperature for 20 min. Percent Activity was determined using a proprietary HOTSPOT microfluidic filter binding technology.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div><div id="sec3_26_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> FLT3 Cellular Assay</h3><div class="NLM_p last">This was performed by Proqinase GMBH, Freiburg, Germany. Briefly, this assay uses a murine embryonal fibroblast (MEF) cell line, which expresses a high level of exogenously introduced full-length human, wild-type FLT3. Stimulation of these cells with human FLT3-ligand results in receptor tyrosine autophosphorylation. MEF-FLT3-wt cells were plated in DMEM supplemented with 10% FCS in multiwell cell culture plates. After serum-starvation overnight, cells were incubated with compounds in serum-free medium. After 90 min incubation at 37 °C, cells were stimulated with FLT3-L at 250 ng/mL for 5 min. Quantification of substrate phosphorylation was assessed in 96 well plates via sandwich ELISA using a substrate specific capture antibody and an antiphosphotyrosine detection antibody. Raw data were converted into percent substrate phosphorylation relative to controls (incubated with FLT3L alone), which were set to 100%. IC<sub>50</sub> values were determined using GraphPad Prism 5.01 software using a nonlinear regression curve fit with variable hill slope. The equation is a four-parameter logistic equation.</div></div><div id="sec3_26_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Plasma Protein Binding</h3><div class="NLM_p last">Protein binding in human plasma was assessed by performing equilibrium dialysis with plasma containing test compounds (10 μM) against 0.1 M PBS (pH 7.4). Following incubation (6 h at 37 °C), the parent compound was measured in both plasma and buffer compartments by LC-MS and the percentage of compound bound to plasma proteins determined. Test compounds (10 μM) were added to plasma (<i>n</i> = 2) and dialyzed against 0.1 M phosphate buffered saline (pH 7.4) for 6 h at 37 °C. After incubation, the contents of each plasma and buffer compartment were removed and mixed with equal volumes of control buffer or plasma as appropriate to maintain matrix equivalence for analysis. Plasma proteins were then precipitated by the addition of acetonitrile containing carbamazepine as analytical internal standard, centrifuged, and the supernatant removed for analysis by mass spectrometry (LC-MS/MS).</div></div><div id="sec3_26_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Molecular Modeling and Ligand Docking</h3><div class="NLM_p last">The <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DTC">3DTC</a>.PDB structure of MLK1 was used as a surrogate for MLK3 to evaluate the binding mode for the series. The compounds contained a conserved scaffold that was hand docked into MLK1 and protein and ligand were energy minimized using the molecular modeling suite MOE. It was hypothesized that the compounds acted as type 1 kinase inhibitor so the scaffold was positioned to ensure that the hydrogen bond donor and acceptor of the 7-azaindole core interacted with the corresponding contacts on the hinge. This provided two binding mode hypotheses for evaluation. The binding mode that fit the SAR data allowed the scaffold to donate and accept a hydrogen bond to and from Glu<sub>221</sub> and Ala<sub>223</sub>, respectively. This placed the side-chain indole group to the rear of the ATP site with the <i>N</i>-methyl-piperazine group positioned toward the solubilizing pocket.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70"><a href="/doi/suppl/10.1021/jm401094t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Kinase inhibition profiles for 442 kinases for compound <b>1</b> and <b>2</b> performed by DiscoverRx; inhibition profile using radio ligand binding assay for 342 wild-type human kinases performed by Reaction Biology Corp for compound <b>1</b>.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401094t/suppl_file/jm401094t_si_001.pdf">jm401094t_si_001.pdf (209.29 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401094t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Val S. Goodfellow</span> - <span class="hlFld-Affiliation affiliation">Califia Bio Inc., 11575
Sorrento Valley Road, San Diego 92121, California, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c5b3b6a2aaaaa1a3a0a9a9aab285a6a4a9aca3aca4a7acaaeba6aaa8"><span class="__cf_email__" data-cfemail="106663777f7f7476757c7c7f675073717c7976797172797f3e737f7d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colin J. Loweth</span> - <span class="hlFld-Affiliation affiliation">Califia Bio Inc., 11575
Sorrento Valley Road, San Diego 92121, California, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satheesh B. Ravula</span> - <span class="hlFld-Affiliation affiliation">Califia Bio Inc., 11575
Sorrento Valley Road, San Diego 92121, California, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Torsten Wiemann</span> - <span class="hlFld-Affiliation affiliation">Califia Bio Inc., 11575
Sorrento Valley Road, San Diego 92121, California, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thong Nguyen</span> - <span class="hlFld-Affiliation affiliation">Califia Bio Inc., 11575
Sorrento Valley Road, San Diego 92121, California, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Xu</span> - <span class="hlFld-Affiliation affiliation">Biofocus DPI, 9640 Towne Centre Drive, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel E. Todd</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden, Essex CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Sheppard</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden, Essex CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Pollack</span> - <span class="hlFld-Affiliation affiliation">BioFocus, Chesterford Research Park, Saffron Walden, Essex CB10 1XL, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oksana Polesskaya</span> - <span class="hlFld-Affiliation affiliation">University of Rochester Medical Center, School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel F. Marker</span> - <span class="hlFld-Affiliation affiliation">University of Rochester Medical Center, School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Dewhurst</span> - <span class="hlFld-Affiliation affiliation">University of Rochester Medical Center, School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harris A. Gelbard</span> - <span class="hlFld-Affiliation affiliation">University of Rochester Medical Center, School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York 14642, United
States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1159e4398-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank John Harris, John McCall, Angus MacLeod, and Sanjay B. Maggirwar for helpful guidance for this project and the National Institutes of Health for continuing funding of these efforts. This work was funded in part by grants from the National Institutes of Health, Division of Mental Health, NIH grant P01MH064570 (H.A.G., PI), and a Qualifying Therapeutic Discovery Project Grant to Califia Bio, Inc.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i77" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i77"> Abbreviations Used</h2><tr><td class="NLM_term">HAND</td><td class="NLM_def"><p class="first last">HIV-1-associated neurocognitive disorders</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">MLK</td><td class="NLM_def"><p class="first last">mixed lineage kinase</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">fms-related tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">MOE</td><td class="NLM_def"><p class="first last">Molecular Operating Environment</p></td></tr><tr><td class="NLM_term">NIS</td><td class="NLM_def"><p class="first last"><i>N</i>-iodosuccinimide</p></td></tr><tr><td class="NLM_term">MeCN, CH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">di-isopropylethylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">1,1′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">EtOAC</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">CH<sub>2</sub>CL<sub>2</sub>, DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 63 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Marker, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantz Marker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loweth, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muly, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodfellow, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">9998</span><span class="NLM_x">–</span> <span class="NLM_lpage">10010</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1523%2FJNEUROSCI.0598-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslKmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=9998-10010&author=D.+F.+Markerauthor=M.+E.+Tremblayauthor=J.+M.+Pucciniauthor=J.+Barbieriauthor=M.+A.+Gantz+Markerauthor=C.+J.+Lowethauthor=E.+C.+Mulyauthor=S.+M.+Luauthor=V.+S.+Goodfellowauthor=S.+Dewhurstauthor=H.+A.+Gelbard&title=The+new+small-molecule+mixed-lineage+kinase+3+inhibitor+URMC-099+is+neuroprotective+and+anti-inflammatory+in+models+of+human+immunodeficiency+virus-associated+neurocognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders</span></div><div class="casAuthors">Marker, Daniel F.; Tremblay, Marie-Eve; Puccini, Jenna M.; Barbieri, Justin; Marker, Mary A. Gantz; Loweth, Colin J.; Muly, E. Chris; Lu, Shao-Ming; Goodfellow, Val S.; Dewhurst, Stephen; Gelbard, Harris A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9998-10010</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV)-assocd. neurocognitive disorders (HAND) is a significant source of disability in the HIV-infected population.  Even with stringent adherence to anti-retroviral therapy, >50% of patients living with HIV-1 will develop HAND.  Because suppression of viral replication alone is not enough to stop HAND progression, there is a need for an adjunctive neuroprotective therapy in this population.  To this end, we have developed a small-mol. brain-penetrant inhibitor with activity against mixed-lineage kinase 3 (MLK3), named URMC-099.  MLK3 activation is assocd. with many of the pathol. hallmarks of HAND and therefore represents a prime target for adjunctive therapy based on small-mol. kinase inhibition.  Here we demonstrate the anti-inflammatory and neuroprotective effects of URMC-099 in multiple murine and rodent models of HAND.  In vitro, URMC-099 treatment reduced inflammatory cytokine prodn. by HIV-1 Tat-exposed microglia and prevented destruction and phagocytosis of cultured neuronal axons by these cells.  In vivo, URMC-099 treatment reduced inflammatory cytokine prodn., protected neuronal architecture, and altered the morphol. and ultrastructural response of microglia to HIV-1 Tat exposure.  In conclusion, these data provide compelling in vitro and in vivo evidence to investigate the utility of URMC-099 in other models of HAND with the goal of advancement to an adjunctive therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNCsZZAzOfCrVg90H21EOLACvtfcHk0liL13vszDP0xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslKmsrw%253D&md5=683f118425138b2ef7447e4a34c87636</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0598-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0598-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DMarker%26aufirst%3DD.%2BF.%26aulast%3DTremblay%26aufirst%3DM.%2BE.%26aulast%3DPuccini%26aufirst%3DJ.%2BM.%26aulast%3DBarbieri%26aufirst%3DJ.%26aulast%3DGantz%2BMarker%26aufirst%3DM.%2BA.%26aulast%3DLoweth%26aufirst%3DC.%2BJ.%26aulast%3DMuly%26aufirst%3DE.%2BC.%26aulast%3DLu%26aufirst%3DS.%2BM.%26aulast%3DGoodfellow%26aufirst%3DV.%2BS.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DThe%2520new%2520small-molecule%2520mixed-lineage%2520kinase%25203%2520inhibitor%2520URMC-099%2520is%2520neuroprotective%2520and%2520anti-inflammatory%2520in%2520models%2520of%2520human%2520immunodeficiency%2520virus-associated%2520neurocognitive%2520disorders%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D9998%26epage%3D10010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Heaton, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCutchan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letendre, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corkran, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, N. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifford, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mindt, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelman, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennema-Notestine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jernigan, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, I.</span><span> </span><span class="NLM_article-title">HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors</span> <span class="citation_source-journal">J NeuroVirol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1007%2Fs13365-010-0006-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=21174240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3-16&author=R.+K.+Heatonauthor=D.+R.+Franklinauthor=R.+J.+Ellisauthor=J.+A.+McCutchanauthor=S.+L.+Letendreauthor=S.+Leblancauthor=S.+H.+Corkranauthor=N.+A+Duarteauthor=D.+B.+Cliffordauthor=S.+P.+Woodsauthor=A.+C.+Collierauthor=C.+M.+Marraauthor=S.+Morgelloauthor=M.+R.+Mindtauthor=M.+J+Taylorauthor=T.+D.+Marcotteauthor=J.+H.+Atkinsonauthor=T.+Wolfsonauthor=B.+B.+Gelmanauthor=J.+C.+McArthurauthor=D.+M.+Simpsonauthor=I.+Abramsonauthor=A.+Gamstauthor=C.+Fennema-Notestineauthor=T.+L.+Jerniganauthor=J.+Wongauthor=I.+Grant&title=HIV-associated+neurocognitive+disorders+before+and+during+the+era+of+combination+antiretroviral+therapy%3A+differences+in+rates%2C+nature%2C+and+predictors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors</span></div><div class="casAuthors">Heaton, Robert K.; Franklin, Donald R.; Ellis, Ronald J.; McCutchan, J. Allen; Letendre, Scott L.; LeBlanc, Shannon; Corkran, Stephanie H.; Duarte, Nichole A.; Clifford, David B.; Woods, Steven P.; Collier, Ann C.; Marra, Christina M.; Morgello, Susan; Mindt, Monica Rivera; Taylor, Michael J.; Marcotte, Thomas D.; Atkinson, J. Hampton; Wolfson, Tanya; Gelman, Benjamin B.; McArthur, Justin C.; Simpson, David M.; Abramson, Ian; Gamst, Anthony; Fennema-Notestine, Christine; Jernigan, Terry L.; Wong, Joseph; Grant, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of NeuroVirology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-16</span>CODEN:
                <span class="NLM_cas:coden">JNVIFK</span>;
        ISSN:<span class="NLM_cas:issn">1355-0284</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and mortality with HIV infection, but high rates of HIV-assocd. neurocognitive disorders (HAND) continue to be reported.  Because large HIV-infected (HIV+) and uninfected (HIV-) groups have not been studied with similar methods in the pre-CART and CART eras, it is unclear whether CART has changed the prevalence, nature, and clin. correlates of HAND.  We used comparable methods of subject screening and assessments to classify neurocognitive impairment (NCI) in large groups of HIV + and HIV - participants from the pre-CART era (1988-1995; N = 857) and CART era (2000-2007; N = 937).  Impairment rate increased with successive disease stages (CDC stages A, B, and C) in both eras: 25, 42, and 52% in pre-CART era and 36, 40, and 45% in CART era.  In the medically asymptomatic stage (CDC-A), NCI was significantly more common in the CART era.  Low nadir CD4 predicted NCI in both eras, whereas degree of current immunosuppression, estd. duration of infection, and viral suppression in CSF (on treatment) were related to impairment only pre-CART.  Pattern of NCI also differed: pre-CART had more impairment in motor skills, cognitive speed, and verbal fluency, whereas CART era involved more memory (learning) and executive function impairment.  High rates of mild NCI persist at all stages of HIV infection, despite improved viral suppression and immune reconstitution with CART.  The consistent assocn. of NCI with nadir CD4 across eras suggests that earlier treatment to prevent severe immunosuppression may also help prevent HAND.  Clin. trials targeting HAND prevention should specifically examine timing of ART initiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonCaVzD1EKJrVg90H21EOLACvtfcHk0liL13vszDP0xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyrtb8%253D&md5=7e59a0c46d8b250b6b14c54ee9b34149</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs13365-010-0006-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13365-010-0006-1%26sid%3Dliteratum%253Aachs%26aulast%3DHeaton%26aufirst%3DR.%2BK.%26aulast%3DFranklin%26aufirst%3DD.%2BR.%26aulast%3DEllis%26aufirst%3DR.%2BJ.%26aulast%3DMcCutchan%26aufirst%3DJ.%2BA.%26aulast%3DLetendre%26aufirst%3DS.%2BL.%26aulast%3DLeblanc%26aufirst%3DS.%26aulast%3DCorkran%26aufirst%3DS.%2BH.%26aulast%3DDuarte%26aufirst%3DN.%2BA%26aulast%3DClifford%26aufirst%3DD.%2BB.%26aulast%3DWoods%26aufirst%3DS.%2BP.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DMarra%26aufirst%3DC.%2BM.%26aulast%3DMorgello%26aufirst%3DS.%26aulast%3DMindt%26aufirst%3DM.%2BR.%26aulast%3DTaylor%26aufirst%3DM.%2BJ%26aulast%3DMarcotte%26aufirst%3DT.%2BD.%26aulast%3DAtkinson%26aufirst%3DJ.%2BH.%26aulast%3DWolfson%26aufirst%3DT.%26aulast%3DGelman%26aufirst%3DB.%2BB.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DSimpson%26aufirst%3DD.%2BM.%26aulast%3DAbramson%26aufirst%3DI.%26aulast%3DGamst%26aufirst%3DA.%26aulast%3DFennema-Notestine%26aufirst%3DC.%26aulast%3DJernigan%26aufirst%3DT.%2BL.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DI.%26atitle%3DHIV-associated%2520neurocognitive%2520disorders%2520before%2520and%2520during%2520the%2520era%2520of%2520combination%2520antiretroviral%2520therapy%253A%2520differences%2520in%2520rates%252C%2520nature%252C%2520and%2520predictors%26jtitle%3DJ%2520NeuroVirol.%26date%3D2011%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiebala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polesskaya, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=392-398&author=H.+A.+Gelbardauthor=S.+Dewhurstauthor=S.+B.+Maggirwarauthor=M.+Kiebalaauthor=O.+Polesskayaauthor=H.+E.+Gendelman&title=Rebuilding+synaptic+architecture+in+HIV-1+associated+neurocognitive+disease%3A+a+therapeutic+strategy+based+on+modulation+of+mixed+lineage+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DKiebala%26aufirst%3DM.%26aulast%3DPolesskaya%26aufirst%3DO.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DRebuilding%2520synaptic%2520architecture%2520in%2520HIV-1%2520associated%2520neurocognitive%2520disease%253A%2520a%2520therapeutic%2520strategy%2520based%2520on%2520modulation%2520of%2520mixed%2520lineage%2520kinase%26jtitle%3DNeurotherapeutics%26date%3D2010%26volume%3D7%26spage%3D392%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gallo, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. L.</span><span> </span><span class="NLM_article-title">Mixed-lineage kinase control of JNK and p38 pathways</span> <span class="citation_source-journal">Nature Rev. Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnrm906" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=663-672&author=K.+A.+Galloauthor=G.+L.+Johnson&title=Mixed-lineage+kinase+control+of+JNK+and+p38+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm906%26sid%3Dliteratum%253Aachs%26aulast%3DGallo%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26atitle%3DMixed-lineage%2520kinase%2520control%2520of%2520JNK%2520and%2520p38%2520pathways%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D663%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Silva, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuan, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakic, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, R. E.</span><span> </span><span class="NLM_article-title">Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=653-664&author=R.+M.+Silvaauthor=C.+Y.+Kuanauthor=P.+Rakicauthor=R.+E.+Burke&title=Mixed+lineage+kinase-c-jun+N-terminal+kinase+signaling+pathway%3A+a+new+therapeutic+target+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DR.%2BM.%26aulast%3DKuan%26aufirst%3DC.%2BY.%26aulast%3DRakic%26aufirst%3DP.%26aulast%3DBurke%26aufirst%3DR.%2BE.%26atitle%3DMixed%2520lineage%2520kinase-c-jun%2520N-terminal%2520kinase%2520signaling%2520pathway%253A%2520a%2520new%2520therapeutic%2520target%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2005%26volume%3D20%26spage%3D653%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wang, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besirli, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.,  Jr.</span><span> </span><span class="NLM_article-title">Mixed-lineage kinases: a target for the prevention of neurodegeneration</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=451-474&author=L.+H.+Wangauthor=C.+G.+Besirliauthor=E.+M.+Johnson&title=Mixed-lineage+kinases%3A+a+target+for+the+prevention+of+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DBesirli%26aufirst%3DC.%2BG.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26atitle%3DMixed-lineage%2520kinases%253A%2520a%2520target%2520for%2520the%2520prevention%2520of%2520neurodegeneration%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2004%26volume%3D44%26spage%3D451%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, J. L.</span><span> </span><span class="NLM_article-title">Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">25302</span><span class="NLM_x">–</span> <span class="NLM_lpage">25308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=25302-25308&author=A.+C.+Maroneyauthor=J.+P.+Finnauthor=T.+J.+Connorsauthor=J.+T.+Durkinauthor=T.+Angelesauthor=G.+Gessnerauthor=Z.+Xuauthor=S.+L.+Meyerauthor=M.+J.+Savageauthor=L.+A.+Greeneauthor=R.+W.+Scottauthor=J.+L.+Vaught&title=Cep-1347+%28KT7515%29%2C+a+semisynthetic+inhibitor+of+the+mixed+lineage+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DFinn%26aufirst%3DJ.%2BP.%26aulast%3DConnors%26aufirst%3DT.%2BJ.%26aulast%3DDurkin%26aufirst%3DJ.%2BT.%26aulast%3DAngeles%26aufirst%3DT.%26aulast%3DGessner%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMeyer%26aufirst%3DS.%2BL.%26aulast%3DSavage%26aufirst%3DM.%2BJ.%26aulast%3DGreene%26aufirst%3DL.%2BA.%26aulast%3DScott%26aufirst%3DR.%2BW.%26aulast%3DVaught%26aufirst%3DJ.%2BL.%26atitle%3DCep-1347%2520%2528KT7515%2529%252C%2520a%2520semisynthetic%2520inhibitor%2520of%2520the%2520mixed%2520lineage%2520kinase%2520family%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D25302%26epage%3D25308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Handley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasaiyaah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollara, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chain, B. M.</span><span> </span><span class="NLM_article-title">Expression and function of mixed lineage kinases in dendritic cells</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1093%2Fintimm%2Fdxm050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWmtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=923-933&author=M.+E.+Handleyauthor=J.+Rasaiyaahauthor=J.+Barnettauthor=M.+Thakkerauthor=G.+Pollaraauthor=D.+R.+Katzauthor=B.+M.+Chain&title=Expression+and+function+of+mixed+lineage+kinases+in+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and function of mixed lineage kinases in dendritic cells</span></div><div class="casAuthors">Handley, Matthew E.; Rasaiyaah, Jane; Barnett, James; Thakker, Manish; Pollara, Gabriele; Katz, David R.; Chain, Benjamin M.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">923-933</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Dendritic cells (DCs) sense the presence of conserved microbial structures in their local microenvironment via specific pattern recognition receptors (PRRs).  This leads to a program of changes, which include migration and activation, and enables them to induce adaptive T cell immunity.  Mitogen-activated protein kinases (MAPKs) are implicated in this response, but the pathways leading from PRR ligation to MAPK activation, and hence DC activation, are not fully understood.  Recent studies in the nervous system have suggested that the mixed lineage kinase (MLK) family of MAPK kinase kinase proteins may be involved as an intermediary step between PRRs and MAPKs.  Therefore, in this study, we have used a well-established DC model to explore the role of MLKs in these cells.  MRNA for MLKs 2, 3, 4 and DLK and protein for MLKs 2, 3 and DLK are found in DC.  DC activation in response to model PRR ligands, such as LPS or poly (I:C), is accompanied by phosphorylation of MLK3.  In contrast, another known PRR ligand, zymosan, induces little MLK3 phosphorylation.  Inhibition of MLK activity using a pharmacol. inhibitor, CEP11004, blocks p38 and Jun N-terminal kinase (JNK) MAPK activation in response to LPS and poly (I:C), but not zymosan.  The inhibition is assocd. with a block in DC activation as measured by cell-surface marker expression and cytokine secretion.  Thus, MLKs are expressed in DC, and are implicated in DC activation, and the involvement of MLKs appears to be selective, depending on the nature of the DC stimulus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRGrsS0Q0JTrVg90H21EOLACvtfcHk0lgdULmRnCTCZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWmtLvO&md5=0ad68705b9d5a01b38d37fd3e8972b25</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxm050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxm050%26sid%3Dliteratum%253Aachs%26aulast%3DHandley%26aufirst%3DM.%2BE.%26aulast%3DRasaiyaah%26aufirst%3DJ.%26aulast%3DBarnett%26aufirst%3DJ.%26aulast%3DThakker%26aufirst%3DM.%26aulast%3DPollara%26aufirst%3DG.%26aulast%3DKatz%26aufirst%3DD.%2BR.%26aulast%3DChain%26aufirst%3DB.%2BM.%26atitle%3DExpression%2520and%2520function%2520of%2520mixed%2520lineage%2520kinases%2520in%2520dendritic%2520cells%26jtitle%3DInt.%2520Immunol.%26date%3D2007%26volume%3D19%26spage%3D923%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Handley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasaiyaah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chain, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, D. R.</span><span> </span><span class="NLM_article-title">Mixed lineage kinases (MLKs): a role in dendritic cells, inflammation and immunity?</span> <span class="citation_source-journal">Int. J. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1111%2Fj.1365-2613.2007.00531.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslWjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2007&pages=111-126&author=M.+E.+Handleyauthor=J.+Rasaiyaahauthor=B.+M.+Chainauthor=D.+R.+Katz&title=Mixed+lineage+kinases+%28MLKs%29%3A+a+role+in+dendritic+cells%2C+inflammation+and+immunity%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinases (MLKs): a role in dendritic cells, inflammation and immunity?</span></div><div class="casAuthors">Handley, Matthew E.; Rasaiyaah, Jane; Chain, Benjamin M.; Katz, David R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Experimental Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-126</span>CODEN:
                <span class="NLM_cas:coden">IJEPEI</span>;
        ISSN:<span class="NLM_cas:issn">0959-9673</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">This review summarizes current knowledge about the mixed lineage kinases (MLKs) and explores their potential role in inflammation and immunity.  MLKs were identified initially as signalling mols. in the nervous system.  They were also shown to play a role in the cell cycle.  Further studies documented three groups of MLKs, and showed that they may be activated via the c-Jun NH2 terminal kinase (JNK) pathway, and by Rho GTPases.  The biochem. of the MLKs has been investigated in considerable detail.  Homodimerization and heterodimerization can occur, and both autophosphorylation and autoinhibition are seen.  The interaction between MLKs and JNK interacting protein (JIP) scaffolds, and the resultant effects on mitogen activated protein kinases, have been identified.  Clearly, there is some redundancy within the MLK pathway(s), since mice which lack the MLK3 mol. are not abnormal.  However, using a combination of biochem. anal. and pharmacol. inhibitors, several recent studies in vitro have suggested that MLKs are not only expressed in cells of the immune system (as well as in the nervous system), but also may be implicated selectively in the signalling pathway that follows on toll-like receptor ligation in innate sentinel cells, such as the dendritic cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHhh8Ep53ApbVg90H21EOLACvtfcHk0lgdULmRnCTCZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslWjtrc%253D&md5=5b5bd1d3bbe4baf015bc9ce202c72480</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2613.2007.00531.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2613.2007.00531.x%26sid%3Dliteratum%253Aachs%26aulast%3DHandley%26aufirst%3DM.%2BE.%26aulast%3DRasaiyaah%26aufirst%3DJ.%26aulast%3DChain%26aufirst%3DB.%2BM.%26aulast%3DKatz%26aufirst%3DD.%2BR.%26atitle%3DMixed%2520lineage%2520kinases%2520%2528MLKs%2529%253A%2520a%2520role%2520in%2520dendritic%2520cells%252C%2520inflammation%2520and%2520immunity%253F%26jtitle%3DInt.%2520J.%2520Exp.%2520Pathol.%26date%3D2007%26volume%3D88%26spage%3D111%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jaeschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. J.</span><span> </span><span class="NLM_article-title">Metabolic stress signaling mediated by mixed-lineage kinases</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=498-508&author=A.+Jaeschkeauthor=R.+J.+Davis&title=Metabolic+stress+signaling+mediated+by+mixed-lineage+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaeschke%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DMetabolic%2520stress%2520signaling%2520mediated%2520by%2520mixed-lineage%2520kinases%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D498%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sathyanarayana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzivion, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, A.</span><span> </span><span class="NLM_article-title">Activation of the drosophila MLK by ceramide reveals TNF-alpha and ceramide as agonists of mammalian MLK3</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1533</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=1527-1533&author=P.+Sathyanarayanaauthor=M.+K.+Barthwalauthor=C.+N.+Kunduauthor=M.+E.+Laneauthor=A.+Bergmannauthor=G.+Tzivionauthor=A.+Rana&title=Activation+of+the+drosophila+MLK+by+ceramide+reveals+TNF-alpha+and+ceramide+as+agonists+of+mammalian+MLK3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSathyanarayana%26aufirst%3DP.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DKundu%26aufirst%3DC.%2BN.%26aulast%3DLane%26aufirst%3DM.%2BE.%26aulast%3DBergmann%26aufirst%3DA.%26aulast%3DTzivion%26aufirst%3DG.%26aulast%3DRana%26aufirst%3DA.%26atitle%3DActivation%2520of%2520the%2520drosophila%2520MLK%2520by%2520ceramide%2520reveals%2520TNF-alpha%2520and%2520ceramide%2520as%2520agonists%2520of%2520mammalian%2520MLK3%26jtitle%3DMol.%2520Cell%26date%3D2002%26volume%3D10%26spage%3D1527%26epage%3D1533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Leung, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassam, N.</span><span> </span><span class="NLM_article-title">Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">32408</span><span class="NLM_x">–</span> <span class="NLM_lpage">32415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=32408-32415&author=I.+W.+Leungauthor=N.+Lassam&title=Dimerization+via+tandem+leucine+zippers+is+essential+for+the+activation+of+the+mitogen-activated+protein+kinase+kinase+kinase%2C+MLK-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DI.%2BW.%26aulast%3DLassam%26aufirst%3DN.%26atitle%3DDimerization%2520via%2520tandem%2520leucine%2520zippers%2520is%2520essential%2520for%2520the%2520activation%2520of%2520the%2520mitogen-activated%2520protein%2520kinase%2520kinase%2520kinase%252C%2520MLK-3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D32408%26epage%3D32415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Leung, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassam, N.</span><span> </span><span class="NLM_article-title">The kinase activation loop is the key to mixed lineage kinase-3 activation via both autophosphorylation and hematopoietic progenitor kinase 1 phosphorylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=1961-1967&author=I.+W.+Leungauthor=N.+Lassam&title=The+kinase+activation+loop+is+the+key+to+mixed+lineage+kinase-3+activation+via+both+autophosphorylation+and+hematopoietic+progenitor+kinase+1+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DI.%2BW.%26aulast%3DLassam%26aufirst%3DN.%26atitle%3DThe%2520kinase%2520activation%2520loop%2520is%2520the%2520key%2520to%2520mixed%2520lineage%2520kinase-3%2520activation%2520via%2520both%2520autophosphorylation%2520and%2520hematopoietic%2520progenitor%2520kinase%25201%2520phosphorylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D1961%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sui, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sniderhan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisinger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litzburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span> </span><span class="NLM_article-title">Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2006&pages=702-711&author=Z.+Suiauthor=S.+Fanauthor=L.+Sniderhanauthor=E.+Reisingerauthor=A.+Litzburgauthor=G.+Schifittoauthor=H.+A.+Gelbardauthor=S.+Dewhurstauthor=S.+B.+Maggirwar&title=Inhibition+of+mixed+lineage+kinase+3+prevents+HIV-1+Tat-mediated+neurotoxicity+and+monocyte+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DSniderhan%26aufirst%3DL.%26aulast%3DReisinger%26aufirst%3DE.%26aulast%3DLitzburg%26aufirst%3DA.%26aulast%3DSchifitto%26aufirst%3DG.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26atitle%3DInhibition%2520of%2520mixed%2520lineage%2520kinase%25203%2520prevents%2520HIV-1%2520Tat-mediated%2520neurotoxicity%2520and%2520monocyte%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D177%26spage%3D702%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">New, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-<i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors by a NFkappaB-independent mechanism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">17852</span><span class="NLM_x">–</span> <span class="NLM_lpage">17858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=17852-17858&author=D.+R.+Newauthor=S.+B.+Maggirwarauthor=L.+G.+Epsteinauthor=S.+Dewhurstauthor=H.+A.+Gelbard&title=HIV-1+Tat+induces+neuronal+death+via+tumor+necrosis+factor-alpha+and+activation+of+non-N-methyl-d-aspartate+receptors+by+a+NFkappaB-independent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNew%26aufirst%3DD.%2BR.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DEpstein%26aufirst%3DL.%2BG.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DHIV-1%2520Tat%2520induces%2520neuronal%2520death%2520via%2520tumor%2520necrosis%2520factor-alpha%2520and%2520activation%2520of%2520non-N-methyl-d-aspartate%2520receptors%2520by%2520a%2520NFkappaB-independent%2520mechanism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D17852%26epage%3D17858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS</span> <span class="citation_source-journal">J. Neuroimmune Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1007%2Fs11481-006-9051-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADC%252BD2sjgtlGntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=93-96&author=S.+Dewhurstauthor=S.+B.+Maggirwarauthor=G.+Schifittoauthor=H.+E.+Gendelmanauthor=H.+A.+Gelbard&title=Glycogen+synthase+kinase+3+beta+%28GSK-3+beta%29+as+a+therapeutic+target+in+neuroAIDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS</span></div><div class="casAuthors">Dewhurst Stephen; Maggirwar Sanjay B; Schifitto Giovanni; Gendelman Howard E; Gelbard Harris A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Highly active antiretroviral therapy (HAART) has made a significant impact on the lives of people living with HIV-1 infection.  The incidence of neurologic disease associated with HIV-1 infection of the CNS plummeted between 1996-2000, but unfortunately the number of people currently HIV-1 infected (i.e., prevalence) with associated cognitive impairment has been steadily rising.  While the reasons for this may be multifactorial, the implication is clear: there is a pressing need for adjunctive therapy directed at reversing or preventing damage to vulnerable pathways in the central nervous system (CNS) from HIV-1 infection.  Using a team of preclinical and clinical investigators, we have focused our efforts on defining how proinflammatory mediators and secretory neurotoxins from HIV-1 disrupt signaling of the survival-regulating enzyme, glycogen synthase kinase 3 beta (GSK-3beta).  In a series of studies initiated using in vitro, then in vivo models of HIV-1-associated dementia (HAD), we have demonstrated the ability of the mood stabilizing and anticonvulsant drug, sodium valproate (VPA), that inhibits GSK-3beta activity and other downstream mediators, to reverse HIV-1-induced damage to synaptic pathways in the CNS.  Based on these results, we successfully performed pharmacokinetic and safety and tolerability trials with VPA in a cohort of HIV-1-infected patients with neurologic disease.  VPA was well tolerated in this population and secondary measures of brain metabolism, as evidenced by an increase in N-acetyl aspartate/creatine (NAA/Cr), further suggested that VPA may improve gray matter integrity in brain regions damaged by HIV-1.  These findings highlight the therapeutic potential of GSK-3beta blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYLomxCS5MYCXXDYhVZBdlfW6udTcc2ebP-LnaNJ-9Vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjgtlGntw%253D%253D&md5=32a04eb612b189d1abfe4dc241df68cd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs11481-006-9051-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11481-006-9051-1%26sid%3Dliteratum%253Aachs%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DSchifitto%26aufirst%3DG.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520beta%2520%2528GSK-3%2520beta%2529%2520as%2520a%2520therapeutic%2520target%2520in%2520neuroAIDS%26jtitle%3DJ.%2520Neuroimmune%2520Pharmacol.%26date%3D2007%26volume%3D2%26spage%3D93%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mishra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondarva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">30393</span><span class="NLM_x">–</span> <span class="NLM_lpage">30405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=30393-30405&author=R.+Mishraauthor=M.+K.+Barthwalauthor=G.+Sondarvaauthor=B.+Ranaauthor=L.+Wongauthor=M.+Chatterjeeauthor=J.+R.+Woodgettauthor=A.+Rana&title=Glycogen+synthase+kinase-3beta+induces+neuronal+cell+death+via+direct+phosphorylation+of+mixed+lineage+kinase+3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DSondarva%26aufirst%3DG.%26aulast%3DRana%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DL.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26aulast%3DRana%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase-3beta%2520induces%2520neuronal%2520cell%2520death%2520via%2520direct%2520phosphorylation%2520of%2520mixed%2520lineage%2520kinase%25203%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D30393%26epage%3D30405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">ACS Chemical Neuroscience Spotlight on CEP-1347</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000793" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWiurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=3-4&author=Z.+K.+Sweeneyauthor=J.+W.+Lewcock&title=ACS+Chemical+Neuroscience+Spotlight+on+CEP-1347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">ACS Chemical Neuroscience Spotlight on CEP-1347</span></div><div class="casAuthors">Sweeney, Zachary K.; Lewcock, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-4</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ot-9NHLazbVg90H21EOLACvtfcHk0lg9NJsPotRUkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWiurzE&md5=f2364649af4f96ac72753fbba21557f7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcn1000793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000793%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DACS%2520Chemical%2520Neuroscience%2520Spotlight%2520on%2520CEP-1347%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D3%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lg9NJsPotRUkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Falsig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pörzgen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotharius, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leist, M.</span><span> </span><span class="NLM_article-title">Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">2762</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2004&pages=2762-2770&author=J.+Falsigauthor=P.+P%C3%B6rzgenauthor=J.+Lothariusauthor=M.+Leist&title=Specific+modulation+of+astrocyte+inflammation+by+inhibition+of+mixed+lineage+kinases+with+CEP-1347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFalsig%26aufirst%3DJ.%26aulast%3DP%25C3%25B6rzgen%26aufirst%3DP.%26aulast%3DLotharius%26aufirst%3DJ.%26aulast%3DLeist%26aufirst%3DM.%26atitle%3DSpecific%2520modulation%2520of%2520astrocyte%2520inflammation%2520by%2520inhibition%2520of%2520mixed%2520lineage%2520kinases%2520with%2520CEP-1347%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D173%26spage%3D2762%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebold, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josef, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holskin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathiasen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozyczko-Coyne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saporito, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl [3,4-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetraphydropyridine models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5680</span><span class="NLM_x">–</span> <span class="NLM_lpage">5689</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8005838" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5680-5689&author=R.+L.+Hudkinsauthor=J.+L.+Dieboldauthor=M.+Taoauthor=K.+A.+Josefauthor=C.+H.+Parkauthor=T.+S.+Angelesauthor=L.+D.+Aimoneauthor=J.+Hustenauthor=M.+A.+Atorauthor=S.+L.+Meyerauthor=B.+P.+Holskinauthor=J.+T.+Durkinauthor=A.+A.+Fedorovauthor=E.+V.+Fedorovauthor=S.+C.+Almoauthor=J.+R.+Mathiasenauthor=D.+Bozyczko-Coyneauthor=M.+S.+Saporitoauthor=R.+W.+Scottauthor=J.+P.+Mallamo&title=Mixed-lineage+kinase+1+and+mixed-lineage+kinase+3+subtype-selective+dihydronaphthyl+%5B3%2C4-a%5Dpyrrolo%5B3%2C4-c%5Dcarbazole-5-ones%3A+optimization%2C+mixed-lineage+kinase+1+crystallography%2C+and+oral+in+vivo+activity+in+1-methyl-4-phenyltetraphydropyridine+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm8005838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8005838%26sid%3Dliteratum%253Aachs%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDiebold%26aufirst%3DJ.%2BL.%26aulast%3DTao%26aufirst%3DM.%26aulast%3DJosef%26aufirst%3DK.%2BA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DHusten%26aufirst%3DJ.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DMeyer%26aufirst%3DS.%2BL.%26aulast%3DHolskin%26aufirst%3DB.%2BP.%26aulast%3DDurkin%26aufirst%3DJ.%2BT.%26aulast%3DFedorov%26aufirst%3DA.%2BA.%26aulast%3DFedorov%26aufirst%3DE.%2BV.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26aulast%3DMathiasen%26aufirst%3DJ.%2BR.%26aulast%3DBozyczko-Coyne%26aufirst%3DD.%26aulast%3DSaporito%26aufirst%3DM.%2BS.%26aulast%3DScott%26aufirst%3DR.%2BW.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DMixed-lineage%2520kinase%25201%2520and%2520mixed-lineage%2520kinase%25203%2520subtype-selective%2520dihydronaphthyl%2520%255B3%252C4-a%255Dpyrrolo%255B3%252C4-c%255Dcarbazole-5-ones%253A%2520optimization%252C%2520mixed-lineage%2520kinase%25201%2520crystallography%252C%2520and%2520oral%2520in%2520vivo%2520activity%2520in%25201-methyl-4-phenyltetraphydropyridine%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5680%26epage%3D5689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lotharius, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Beek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dringen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brundin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leist, M.</span><span> </span><span class="NLM_article-title">Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6329</span><span class="NLM_x">–</span> <span class="NLM_lpage">6342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1523%2FJNEUROSCI.1746-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=16000623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtF2ksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6329-6342&author=J.+Lothariusauthor=J.+Falsigauthor=J.+van+Beekauthor=S.+Payneauthor=R.+Dringenauthor=P.+Brundinauthor=M.+Leist&title=Progressive+degeneration+of+human+mesencephalic+neuron-derived+cells+triggered+by+dopamine-dependent+oxidative+stress+is+dependent+on+the+mixed-lineage+kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway</span></div><div class="casAuthors">Lotharius, Julie; Falsig, Jeppe; van Beek, Johan; Payne, Sarah; Dringen, Ralf; Brundin, Patrik; Leist, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6329-6342</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Models of Parkinson's disease (PD) based on selective neuronal death have been used to study pathogenic mechanisms underlying nigral cell death and in some instances to develop symptomatic therapies.  For validation of putative neuroprotectants, a model is desirable in which the events leading to neurodegeneration replicate those occurring in the disease.  We developed a human in vitro model of PD based on the assumption that dysregulated cytoplasmic dopamine levels trigger cell loss in this disorder.  Differentiated human mesencephalic neuron-derived cells were exposed to methamphetamine (METH) to promote cytoplasmic dopamine accumulation.  In the presence of elevated iron concns., as obsd. in PD, increased cytosolic dopamine led to oxidative stress, c-Jun N-terminal kinase (JNK) pathway activation, neurite degeneration, and eventually apoptosis.  We examd. the role of the mixed-lineage kinases (MLKs) in this complex degenerative cascade by using the potent inhibitor 3,9-bis[(ethylthio)methyl]-K-252a (CEP1347).  Inhibition of MLKs not only prevented FeCl2+/METH-induced JNK activation and apoptosis but also early events such as neurite degeneration and oxidative stress.  This broad neuroprotective action of CEP1347 was assocd. with increased expression of an oxidative stress-response modulator, activating transcription factor 4.  As a functional consequence, transcription of the cystine/glutamate and glycine transporters, cellular cystine uptake and intracellular levels of the redox buffer glutathione were augmented.  In conclusion, this new human model of parkinsonian neurodegeneration has the potential to yield new insights into neurorestorative therapeutics and suggests that enhancement of cytoprotective mechanisms, in addn. to blockade of apoptosis, may be essential for disease modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqavEJ7HFAQ5rVg90H21EOLACvtfcHk0li1ZSEXeO7Rrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtF2ksb4%253D&md5=51fab9639a0de3e6029ec86e7c62bae5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1746-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1746-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLotharius%26aufirst%3DJ.%26aulast%3DFalsig%26aufirst%3DJ.%26aulast%3Dvan%2BBeek%26aufirst%3DJ.%26aulast%3DPayne%26aufirst%3DS.%26aulast%3DDringen%26aufirst%3DR.%26aulast%3DBrundin%26aufirst%3DP.%26aulast%3DLeist%26aufirst%3DM.%26atitle%3DProgressive%2520degeneration%2520of%2520human%2520mesencephalic%2520neuron-derived%2520cells%2520triggered%2520by%2520dopamine-dependent%2520oxidative%2520stress%2520is%2520dependent%2520on%2520the%2520mixed-lineage%2520kinase%2520pathway%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6329%26epage%3D6342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Saporito, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carswell, S.</span><span> </span><span class="NLM_article-title">CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=9918541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADyaK1MXpvFOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1999&pages=421-427&author=M.+S.+Saporitoauthor=E.+M.+Brownauthor=M.+S.+Millerauthor=S.+Carswell&title=CEP-1347%2FKT-7515%2C+an+inhibitor+of+c-jun+N-terminal+kinase+activation%2C+attenuates+the+1-methyl-4-phenyl+tetrahydropyridine-mediated+loss+of+nigrostriatal+dopaminergic+neurons+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo</span></div><div class="casAuthors">Saporito, Michael S.; Brown, Ellen M.; Miller, Matthew S.; Carswell, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-427</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have identified a bis-ethylthiomethyl analog of K-252a, CEP-1347/KT-7515, that promotes neuronal survival in culture and in vivo.  The neuronal survival properties of CEP-1347/KT-7515 may be related to its ability to inhibit the activation of c-jun N-terminal kinase, a key kinase in some forms of stress-induced neuronal death and perhaps apoptosis.  There is evidence that the selective nigrostriatal dopaminergic neurotoxin, MPTP, produces neuronal apoptosis in culture and in adult mice.  Thus, our studies were designed to det. if CEP-1347/KT-7515 could protect dopaminergic neurons from MPTP-mediated neurotoxicity.  CEP-1347/KT-7515 was assessed for neuroprotective activity in a low dose MPTP model (20 mg/kg) where there was a 50% loss of striatal dopaminergic terminals in the absence of substantia nigra neuronal loss, and a high dose (40 mg/kg) MPTP model where there was a complete loss of dopaminergic terminals and 80% loss of dopaminergic cell bodies.  In the low dose MPTP model, CEP-1347/KT-7515 (0.3 mg/kg/day) attenuated the MPTP-mediated loss of striatal dopaminergic terminals by 50%.  In the high dose model, CEP-1347/KT-7515 ameliorated the loss of dopaminergic cell bodies by 50% and partially preserved striatal dopaminergic terminals.  CEP-1347/KT-7515 did not inhibit monoamine oxidase B or the dopamine transporter, suggesting that the neuroprotective effects of CEP-1347/KT-7515 occur down-stream of the metabolic conversion of MPTP to MPP+ and accumulation of MPP+ into dopaminergic neurons.  These data implicate a c-jun N-terminal kinase signaling system in MPTP-mediated dopaminergic degeneration and suggest that CEP-1347/KT-7515 may have potential as a treatment for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsVZsdmWMSYbVg90H21EOLACvtfcHk0lgvqNMD9NXoXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXpvFOisA%253D%253D&md5=118b9beb6f0d924aab55e1a474e78951</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaporito%26aufirst%3DM.%2BS.%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMiller%26aufirst%3DM.%2BS.%26aulast%3DCarswell%26aufirst%3DS.%26atitle%3DCEP-1347%252FKT-7515%252C%2520an%2520inhibitor%2520of%2520c-jun%2520N-terminal%2520kinase%2520activation%252C%2520attenuates%2520the%25201-methyl-4-phenyl%2520tetrahydropyridine-mediated%2520loss%2520of%2520nigrostriatal%2520dopaminergic%2520neurons%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D288%26spage%3D421%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mathiasen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saporito, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghadge, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holskin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusko, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozyczko-Coyne, D.</span><span> </span><span class="NLM_article-title">Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1003</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2Fj.brainres.2003.11.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=15019567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFaitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1003&publication_year=2004&pages=86-97&author=J.+R.+Mathiasenauthor=B.+A.+McKennaauthor=M.+S.+Saporitoauthor=G.+D.+Ghadgeauthor=R.+P.+Roosauthor=B.+P.+Holskinauthor=Z.+L.+Wuauthor=S.+P.+Truskoauthor=T.+C.+Connorsauthor=A.+C.+Maroneyauthor=B.+A.+Thomasauthor=J.+C.+Thomasauthor=D.+Bozyczko-Coyne&title=Inhibition+of+mixed+lineage+kinase+3+attenuates+MPP%2B-induced+neurotoxicity+in+SH-SY5Y+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells</span></div><div class="casAuthors">Mathiasen, Joanne R.; McKenna, Beth Ann W.; Saporito, Michael S.; Ghadge, Ghanashyam D.; Roos, Raymond P.; Holskin, Beverly P.; Wu, Zhi-Liang; Trusko, Stephen P.; Connors, Thomas C.; Maroney, Anna C.; Thomas, Beth Ann; Thomas, Jeffrey C.; Bozyczko-Coyne, Donna</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1003</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">86-97</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The neuropathol. of Parkinson's Disease has been modeled in exptl. animals following MPTP treatment and in dopaminergic cells in culture treated with the MPTP neurotoxic metabolite, MPP+.  MPTP through MPP+ activates the stress-activated c-Jun N-terminal kinase (JNK) pathway in mice and SH-SY5Y neuroblastoma cells.  Recently, it was demonstrated that CEP-1347/KT7515 attenuated MPTP-induced nigrostriatal dopaminergic neuron degeneration in mice, as well as MPTP-induced JNK phosphorylation.  Presumably, CEP-1347 acts through inhibition of at least one upstream kinase within the mixed lineage kinase (MLK) family since it has been shown to inhibit MLK 1, 2 and 3 in vitro.  Activation of the MLK family leads to JNK activation.  In this study, the potential role of MLK and the JNK pathway was examd. in MPP+-induced cell death of differentiated SH-SY5Y cells using CEP-1347 as a pharmacol. probe and dominant neg. adenoviral constructs to MLKs.  CEP-1347 inhibited MPP+-induced cell death and the morphol. features of apoptosis.  CEP-1347 also prevented MPP+-induced JNK activation in SH-SY5Y cells.  Endogenous MLK 3 expression was demonstrated in SH-SY5Y cells through protein levels and RT-PCR.  Adenoviral infection of SH-SY5Y cells with a dominant neg. MLK 3 construct attenuated the MPP+-mediated increase in activated JNK levels and inhibited neuronal death following MPP+ addn. compared to cultures infected with a control construct.  Adenoviral dominant neg. constructs of two other MLK family members (MLK 2 and DLK) did not protect against MPP+-induced cell death.  These studies show that inhibition of the MLK 3/JNK pathway attenuates MPP+-mediated SH-SY5Y cell death in culture and supports the mechanism of action of CEP-1347 as an MLK family inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWMfFo7PHTlrVg90H21EOLACvtfcHk0lh2DAW6egbsWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFaitr0%253D&md5=f82cbb2b5c6f2b3b765ee1f58cbccbfd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2003.11.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2003.11.073%26sid%3Dliteratum%253Aachs%26aulast%3DMathiasen%26aufirst%3DJ.%2BR.%26aulast%3DMcKenna%26aufirst%3DB.%2BA.%26aulast%3DSaporito%26aufirst%3DM.%2BS.%26aulast%3DGhadge%26aufirst%3DG.%2BD.%26aulast%3DRoos%26aufirst%3DR.%2BP.%26aulast%3DHolskin%26aufirst%3DB.%2BP.%26aulast%3DWu%26aufirst%3DZ.%2BL.%26aulast%3DTrusko%26aufirst%3DS.%2BP.%26aulast%3DConnors%26aufirst%3DT.%2BC.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DThomas%26aufirst%3DB.%2BA.%26aulast%3DThomas%26aufirst%3DJ.%2BC.%26aulast%3DBozyczko-Coyne%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520mixed%2520lineage%2520kinase%25203%2520attenuates%2520MPP%252B-induced%2520neurotoxicity%2520in%2520SH-SY5Y%2520cells%26jtitle%3DBrain%2520Res.%26date%3D2004%26volume%3D1003%26spage%3D86%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bodner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span> </span><span class="NLM_article-title">Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2Fj.expneurol.2004.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2004&pages=246-253&author=A.+Bodnerauthor=P.+T.+Tothauthor=R.+J.+Miller&title=Activation+of+c-Jun+N-terminal+kinase+mediates+gp120IIIB-+and+nucleoside+analogue-induced+sensory+neuron+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity</span></div><div class="casAuthors">Bodner, Amos; Toth, Peter T.; Miller, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-253</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Peripheral neuropathy is the most common neurol. symptom in patients with acquired immunodeficiency syndrome (AIDS).  Here, we examine possible mechanisms of gp120 and nucleoside reverse transcriptase inhibitors (NRTIs) in the pathogenesis of AIDS peripheral neuropathy.  Neonatal dorsal root ganglion (DRG) neurons were found to undergo apoptosis in response to chronic treatment with gp120IIIB, an effect enhanced by the co-application of hCD4, as well as upon exposure to the nucleoside reverse transcriptase inhibitor (NRTI), 2',3'-dideoxyinosine (ddI).  DRG neurons were rescued from the neurotoxic effects of these agents by CEP-1347, an inhibitor of the mixed lineage kinases (MLKs), upstream activators of the c-Jun N-terminal kinase (JNK) signaling pathway.  In addn., gp120- or ddI-mediated toxicity were also inhibited by neuronal expression of dominant neg. versions of the MLKs.  Our results suggest that both gp120 and the NRTIs cause sensory neuron apoptosis through the activation of the JNK pathway, and that CEP-1347-like compds. may serve as a therapeutic option in patients with AIDS-assocd. peripheral neuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0rJtGYlG1YrVg90H21EOLACvtfcHk0lh2DAW6egbsWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFygtL0%253D&md5=ef951667e4c1fc67f380951a95742127</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2004.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2004.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DBodner%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DP.%2BT.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DActivation%2520of%2520c-Jun%2520N-terminal%2520kinase%2520mediates%2520gp120IIIB-%2520and%2520nucleoside%2520analogue-induced%2520sensory%2520neuron%2520toxicity%26jtitle%3DExp.%2520Neurol.%26date%3D2004%26volume%3D188%26spage%3D246%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bodner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghadge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span> </span><span class="NLM_article-title">Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1424</span><span class="NLM_x">–</span> <span class="NLM_lpage">1434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1046%2Fj.1471-4159.2002.01088.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2hs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1424-1434&author=A.+Bodnerauthor=A.+C.+Maroneyauthor=J.+P.+Finnauthor=G.+Ghadgeauthor=R.+Roosauthor=R.+J.+Miller&title=Mixed+lineage+kinase+3+mediates+gp120IIIB-induced+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity</span></div><div class="casAuthors">Bodner, Amos; Maroney, Anna C.; Finn, James P.; Ghadge, Ghanashyam; Roos, Raymond; Miller, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1424-1434</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Overexpression of gp120, the major coat protein of the HIV-1 virus, in central glial cells, or treatment of neurons with gp120 in culture, produces apoptotic neuronal death.  Here the authors demonstrate that CEP-1347 (KT7515), an inhibitor of mixed lineage kinase 3 (MLK3), an upstream activator of JNK, inhibits gp120IIIB-induced apoptosis of hippocampal neurons.  Furthermore, expression of wild type MLK3 in hippocampal pyramidal neurons enhanced gp120IIIB-induced neurotoxicity, whereas expression of a dominant neg. MLK3 protected neurons from the toxic effects of the glycoprotein.  These results indicate a role for MLK3 signaling in gp120IIIB-induced neuronal death, and suggest potential clin. utility of CEP-1347 in inhibiting the progression of AIDS dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkGW6_iGg5LVg90H21EOLACvtfcHk0lh2DAW6egbsWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2hs74%253D&md5=706f55838667df62fb58a675c5d02f1d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01088.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01088.x%26sid%3Dliteratum%253Aachs%26aulast%3DBodner%26aufirst%3DA.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DFinn%26aufirst%3DJ.%2BP.%26aulast%3DGhadge%26aufirst%3DG.%26aulast%3DRoos%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DMixed%2520lineage%2520kinase%25203%2520mediates%2520gp120IIIB-induced%2520neurotoxicity%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1424%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Eggert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dash, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorantla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluektova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Neuroprotective activities of CEP-1347 in models of neuroAIDS</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=746-756&author=D.+Eggertauthor=P.+K.+Dashauthor=S.+Gorantlaauthor=H.+Douauthor=G.+Schifittoauthor=S.+B.+Maggirwarauthor=S.+Dewhurstauthor=L.+Poluektovaauthor=H.+A.+Gelbardauthor=H.+E.+Gendelman&title=Neuroprotective+activities+of+CEP-1347+in+models+of+neuroAIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEggert%26aufirst%3DD.%26aulast%3DDash%26aufirst%3DP.%2BK.%26aulast%3DGorantla%26aufirst%3DS.%26aulast%3DDou%26aufirst%3DH.%26aulast%3DSchifitto%26aufirst%3DG.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DPoluektova%26aufirst%3DL.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DNeuroprotective%2520activities%2520of%2520CEP-1347%2520in%2520models%2520of%2520neuroAIDS%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D184%26spage%3D746%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span>Parkinson Study Group PRECEPT Investigators. <span> </span><span class="NLM_article-title">Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease</span>.  <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Parkinson+Study+Group+PRECEPT+Investigators.+Mixed+lineage+kinase+inhibitor+CEP-1347+fails+to+delay+disability+in+early+Parkinson+disease.+Neurology+2007%2C+69%2C+1480%E2%80%931490."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DMixed%2520lineage%2520kinase%2520inhibitor%2520CEP-1347%2520fails%2520to%2520delay%2520disability%2520in%2520early%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2007%26volume%3D69%26spage%3D1480%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Difrancesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochreiter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span> </span><span class="NLM_article-title">Pharmacokinetic interaction of CEP-1347 and atazanavir in HIV-infected patients</span> <span class="citation_source-journal">J. Neurovirol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=254-60&author=Q.+Maauthor=H.+A.+Gelbardauthor=S.+B.+Maggirwarauthor=S.+Dewhurstauthor=H.+E.+Gendelmanauthor=D.+R.+Petersonauthor=R.+Difrancescoauthor=J.+S.+Hochreiterauthor=G.+D.+Morseauthor=G.+Schifitto&title=Pharmacokinetic+interaction+of+CEP-1347+and+atazanavir+in+HIV-infected+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26aulast%3DPeterson%26aufirst%3DD.%2BR.%26aulast%3DDifrancesco%26aufirst%3DR.%26aulast%3DHochreiter%26aufirst%3DJ.%2BS.%26aulast%3DMorse%26aufirst%3DG.%2BD.%26aulast%3DSchifitto%26aufirst%3DG.%26atitle%3DPharmacokinetic%2520interaction%2520of%2520CEP-1347%2520and%2520atazanavir%2520in%2520HIV-infected%2520patients%26jtitle%3DJ.%2520Neurovirol.%26date%3D2013%26volume%3D3%26spage%3D254%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span>StarDrop: Guiding Decisions in Drug Discovery; <span class="NLM_publisher-name">Optibrium Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.optibrium.com/stardrop/" class="extLink">http://www.optibrium.com/stardrop/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=StarDrop%3A+Guiding+Decisions+in+Drug+Discovery%3B+Optibrium+Ltd.%3A+Cambridge%2C+UK%2C+2013%3B+http%3A%2F%2Fwww.optibrium.com%2Fstardrop%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DStarDrop%253A%2520Guiding%2520Decisions%2520in%2520Drug%2520Discovery%26pub%3DOptibrium%2520Ltd%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Dash, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorantla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knibbe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makarov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boska, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluektova, L. Y.</span><span> </span><span class="NLM_article-title">Loss of neuronal integrity during progressive HIV-1 infection of humanized mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3148</span><span class="NLM_x">–</span> <span class="NLM_lpage">3157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1523%2FJNEUROSCI.5473-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=21368026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVaht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=3148-3157&author=P.+K.+Dashauthor=S.+Gorantlaauthor=H.+E.+Gendelmanauthor=J.+Knibbeauthor=G.+P.+Casaleauthor=E.+Makarovauthor=A.+A.+Epsteinauthor=H.+A.+Gelbardauthor=M.+D.+Boskaauthor=L.+Y.+Poluektova&title=Loss+of+neuronal+integrity+during+progressive+HIV-1+infection+of+humanized+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of neuronal integrity during progressive HIV-1 infection of humanized mice</span></div><div class="casAuthors">Dash, Prasanta K.; Gorantla, Santhi; Gendelman, Howard E.; Knibbe, Jaclyn; Casale, George P.; Makarov, Edward; Epstein, Adrian A.; Gelbard, Harris A.; Boska, Michael D.; Poluektova, Larisa Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3148-3157</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuronal damage induced by ongoing human immunodeficiency virus type 1 (HIV-1) infection was investigated in humanized NOD/scid-IL-2Rγnullc mice transplanted at birth with human CD34-pos. hematopoietic stem cells.  Mice infected at 5 mo of age and followed for up to 15 wk maintained significant plasma viral loads and showed reduced nos. of CD4+ T-cells.  Prospective serial proton magnetic resonance spectroscopy tests showed selective redns. in cortical N-acetyl aspartate in infected animals.  Diffusion tensor imaging revealed structural changes in cortical gray matter.  Postmortem immunofluorescence brain tissue examns. for neuronal and glial markers, captured by multispectral imaging microscopy and quantified by morphometric and fluorescence emission, showed regional redn. of neuronal soma and synaptic architectures.  This was evidenced by loss of microtubule-assocd. protein 2, synaptophysin, and neurofilament antigens.  This study is the first, to our knowledge, demonstrating lost neuronal integrity after HIV-1 infection in humanized mice.  As such, the model permits studies of the relationships between ongoing viral replication and virus-assocd. neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTHkYAVHLi67Vg90H21EOLACvtfcHk0ljEO5LUYMY2bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVaht7g%253D&md5=1e099151579fba50c6cc58d43174d7b3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5473-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5473-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DDash%26aufirst%3DP.%2BK.%26aulast%3DGorantla%26aufirst%3DS.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26aulast%3DKnibbe%26aufirst%3DJ.%26aulast%3DCasale%26aufirst%3DG.%2BP.%26aulast%3DMakarov%26aufirst%3DE.%26aulast%3DEpstein%26aufirst%3DA.%2BA.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DBoska%26aufirst%3DM.%2BD.%26aulast%3DPoluektova%26aufirst%3DL.%2BY.%26atitle%3DLoss%2520of%2520neuronal%2520integrity%2520during%2520progressive%2520HIV-1%2520infection%2520of%2520humanized%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D3148%26epage%3D3157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Genis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernton, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzenko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keane, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrachi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volsky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Cytokins and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage–astroglia interactions: implications for the neuropathogenesis of HIV disease</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=1992&pages=1703-1718&author=P.+Genisauthor=M.+Jettauthor=E.+W.+Berntonauthor=T.+Boyleauthor=H.+A.+Gelbardauthor=K.+Dzenkoauthor=R.+W.+Keaneauthor=L.+Resnickauthor=Y.+Mizrachiauthor=D.+J.+Volskyauthor=L.+G.+Epsteinauthor=H.+E.+Gendelman&title=Cytokins+and+arachidonic+metabolites+produced+during+human+immunodeficiency+virus+%28HIV%29-infected+macrophage%E2%80%93astroglia+interactions%3A+implications+for+the+neuropathogenesis+of+HIV+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGenis%26aufirst%3DP.%26aulast%3DJett%26aufirst%3DM.%26aulast%3DBernton%26aufirst%3DE.%2BW.%26aulast%3DBoyle%26aufirst%3DT.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DDzenko%26aufirst%3DK.%26aulast%3DKeane%26aufirst%3DR.%2BW.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DMizrachi%26aufirst%3DY.%26aulast%3DVolsky%26aufirst%3DD.%2BJ.%26aulast%3DEpstein%26aufirst%3DL.%2BG.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DCytokins%2520and%2520arachidonic%2520metabolites%2520produced%2520during%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529-infected%2520macrophage%25E2%2580%2593astroglia%2520interactions%253A%2520implications%2520for%2520the%2520neuropathogenesis%2520of%2520HIV%2520disease%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1992%26volume%3D176%26spage%3D1703%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wesselingh, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyor, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, D. E.</span><span> </span><span class="NLM_article-title">Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1002%2Fana.410330604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADyaK3s3ntVClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1993&pages=576-582&author=S.+L.+Wesselinghauthor=C.+Powerauthor=J.+D.+Glassauthor=W.+R.+Tyorauthor=J.+C.+McArthurauthor=J.+M.+Farberauthor=J.+W.+Griffinauthor=D.+E.+Griffin&title=Intracerebral+cytokine+messenger+RNA+expression+in+acquired+immunodeficiency+syndrome+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia</span></div><div class="casAuthors">Wesselingh S L; Power C; Glass J D; Tyor W R; McArthur J C; Farber J M; Griffin J W; Griffin D E</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">576-82</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">The pathogenesis of the dementia associated with human immunodeficiency virus (HIV) infection is unclear, but has been postulated to be due to indirect effects of HIV infection including the local production of cytokines.  To determine which cytokines are produced in the nervous system and to identify any correlations with dementia, cytokine and HIV messenger RNA expression was analyzed by reverse transcriptase-polymerase chain reaction in the brains from 24 HIV-infected patients with and without dementia and 9 HIV-uninfected control subjects.  Levels of tumor necrosis factor-alpha messenger RNA were significantly higher and levels of interleukin (IL)-4 messenger RNA were significantly lower in demented compared to nondemented HIV-infected patients.  Demented patients also had lower IL-1 beta levels than did nondemented patients.  No significant differences were detected in the amounts of leukemia inhibitory factor, IL-6, transforming growth factor-beta 1 and -beta 2, monokine induced by gamma interferon-2 (MIG-2), or interferon-gamma messenger RNAs.  IL-10 and IL-2 messenger RNAs were undetectable in all brains examined.  Cytokine messenger RNA levels in nondemented HIV-positive patients were similar to those in HIV-negative control subjects.  HIV transcripts were more abundant in subcortical white matter than in the basal ganglia, cortex, or deep white matter.  Our findings suggest a possible role for tumor necrosis factor-alpha in the development of neurological dysfunction.  Increased levels of tumor necrosis factor-alpha messenger RNA were not associated with increased levels of IL-1 beta messenger RNA, suggesting differential regulation of these monokines in acquired immunodeficiency syndrome dementia.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6gZt_4NNPoQvupmecNw_lfW6udTcc2eb8y1KEx2T1XLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3ntVClsA%253D%253D&md5=b2955d77cbb5d826144d4f9fd973a1bf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fana.410330604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410330604%26sid%3Dliteratum%253Aachs%26aulast%3DWesselingh%26aufirst%3DS.%2BL.%26aulast%3DPower%26aufirst%3DC.%26aulast%3DGlass%26aufirst%3DJ.%2BD.%26aulast%3DTyor%26aufirst%3DW.%2BR.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DFarber%26aufirst%3DJ.%2BM.%26aulast%3DGriffin%26aufirst%3DJ.%2BW.%26aulast%3DGriffin%26aufirst%3DD.%2BE.%26atitle%3DIntracerebral%2520cytokine%2520messenger%2520RNA%2520expression%2520in%2520acquired%2520immunodeficiency%2520syndrome%2520dementia%26jtitle%3DAnn.%2520Neurol.%26date%3D1993%26volume%3D33%26spage%3D576%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Tyor, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, D. E.</span><span> </span><span class="NLM_article-title">Cytokine expression in the brain during the acquired immunodeficiency syndrome</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1002%2Fana.410310402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADyaK383msVKqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1992&pages=349-360&author=W.+R.+Tyorauthor=J.+D.+Glassauthor=J.+W.+Griffinauthor=P.+S.+Beckerauthor=J.+C.+McArthurauthor=L.+Bezmanauthor=D.+E.+Griffin&title=Cytokine+expression+in+the+brain+during+the+acquired+immunodeficiency+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine expression in the brain during the acquired immunodeficiency syndrome</span></div><div class="casAuthors">Tyor W R; Glass J D; Griffin J W; Becker P S; McArthur J C; Bezman L; Griffin D E</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-60</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">The pathogenesis of central nervous system (CNS) disease in acquired immunodeficiency syndrome (AIDS) is poorly understood but may be related to specific effects of the immune system.  Cytokines such as tumor necrosis factor and interleukin-1 may have toxic effects on CNS cells and have been postulated to contribute to the pathogenesis of the neurological complications of human immunodeficiency virus (HIV) infection.  To characterize viral and immunological activity in the CNS, frozen specimens taken at autopsy from the cerebral cortex and white matter of HIV-seropositive and -seronegative individuals were stained immunocytochemically for mononuclear cells, major histocompatibility complex (MHC) antigens, HIV, astrocytes, and the cytokines interleukin-1 and -6, tumor necrosis factor-alpha and -beta, and interferon gamma.  Levels of soluble CD4, CD8, and interleukin-2 receptor, as well as interferon gamma, tumor necrosis factor-alpha, beta 2-microglobulin, neopterin, and interleukin-6 and -1 beta were assayed in the cerebrospinal fluid and plasma of many of these individuals during life.  The HIV-seropositive group included individuals without neurological disease, those with CNS opportunistic infections, and those with HIV encephalopathy.  Perivascular cells, consisting primarily of macrophages with some CD4+ and CD8+ T cells and rare B cells, were consistently MHC class II positive.  MHC class II antigen was also present on microglial cells, which were frequently positive for tumor necrosis factor-alpha.  HIV p24 antigen, when present, was found on macrophages and microglia.  Endothelial cells were frequently positive for interleukin-1 and interferon gamma and less frequently for tumor necrosis factor and interleukin-6.  There were gliosis and significant increases in MHC class II antigen, interleukin-1, and tumor necrosis factor-alpha in HIV-positive patients compared to HIV-negative brains.  Cerebrospinal fluid from most of the patients tested had increased levels of tumor necrosis factor, beta 2-microglobulin, and neopterin.  There was no correlation in HIV-positive individuals between levels of cytokines and the presence or absence of CNS disease.  These data indicate that there is a relative state of "immune activation" in the brains of HIV-positive compared to HIV-negative individuals, and suggest a potential role for the immune system in the pathogenesis of HIV encephalopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWgysHNiySORe4jJGKT5N0fW6udTcc2eb8y1KEx2T1XLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383msVKqtw%253D%253D&md5=9e94fa380431a954bf8b50b97737f86c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fana.410310402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410310402%26sid%3Dliteratum%253Aachs%26aulast%3DTyor%26aufirst%3DW.%2BR.%26aulast%3DGlass%26aufirst%3DJ.%2BD.%26aulast%3DGriffin%26aufirst%3DJ.%2BW.%26aulast%3DBecker%26aufirst%3DP.%2BS.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DBezman%26aufirst%3DL.%26aulast%3DGriffin%26aufirst%3DD.%2BE.%26atitle%3DCytokine%2520expression%2520in%2520the%2520brain%2520during%2520the%2520acquired%2520immunodeficiency%2520syndrome%26jtitle%3DAnn.%2520Neurol.%26date%3D1992%26volume%3D31%26spage%3D349%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wesselingh, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, D. E.</span><span> </span><span class="NLM_article-title">Cytokine dysregulation in HIV-associated neurological disease</span> <span class="citation_source-journal">Adv. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2FS0960-5428%2806%2980258-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADyaK2M7nvFCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=199-206&author=S.+L.+Wesselinghauthor=J.+Glassauthor=J.+C.+McArthurauthor=J.+W.+Griffinauthor=D.+E.+Griffin&title=Cytokine+dysregulation+in+HIV-associated+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine dysregulation in HIV-associated neurological disease</span></div><div class="casAuthors">Wesselingh S L; Glass J; McArthur J C; Griffin J W; Griffin D E</div><div class="citationInfo"><span class="NLM_cas:title">Advances in neuroimmunology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-206</span>
        ISSN:<span class="NLM_cas:issn">0960-5428</span>.
    </div><div class="casAbstract">AIDS is associated with three major neurological syndromes: dementia (HIVD), vacuolar myelopathy (VM) and plainful sensory neuropathy (PSN).  The pathogenesis of these conditions remains unclear although they all demonstrate a marked increase in macrophage number and activation despite systemic immunosuppression.  It was therefore of interest to determine the profile of cytokine and HIV expression in brain, spinal cord and peripheral nerves of AIDS patients with AD, VM and PSN, as compared to AIDS patients without neurological disease and seronegative controls.  RNA was extracted from brain, spinal cord and peripheral nerve and RT/PCR for cytokine and HIV mRNA was performed.  In situ RT/PCR was performed to determine the number and type of cells expressing cytokine message and this was compared to the number of cells containing HIV DNA detected with in situ PCR.  We found a consistent profile of increased TNF alpha and decreased IFN gamma and IL4 in all three syndromes compared to AIDS patients without neurological disease.  IL1 did not increase in parallel with TNF alpha IL10 was decreased in the VM tissue.  HIV transcripts were increased in the AD brains compared to non-demented controls but were detected only occasionally in spinal cord and not at all in peripheral nerve.  Preliminary data from in situ RT/PCR suggests that a large number of cells are expressing.  TNF alpha but only a small number are infected with HIV.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThUbQG7zCGRwMthz5_Rx5rfW6udTcc2eb8onwgQCmINrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7nvFCjuw%253D%253D&md5=cb3cc28a4c89a816858a27117e9e7344</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0960-5428%2806%2980258-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-5428%252806%252980258-5%26sid%3Dliteratum%253Aachs%26aulast%3DWesselingh%26aufirst%3DS.%2BL.%26aulast%3DGlass%26aufirst%3DJ.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DGriffin%26aufirst%3DJ.%2BW.%26aulast%3DGriffin%26aufirst%3DD.%2BE.%26atitle%3DCytokine%2520dysregulation%2520in%2520HIV-associated%2520neurological%2520disease%26jtitle%3DAdv.%2520Neuroimmunol.%26date%3D1994%26volume%3D4%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>Cardiac Toxicity hERG; <span class="NLM_publisher-name">Cerep</span>: <span class="NLM_publisher-loc">Celle L’Evescault, France</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.cerep.fr/cerep/users/pages/downloads/Documents/Marketing/Pharmacology%20&amp;%20ADME/Application%20notes/Cardiac%20toxicity%20hERG-2012.pdf" class="extLink">http://www.cerep.fr/cerep/users/pages/downloads/Documents/Marketing/Pharmacology%20&%20ADME/Application%20notes/Cardiac%20toxicity%20hERG-2012.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cardiac+Toxicity+hERG%3B+Cerep%3A+Celle+L%E2%80%99Evescault%2C+France%2C+2012%3B+http%3A%2F%2Fwww.cerep.fr%2Fcerep%2Fusers%2Fpages%2Fdownloads%2FDocuments%2FMarketing%2FPharmacology%2520%26%2520ADME%2FApplication%2520notes%2FCardiac%2520toxicity%2520hERG-2012.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DCardiac%2520Toxicity%2520hERG%26pub%3DCerep%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Weiss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, J. W.</span><span> </span><span class="NLM_article-title">HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood–brain barrier and up-regulates CCR5 expression on human monocytes</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">2953</span><span class="NLM_x">–</span> <span class="NLM_lpage">2959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=2953-2959&author=J.+M.+Weissauthor=A.+Nathauthor=E.+O.+Majorauthor=J.+W.+Berman&title=HIV-1+Tat+induces+monocyte+chemoattractant+protein-1-mediated+monocyte+transmigration+across+a+model+of+the+human+blood%E2%80%93brain+barrier+and+up-regulates+CCR5+expression+on+human+monocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DJ.%2BM.%26aulast%3DNath%26aufirst%3DA.%26aulast%3DMajor%26aufirst%3DE.%2BO.%26aulast%3DBerman%26aufirst%3DJ.%2BW.%26atitle%3DHIV-1%2520Tat%2520induces%2520monocyte%2520chemoattractant%2520protein-1-mediated%2520monocyte%2520transmigration%2520across%2520a%2520model%2520of%2520the%2520human%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520up-regulates%2520CCR5%2520expression%2520on%2520human%2520monocytes%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D2953%26epage%3D2959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Gonzalez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovin, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mummidi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamshad, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telles, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deucher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SBologna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, S. K.</span><span> </span><span class="NLM_article-title">HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">13795</span><span class="NLM_x">–</span> <span class="NLM_lpage">13800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=13795-13800&author=E.+Gonzalezauthor=B.+H.+Rovinauthor=L.+Senauthor=G.+Cookeauthor=R.+Dhandaauthor=S.+Mummidiauthor=H.+Kulkarniauthor=M.+J.+Bamshadauthor=V.+Tellesauthor=S.+A.+Andersonauthor=E.+A.+Walterauthor=K.+T.+Stephanauthor=M.+Deucherauthor=A.+Manganoauthor=R.+SBolognaauthor=S.+S.+Ahujaauthor=M.+J.+Dolanauthor=S.+K.+Ahuja&title=HIV-1+infection+and+AIDS+dementia+are+influenced+by+a+mutant+MCP-1+allele+linked+to+increased+monocyte+infiltration+of+tissues+and+MCP-1+levels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DE.%26aulast%3DRovin%26aufirst%3DB.%2BH.%26aulast%3DSen%26aufirst%3DL.%26aulast%3DCooke%26aufirst%3DG.%26aulast%3DDhanda%26aufirst%3DR.%26aulast%3DMummidi%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DH.%26aulast%3DBamshad%26aufirst%3DM.%2BJ.%26aulast%3DTelles%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DS.%2BA.%26aulast%3DWalter%26aufirst%3DE.%2BA.%26aulast%3DStephan%26aufirst%3DK.%2BT.%26aulast%3DDeucher%26aufirst%3DM.%26aulast%3DMangano%26aufirst%3DA.%26aulast%3DSBologna%26aufirst%3DR.%26aulast%3DAhuja%26aufirst%3DS.%2BS.%26aulast%3DDolan%26aufirst%3DM.%2BJ.%26aulast%3DAhuja%26aufirst%3DS.%2BK.%26atitle%3DHIV-1%2520infection%2520and%2520AIDS%2520dementia%2520are%2520influenced%2520by%2520a%2520mutant%2520MCP-1%2520allele%2520linked%2520to%2520increased%2520monocyte%2520infiltration%2520of%2520tissues%2520and%2520MCP-1%2520levels%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D13795%26epage%3D13800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Mankowski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queen, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zink, M. C.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid markers that predict SIV CNS disease</span> <span class="citation_source-journal">J Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2Fj.jneuroim.2004.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVaqsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2004&pages=66-70&author=J.+L.+Mankowskiauthor=S.+E.+Queenauthor=J.+E.+Clementsauthor=M.+C.+Zink&title=Cerebrospinal+fluid+markers+that+predict+SIV+CNS+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid markers that predict SIV CNS disease</span></div><div class="casAuthors">Mankowski, J. L.; Queen, S. E.; Clements, J. E.; Zink, M. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">66-70</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Predictive cerebrospinal fluid markers would provide valuable tools for tracking the development and progression of HIV CNS disease.  In this study, expression of IL-6, MCP-1, and viral RNA in cerebrospinal fluid collected from SIV-inoculated macaques during acute, asymptomatic, and terminal stages of infection was quantitated to det. whether one or several of these parameters paralleled the severity of SIV encephalitis.  Animals that developed moderate to severe SIV encephalitis had significantly elevated levels of CSF IL-6, MCP-1, and SIV RNA during asymptomatic infection and persisting through terminal disease as compared to animals developing mild or no CNS disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAK4LjQm8oFbVg90H21EOLACvtfcHk0liSYF28D6BX2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVaqsLjM&md5=b8d4d0312079a1c533b766908480ae74</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2004.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2004.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DMankowski%26aufirst%3DJ.%2BL.%26aulast%3DQueen%26aufirst%3DS.%2BE.%26aulast%3DClements%26aufirst%3DJ.%2BE.%26aulast%3DZink%26aufirst%3DM.%2BC.%26atitle%3DCerebrospinal%2520fluid%2520markers%2520that%2520predict%2520SIV%2520CNS%2520disease%26jtitle%3DJ%2520Neuroimmunol.%26date%3D2004%26volume%3D157%26spage%3D66%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Li, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borodyansky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardee, A. B.</span><span> </span><span class="NLM_article-title">Tat protein induces self-perpetuating permissivity for productive HIV-1 infection</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">8116</span><span class="NLM_x">–</span> <span class="NLM_lpage">8120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=8116-8120&author=C.+J.+Liauthor=Y.+Uedaauthor=B.+Shiauthor=L.+Borodyanskyauthor=L.+Huangauthor=Y.+Z.+Liauthor=A.+B.+Pardee&title=Tat+protein+induces+self-perpetuating+permissivity+for+productive+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BJ.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DB.%26aulast%3DBorodyansky%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%2BZ.%26aulast%3DPardee%26aufirst%3DA.%2BB.%26atitle%3DTat%2520protein%2520induces%2520self-perpetuating%2520permissivity%2520for%2520productive%2520HIV-1%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D8116%26epage%3D8120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ganju, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groopman, J. E.</span><span> </span><span class="NLM_article-title">Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi’s sarcoma cells</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">6131</span><span class="NLM_x">–</span> <span class="NLM_lpage">6137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFGltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1998&pages=6131-6137&author=R.+K.+Ganjuauthor=N.+Munshiauthor=B.+C.+Nairauthor=Z.+Y.+Liuauthor=P.+Gillauthor=J.+E.+Groopman&title=Human+immunodeficiency+virus+tat+modulates+the+Flk-1%2FKDR+receptor%2C+mitogen-activated+protein+kinases%2C+and+components+of+focal+adhesion+in+Kaposi%E2%80%99s+sarcoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Human immunodeficiency virus Tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells</span></div><div class="casAuthors">Ganju, Ramesh K.; Munshi, Neru; Nair, B. C.; Liu, Zhong-Ying; Gill, Parkash; Groopman, Jerome E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">6131-6137</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Kaposi's sarcoma (KS) spindle cell growth and spread have been reported to be modulated by various cytokines as well as the human immunodeficiency virus (HIV) gene product Tat.  Recently, HIV-1 Tat has been shown to act like a cytokine and bind to the Flk-1/KDR receptor for the vascular endothelial growth factor A (VEGF-A), which is expressed by KS cells.  The authors have characterized signal transduction pathways stimulated by HIV-1 Tat upon its binding to surface receptors on KS cells.  The authors obsd. that stimulation in KS 38 spindle cells resulted in tyrosine phosphorylation and activation of the Flk-1/KDR receptor.  The authors also report that HIV-1 Tat treatment enhanced the phosphorylation and assocn. of proteins found in focal adhesions, such as the related adhesion focal tyrosine kinase RAFTK, paxillin, and p130cas.  Further characterization revealed the activation of mitogen-activated protein kinase, c-Jun amino-terminal kinase (JNK), and Src kinase.  HIV-1 Tat contains a basic domain which can interact with growth factor tyrosine kinase receptors and a classical RGD sequence which may bind to and activate the surface integrin receptors for fibronectin and vitronectin.  The authors obsd. that stimulation of KS cells with basic as well as RGD sequence-contg. Tat peptides resulted in enhanced phosphorylation of RAFTK and activation of MAP kinase.  These studies reveal that Tat stimulation activates a no. of signal transduction pathways that are assocd. with cell growth and migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopiH57t1sHdbVg90H21EOLACvtfcHk0liSYF28D6BX2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFGltbw%253D&md5=6f69f3d6a221cef72616dffaf0c4fbc3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGanju%26aufirst%3DR.%2BK.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DNair%26aufirst%3DB.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BY.%26aulast%3DGill%26aufirst%3DP.%26aulast%3DGroopman%26aufirst%3DJ.%2BE.%26atitle%3DHuman%2520immunodeficiency%2520virus%2520tat%2520modulates%2520the%2520Flk-1%252FKDR%2520receptor%252C%2520mitogen-activated%2520protein%2520kinases%252C%2520and%2520components%2520of%2520focal%2520adhesion%2520in%2520Kaposi%25E2%2580%2599s%2520sarcoma%2520cells%26jtitle%3DJ.%2520Virol.%26date%3D1998%26volume%3D72%26spage%3D6131%26epage%3D6137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manna, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khawan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span> </span><span class="NLM_article-title">HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=1998&pages=776-781&author=A.+Kumarauthor=S.+K.+Mannaauthor=S.+Khawanauthor=B.+B.+Aggarwal&title=HIV-Tat+protein+activates+c-Jun+N-terminal+kinase+and+activator+protein-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DS.%2BK.%26aulast%3DKhawan%26aufirst%3DS.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DHIV-Tat%2520protein%2520activates%2520c-Jun%2520N-terminal%2520kinase%2520and%2520activator%2520protein-1%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D161%26spage%3D776%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Singh, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Hage, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, K. F.</span><span> </span><span class="NLM_article-title">Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2005&pages=781-790&author=I.+N.+Singhauthor=N.+El-Hageauthor=M.+E.+Campbellauthor=S.+E.+Lutzauthor=P.+E.+Knappauthor=A.+Nathauthor=K.+F.+Hauser&title=Differential+involvement+of+p38+and+JNK+MAP+kinases+in+HIV-1+Tat+and+gp120-induced+apoptosis+and+neurite+degeneration+in+striatal+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DI.%2BN.%26aulast%3DEl-Hage%26aufirst%3DN.%26aulast%3DCampbell%26aufirst%3DM.%2BE.%26aulast%3DLutz%26aufirst%3DS.%2BE.%26aulast%3DKnapp%26aufirst%3DP.%2BE.%26aulast%3DNath%26aufirst%3DA.%26aulast%3DHauser%26aufirst%3DK.%2BF.%26atitle%3DDifferential%2520involvement%2520of%2520p38%2520and%2520JNK%2520MAP%2520kinases%2520in%2520HIV-1%2520Tat%2520and%2520gp120-induced%2520apoptosis%2520and%2520neurite%2520degeneration%2520in%2520striatal%2520neurons%26jtitle%3DNeuroscience%26date%3D2005%26volume%3D135%26spage%3D781%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Davies, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tournier, C.</span><span> </span><span class="NLM_article-title">Exploring the function of the JNK (c-Jun N-terminal kinase) signaling pathway in physiological and pathological processes to design novel therapeutic strategies</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1042%2FBST20110641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=85-89&author=C.+Daviesauthor=C.+Tournier&title=Exploring+the+function+of+the+JNK+%28c-Jun+N-terminal+kinase%29+signaling+pathway+in+physiological+and+pathological+processes+to+design+novel+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies</span></div><div class="casAuthors">Davies, Clare; Tournier, Cathy</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-89</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  JNK (c-Jun N-terminal kinase) is a member of the MAPK (mitogen-activated protein kinase) family that regulates a range of biol. processes implicated in tumorigenesis and neurodegenerative disorders.  For example, genetic studies have demonstrated that the removal of specific Jnk genes can reduce neuronal death assocd. with cerebral ischemia.  As such, targeting JNK signalling constitutes an obvious opportunity for therapeutic intervention.  However, MAPK inhibitors can display toxic effects.  Consequently, dual-specificity MKKs (MAPK kinases) may represent more attractive targets.  In particular, evidence that blocking JNK activation by removing MKK4 offers an effective therapy to treat pathol. conditions has started to emerge.  MKK4 was the first JNK activator identified.  The remaining level of JNK activity in cells lacking MKK4 expression led to the discovery of a second activator of JNK, named MKK7.  Distinct phenotypic abnormalities assocd. with the targeted deletion of Mkk4 and Mkk7 in mice have revealed that MKK4 and MKK7 have non-redundant function in vivo.  Further insights into the specific functions of the JNK activators in cancer cells and in neurons will be of crit. importance to validate MKK4 and MKK7 as promising drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE5YUaVM80x7Vg90H21EOLACvtfcHk0lgvLeaDlegkFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqurk%253D&md5=23da2741d00c642daf9d90f9f1c85e80</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1042%2FBST20110641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110641%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DTournier%26aufirst%3DC.%26atitle%3DExploring%2520the%2520function%2520of%2520the%2520JNK%2520%2528c-Jun%2520N-terminal%2520kinase%2529%2520signaling%2520pathway%2520in%2520physiological%2520and%2520pathological%2520processes%2520to%2520design%2520novel%2520therapeutic%2520strategies%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D85%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Santiago, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefano, M.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry and the Molecular Operating Environment (MOE): application of QSAR and molecular docking to drug discovery</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.2174%2F156802608786786624" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1555-1572&author=V.+Santiagoauthor=C.+Giorgioauthor=M.+Stefano&title=Medicinal+Chemistry+and+the+Molecular+Operating+Environment+%28MOE%29%3A+application+of+QSAR+and+molecular+docking+to+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F156802608786786624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608786786624%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago%26aufirst%3DV.%26aulast%3DGiorgio%26aufirst%3DC.%26aulast%3DStefano%26aufirst%3DM.%26atitle%3DMedicinal%2520Chemistry%2520and%2520the%2520Molecular%2520Operating%2520Environment%2520%2528MOE%2529%253A%2520application%2520of%2520QSAR%2520and%2520molecular%2520docking%2520to%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1555%26epage%3D1572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Braselmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurcevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1124%2Fjpet.106.109058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=16946104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yltL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=998-1008&author=S.+Braselmannauthor=V.+Taylorauthor=H.+Zhaoauthor=S.+Wangauthor=C.+Sylvainauthor=M.+Baluomauthor=K.+Quauthor=E.+Herlaarauthor=A.+Lauauthor=C.+Youngauthor=B.+R.+Wongauthor=S.+Lovelauthor=T.+Sunauthor=G.+Parkauthor=A.+Argadeauthor=S.+Jurcevicauthor=P.+Pineauthor=R.+Singhauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+S.+Masuda&title=R406%2C+an+orally+available+spleen+tyrosine+kinase+inhibitor+blocks+fc+receptor+signaling+and+reduces+immune+complex-mediated+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation</span></div><div class="casAuthors">Braselmann, Sylvia; Taylor, Vanessa; Zhao, Haoran; Wang, Su; Sylvain, Catherine; Baluom, Muhammad; Qu, Kunbin; Herlaar, Ellen; Lau, Angela; Young, Chi; Wong, Brian R.; Lovell, Scott; Sun, Thomas; Park, Gary; Argade, Ankush; Jurcevic, Stipo; Pine, Polly; Singh, Rajinder; Grossbard, Elliott B.; Payan, Donald G.; Masuda, Esteban S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">998-1008</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent compelling evidence has lead to renewed interest in the role of antibodies and immune complexes in the pathogenesis of several autoimmune disorders, such as rheumatoid arthritis.  These immune complexes, consisting of autoantibodies to self-antigens, can mediate inflammatory responses largely through binding and activating the Ig Fc receptors (FcRs).  Using cell-based structure activity relationships with cultured human mast cells, we have identified the small mol. R406 [N4-(2,2-dimethyl-3-oxo-4H-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2- (3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine] as a potent inhibitor of IgE (IgE)- and IgG-mediated activation of Fc receptor signaling (EC50 for degranulation = 56-64 nM).  Here we show that the primary target for R406 is the spleen tyrosine kinase (Syk), which plays a key role in the signaling of activating Fc receptors and the B-cell receptor (BCR).  R406 inhibited phosphorylation of Syk substrate linker for activation of T cells in mast cells and B-cell linker protein/SLP65 in B cells.  R406 bound to the ATP binding pocket of Syk and inhibited its kinase activity as an ATP-competitive inhibitor (Ki = 30 nM).  Furthermore, R406 blocked Syk-dependent FcR-mediated activation of monocytes/macrophages and neutrophils and BCR-mediated activation of B lymphocytes.  R406 was selective as assessed using a large panel of Syk-independent cell-based assays representing both specific and general signaling pathways.  Consistent with Syk inhibition, oral administration of R406 to mice reduced immune complex-mediated inflammation in a reverse-passive Arthus reaction and two antibody-induced arthritis models.  Finally, we report a first-in-human study showing that R406 is orally bioavailable, achieving exposures capable of inhibiting Syk-dependent IgE-mediated basophil activation.  Collectively, the results show R406 potential for modulating Syk activity in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohoeT9BJQAyLVg90H21EOLACvtfcHk0lhPFLXGbWg-4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yltL7P&md5=18fea516041ea075d2123158f321a186</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.109058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.109058%26sid%3Dliteratum%253Aachs%26aulast%3DBraselmann%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DK.%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DB.%2BR.%26aulast%3DLovel%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DArgade%26aufirst%3DA.%26aulast%3DJurcevic%26aufirst%3DS.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DR406%252C%2520an%2520orally%2520available%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520fc%2520receptor%2520signaling%2520and%2520reduces%2520immune%2520complex-mediated%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D998%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellow, G. W.</span><span> </span><span class="NLM_article-title">Selectivity of kinase inhibitor fragments</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5131</span><span class="NLM_x">–</span> <span class="NLM_lpage">5143</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200349b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5131-5143&author=P.+Bamboroughauthor=M.+J.+Brownauthor=J.+A.+Christopherauthor=C.+Chungauthor=G.+W.+Mellow&title=Selectivity+of+kinase+inhibitor+fragments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm200349b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200349b%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DM.%2BJ.%26aulast%3DChristopher%26aufirst%3DJ.%2BA.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DMellow%26aufirst%3DG.%2BW.%26atitle%3DSelectivity%2520of%2520kinase%2520inhibitor%2520fragments%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5131%26epage%3D5143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhardauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhPFLXGbWg-4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhard%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lj3ZrbjRKw5lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNature%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, K.</span><span> </span><span class="NLM_article-title">The challenge of selecting protein kinase assays for lead discovery optimization</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1517%2F17460441.3.6.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=19662101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotVyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=607-621&author=H.+Maauthor=S.+Deaconauthor=K.+Horiuchi&title=The+challenge+of+selecting+protein+kinase+assays+for+lead+discovery+optimization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of selecting protein kinase assays for lead discovery optimization</span></div><div class="casAuthors">Ma, Haiching; Deacon, Sean; Horiuchi, Kurumi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">607-621</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Protein kinases represent one of the most promising groups of drug targets owing to their involvement in such pathol. conditions as cancer, inflammatory diseases, neural disorders, and metab. problems.  In the last few years, numerous pharmaceutical and biotech companies have established kinase high-throughput screening (HTS) programs, and the reagent and service industries for kinase assay platforms, kits, and profiling services have begun to thrive.  Objective: The plethora of different assay formats available today poses a great challenge to scientists who want to select a technol. that will be cost efficient, convenient to use, and have low false pos. and false neg. rates.  Methods: In the current review, we summarize the most commonly used kinase assay methods in the drug discovery process, present the advantages and disadvantages of each of these methods, and discuss the challenges of discovering kinase inhibitors by using these technologies.  Conclusions: The decision of selecting the assay formats for HTS or service platform for profiling should take into account not only the final goals of the screens but also the limitation of resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-z-puxv_a7Vg90H21EOLACvtfcHk0lj3ZrbjRKw5lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotVyrt70%253D&md5=d01a65a4560c5edb357f02c788631c69</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1517%2F17460441.3.6.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.3.6.607%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DDeacon%26aufirst%3DS.%26aulast%3DHoriuchi%26aufirst%3DK.%26atitle%3DThe%2520challenge%2520of%2520selecting%2520protein%2520kinase%2520assays%2520for%2520lead%2520discovery%2520optimization%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D607%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kaneko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionne, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakata, C.</span><span> </span><span class="NLM_article-title">Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970031d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1863-1869&author=M.+Kanekoauthor=Y.+Saitoauthor=H.+Saitoauthor=T.+Matsumotoauthor=Y.+Matsudaauthor=J.+L.+Vaughtauthor=C.+A.+Dionneauthor=T.+S.+Angelesauthor=M.+A.+Glicksmanauthor=N.+T.+Neffauthor=D.+P.+Rotellaauthor=J.+C.+Kauerauthor=J.+P.+Mallamoauthor=R.+L.+Hudkinsauthor=C.+Murakata&title=Neurotrophic+3%2C9-bis%5B%28alkylthio%29methyl%5D-and-bis%28alkoxymethyl%29-K-252a+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm970031d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970031d%26sid%3Dliteratum%253Aachs%26aulast%3DKaneko%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DVaught%26aufirst%3DJ.%2BL.%26aulast%3DDionne%26aufirst%3DC.%2BA.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DNeff%26aufirst%3DN.%2BT.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DKauer%26aufirst%3DJ.%2BC.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DMurakata%26aufirst%3DC.%26atitle%3DNeurotrophic%25203%252C9-bis%255B%2528alkylthio%2529methyl%255D-and-bis%2528alkoxymethyl%2529-K-252a%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1863%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Olaharski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzaludo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K.</span><span> </span><span class="NLM_article-title">Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1000446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000446&author=A.+J.+Olaharskiauthor=N.+Gonzaludoauthor=H.+Bitterauthor=D.+Goldsteinauthor=S.+Kirchnerauthor=H.+Uppalauthor=K.+Kolaja&title=Identification+of+a+kinase+profile+that+predicts+chromosome+damage+induced+by+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlaharski%26aufirst%3DA.%2BJ.%26aulast%3DGonzaludo%26aufirst%3DN.%26aulast%3DBitter%26aufirst%3DH.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DKirchner%26aufirst%3DS.%26aulast%3DUppal%26aufirst%3DH.%26aulast%3DKolaja%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520a%2520kinase%2520profile%2520that%2520predicts%2520chromosome%2520damage%2520induced%2520by%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3De1000446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901132v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1413-1437&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Selectively Nonselective Kinase Inhibition: Striking the Right Balance</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1413-1437</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Marketed kinase inhibitors (MKIs) can deliver superior efficacy compared to inhibitors with high specificity for a single kinase, and the recent introduction of several MKIs to the market opens the door to a new era of safer and effective anticancer therapy.  The key to combining high efficacy with acceptable safety is to inhibit multiple targets in a selectively nonselective fashion.  Strategies for intentionally designing MKIs are emerging, but the field is still in its infancy and we are as medicinal chemists currently on the steepest part of the learning curve.  MTDD can be time-consuming and expensive, and we need to become more proficient first at identifying disease-relevant target combinations and second at discovering MKIs that combine optimal physicochem. and biol. properties.  Bold and innovative medicinal chem. strategies are required to tackle "difficult combinations" where the disease rationale is compelling but where it is a struggle to combine all the desired attributes of an oral MKI drug into a single mol.  At present it is unclear to what extent MKIs with highly tuned selectivity profiles can be rationally designed, particularly for targets that are unrelated by sequence.  In addn. to the well-known selectivity challenge, the physicochem. property profiles of AT P-competitive MKIs can be inherently challenging and limited scope for patentability can also be a serious hindrance.  On the plus side, the amt. of kinase-specific structural information is growing very rapidly, and ultimately this may reveal distinct features and design rules that enable a medicinal chemist to rationally modify and refine the profile of MKIs.  In addn., increasing SAR knowledge is emerging from large scale panel screening with the binding profiles starting to reveal to medicinal chemists how chem. structure affects cross-reactivity across large parts of the kinome.  The merit of MKIs compared with single kinase inhibitors is a subject of controversy in drug discovery that is unlikely to be resolved in the near future.  At the start of a new MTDD project, a rigorous debate needs to take place as to whether it makes more sense to seek a combination of highly selective agents or a DML.  Many factors need to be taken into account in this decision such as the no., similarity, and promiscuity of the targets in the profile and the disease area.  Conformational plasticity and the occurrence of multiple binding modes complicate the in silico prediction of kinase polypharmacol. based solely upon protein structure.  The use of ligand-based similarity to assess the feasibility of a given combination can add real value.  Currently, serendipity plays a significant role in MKI discovery and many, if not most, MKIs have been discovered by chance during the search for selective inhibitors.  Medicinal chemists need to be alert to the possibilities when a surprising combination is found by chance.  To exploit such serendipity, you need a good appreciation of when you have a sufficiently high quality starting compd. and then you need to be able to make and test sufficient analogs to explore your new disease-based hypothesis.  MKIs are costly to develop and are consequently priced at a premium level, so they will need to show clear improvements in order to get reimbursement.  There have already been problems with reimbursement for some MKIs in some markets due to concerns from funding bodies over insufficient efficacy.  The true value of MKIs relative to other anticancer drugs still has to be established, and the results from recent clin. trials have been mixed.  Despite the broad activity profile of many MKIs, the patient response can be inconsistent and unpredictable.  The identification of predictive biomarkers of response or resistance is a crit. step to ascertain which specific combination of targets produces a significant clin. benefit with respect to specific tumor types.  More clin. feedback is needed to facilitate the design of the next generation of inhibitors with more precisely defined profiles.  Although it might seem immeasurably distant at the present time, the ultimate goal should be to derive the prerequisite knowledge and tools so that MTDD becomes a rational endeavor rather than a black box approach that relies upon serendipity.  This will help banish claims that MKIs are merely dirty, nonspecific drugs with insufficient specificity for treating a wider range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-L-NWmtdikbVg90H21EOLACvtfcHk0lhq_FBu-CUcgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF&md5=3c915b5debf9d005993c8ad31c68bc2e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901132v%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Grunwald, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M. J.</span><span> </span><span class="NLM_article-title">FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance</span> <span class="citation_source-journal">Int. J. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1007%2Fs12185-013-1334-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1ynt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2013&pages=683-694&author=M.+R.+Grunwaldauthor=M.+J.+Levis&title=FLT3+inhibitors+for+acute+myeloid+leukemia%3A+a+review+of+their+efficacy+and+mechanisms+of+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance</span></div><div class="casAuthors">Grunwald, Michael R.; Levis, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Hematology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">683-694</span>CODEN:
                <span class="NLM_cas:coden">IJHEEY</span>;
        ISSN:<span class="NLM_cas:issn">0925-5710</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">A review.  Since the Food and Drug Administration approval of imatinib for treatment of chronic myeloid leukemia in 2001, tyrosine kinase inhibitors (TKIs) have become a mainstay in the care of many malignancies.  In acute myeloid leukemia (AML), activating mutations in the FMS-like tyrosine kinase 3 (FLT3) gene result in survival and proliferation of leukemic blasts and are assocd. with adverse prognosis.  Therefore, the FLT3 receptor is an appealing target for inhibition.  Multiple small mol. TKIs are currently in development for FLT3-mutated AML, and agents are beginning to show promising efficacy.  In other malignancies, the development of resistance to TKIs during the course of therapy has proven to be a challenge, and thus far, in clin. trials of FLT3 TKIs, resistance to inhibition represents a significant barrier to successful FLT3 inhibition.  Understanding the mechanisms of resistance and overcoming these obstacles to target inhibition will be central to the success of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLGvQhRtVOcLVg90H21EOLACvtfcHk0lhq_FBu-CUcgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1ynt7Y%253D&md5=f760866dbcd953c09143e0290fbffe3c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs12185-013-1334-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12185-013-1334-8%26sid%3Dliteratum%253Aachs%26aulast%3DGrunwald%26aufirst%3DM.%2BR.%26aulast%3DLevis%26aufirst%3DM.%2BJ.%26atitle%3DFLT3%2520inhibitors%2520for%2520acute%2520myeloid%2520leukemia%253A%2520a%2520review%2520of%2520their%2520efficacy%2520and%2520mechanisms%2520of%2520resistance%26jtitle%3DInt.%2520J.%2520Hematol.%26date%3D2013%26volume%3D97%26spage%3D683%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">DeBoy, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cudrici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whartenby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P. A.</span><span> </span><span class="NLM_article-title">FLT-3 expression and function on microglia in multiple sclerosis</span> <span class="citation_source-journal">Exp. Mol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2Fj.yexmp.2010.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADC%252BC3cfgvVWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2010&pages=109-116&author=C.+A.+DeBoyauthor=H.+Rusauthor=C.+Teglaauthor=C.+Cudriciauthor=M.+V.+Jonesauthor=C.+A.+Pardoauthor=D.+Smallauthor=K.+A.+Whartenbyauthor=P.+A.+Calabresi&title=FLT-3+expression+and+function+on+microglia+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">FLT-3 expression and function on microglia in multiple sclerosis</span></div><div class="casAuthors">DeBoy Cynthia A; Rus Horea; Tegla Cosmin; Cudrici Cornelia; Jones Melina V; Pardo Carlos A; Small Donald; Whartenby Katharine A; Calabresi Peter A</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and molecular pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammatory cell infiltration and resident microglial activation within the central nervous system (CNS) are pathological events in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).  While MS therapies target the peripheral immune system, no treatment is currently known to also modulate microglia.  FMS-like tyrosine-3 (FLT-3) is expressed on hematopoietic and dendritic cells.  We reported that FLT-3 inhibition ameliorates early actively induced EAE by predominantly modulating dendritic cell function as compared to microglia.  We demonstrate in this report that FLT-3 is expressed in perivascular cuffs, brain parenchyma and in non-lesioned gray and white matter within MS brain but not in these regions within control brain.  Furthermore, we demonstrate that FLT-3 is expressed on two populations of cells within MS brain; one which expresses the dendritic cell marker CD209, and the other which does not, suggesting that FLT-3 within MS brain is expressed on infiltrating dendritic cells and a non-dendritic cell such as microglia.  Additionally, we report that FLT-3 inhibition in murine microglia blocks, in a dose-dependent manner, IFN-γ-induced expression of MHC class II and CD86, and LPS-induced secretion of IL-6.  These data suggest that FLT-3 is involved in microglial cells' capacity to respond to environmental cues to function as antigen presenting cells and mediate CNS inflammation.  Furthermore these data suggest that FLT-3 may be a therapeutic target on microglia to mitigate CNS inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCpUbo7qjyD1UIs6wFK5xJfW6udTcc2eaOkQTFtYmAz7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfgvVWksg%253D%253D&md5=2d9f1bbf587ed9bf1f317ecc2d96d90e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.yexmp.2010.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexmp.2010.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DDeBoy%26aufirst%3DC.%2BA.%26aulast%3DRus%26aufirst%3DH.%26aulast%3DTegla%26aufirst%3DC.%26aulast%3DCudrici%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DM.%2BV.%26aulast%3DPardo%26aufirst%3DC.%2BA.%26aulast%3DSmall%26aufirst%3DD.%26aulast%3DWhartenby%26aufirst%3DK.%2BA.%26aulast%3DCalabresi%26aufirst%3DP.%2BA.%26atitle%3DFLT-3%2520expression%2520and%2520function%2520on%2520microglia%2520in%2520multiple%2520sclerosis%26jtitle%3DExp.%2520Mol.%2520Pathol.%26date%3D2010%26volume%3D89%26spage%3D109%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lhQUZU3OSEh9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Santos, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Manero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Extrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=1131-1136&author=F.+P.+Santosauthor=H.+M.+Kantarjianauthor=N.+Jainauthor=T.+Manshouriauthor=D.+A.+Thomasauthor=G.+Garcia-Maneroauthor=D.+Kennedyauthor=Z.+Extrovauthor=J.+Cortesauthor=S.+Verstovsek&title=Phase+2+study+of+CEP-701%2C+an+orally+available+JAK2+inhibitor%2C+in+patients+with+primary+or+post-polycythemia+vera%2Fessential+thrombocythemia+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DF.%2BP.%26aulast%3DKantarjian%26aufirst%3DH.%2BM.%26aulast%3DJain%26aufirst%3DN.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DGarcia-Manero%26aufirst%3DG.%26aulast%3DKennedy%26aufirst%3DD.%26aulast%3DExtrov%26aufirst%3DZ.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPhase%25202%2520study%2520of%2520CEP-701%252C%2520an%2520orally%2520available%2520JAK2%2520inhibitor%252C%2520in%2520patients%2520with%2520primary%2520or%2520post-polycythemia%2520vera%252Fessential%2520thrombocythemia%2520myelofibrosis%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Olaharski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzaludo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K.</span><span> </span><span class="NLM_article-title">Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1093%2Ftoxsci%2Fkfq258" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=226-275&author=A.+J.+Olaharskiauthor=H.+Bitterauthor=N.+Gonzaludoauthor=R.+Kondruauthor=D.+M.+Goldsteinauthor=T.+S.+Zabkaauthor=H.+Linauthor=T.+Singerauthor=K.+Kolaja&title=Modeling+bone+marrow+toxicity+using+kinase+structural+motifs+and+the+inhibition+profiles+of+small+molecular+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq258%26sid%3Dliteratum%253Aachs%26aulast%3DOlaharski%26aufirst%3DA.%2BJ.%26aulast%3DBitter%26aufirst%3DH.%26aulast%3DGonzaludo%26aufirst%3DN.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DZabka%26aufirst%3DT.%2BS.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DSinger%26aufirst%3DT.%26aulast%3DKolaja%26aufirst%3DK.%26atitle%3DModeling%2520bone%2520marrow%2520toxicity%2520using%2520kinase%2520structural%2520motifs%2520and%2520the%2520inhibition%2520profiles%2520of%2520small%2520molecular%2520kinase%2520inhibitors%26jtitle%3DToxicol.%2520Sci.%26date%3D2010%26volume%3D118%26spage%3D226%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Tsika, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span> </span><span class="NLM_article-title">Mechanisms of LRRK2-mediated neurodegeneration</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1007%2Fs11910-012-0265-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsF2jsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=251-260&author=E.+Tsikaauthor=D.+J.+Moore&title=Mechanisms+of+LRRK2-mediated+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of LRRK2-Mediated Neurodegeneration</span></div><div class="casAuthors">Tsika, Elpida; Moore, Darren J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neurology and Neuroscience Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">CNNRBS</span>;
        ISSN:<span class="NLM_cas:issn">1534-6293</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene represent the most common cause of familial Parkinson's disease (PD), whereas common variation at the LRRK2 locus is assocd. with an increased risk of idiopathic PD.  Considerable progress has been made toward understanding the biol. functions of LRRK2 and the mol. mechanisms underlying the pathogenic effects of disease-assocd. mutations.  The development of neuronal culture models and transgenic or viral-based rodent models have proved useful for identifying a no. of emerging pathways implicated in LRRK2-dependent neuronal damage, including the microtubule network, actin cytoskeleton, autophagy, mitochondria, vesicular trafficking, and protein quality control.  However, many important questions remain to be posed and answered.  Elucidating the mol. mechanisms and pathways underlying LRRK2-mediated neurodegeneration is crit. for the identification of new mol. targets for therapeutic intervention in PD.  In this review we discuss recent advances and unanswered questions in understanding the pathophysiol. of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5tcBB2SWeZbVg90H21EOLACvtfcHk0lhW2nrILciz0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2jsb0%253D&md5=0d2a3d62fb96d6b8b9f0bae6ddcf7c11</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2Fs11910-012-0265-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-012-0265-8%26sid%3Dliteratum%253Aachs%26aulast%3DTsika%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26atitle%3DMechanisms%2520of%2520LRRK2-mediated%2520neurodegeneration%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2012%26volume%3D12%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Marker, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mockus, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1186%2F1742-2094-9-261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=261&author=D.+F.+Markerauthor=J.+M.+Pucciniauthor=T.+E.+Mockusauthor=J.+Barbieriauthor=S.+M.+Luauthor=H.+A.+Gelbard&title=LRRK2+kinase+inhibition+prevents+pathological+microglial+phagocytosis+in+response+to+HIV-1+Tat+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein</span></div><div class="casAuthors">Marker, Daniel F.; Puccini, Jenna M.; Mockus, Taryn E.; Barbieri, Justin; Lu, Shao-Ming; Gelbard, Harris A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Human Immunodeficiency Virus-1 (HIV-1) assocd. neurocognitive disorders (HANDs) are accompanied by significant morbidity, which persists despite the use of combined antiretroviral therapy (cART).  While activated microglia play a role in pathogenesis, changes in their immune effector functions, including phagocytosis and proinflammatory signaling pathways, are not well understood.  We have identified leucine-rich repeat kinase 2 (LRRK2) as a novel regulator of microglial phagocytosis and activation in an in vitro model of HANDs, and hypothesize that LRRK2 kinase inhibition will attenuate microglial activation during HANDs.  Methods: We treated BV-2 immortalized mouse microglia cells with the HIV-1 trans activator of transcription (Tat) protein in the absence or presence of LRRK2 kinase inhibitor (LRRK2i).  We used Western blot, qRT-PCR, immunocytochem. and latex bead engulfment assays to analyze LRRK2 protein levels, proinflammatory cytokine and phagocytosis receptor expression, LRRK2 cellular distribution and phagocytosis, resp.  Finally, we utilized ex vivo microfluidic chambers contg. primary hippocampal neurons and BV-2 microglia cells to investigate microglial phagocytosis of neuronal axons.  Results: We found that Tat-treatment of BV-2 cells induced kinase activity assocd. phosphorylation of serine 935 on LRRK2 and caused the formation of cytoplasmic LRRK2 inclusions.  LRRK2i decreased Tat-induced phosphorylation of serine 935 on LRRK2 and inhibited the formation of Tat-induced cytoplasmic LRRK2 inclusions.  LRRK2i also decreased Tat-induced process extension in BV-2 cells.  Furthermore, LRRK2i attenuated Tat-induced cytokine expression and latex bead engulfment.  We examd. relevant cellular targets in microfluidic chambers and found that Tat-treated BV-2 microglia cells cleared axonal arbor and engulfed neuronal elements, whereas saline treated controls did not.  LRRK2i was found to protect axons in the presence of Tat-activated microglia, as well as AnnexinV, a phosphatidylserine-binding protein.  In addn., LRRK2i decreased brain-specific angiogenesis inhibitor 1 (BAI1) receptor expression on BV-2 cells after Tat-treatment, a key receptor in phosphatidylserine-mediated phagocytosis.  Conclusion: Taken together, these results implicate LRRK2 as a key player in microglial inflammation and, in particular, in the phagocytosis of neuronal elements.  These studies show that LRRK2 kinase inhibition may prove an effective therapeutic strategy for HANDs, as well as other neuroinflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoKzmyQBRIXLVg90H21EOLACvtfcHk0lhW2nrILciz0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyju7g%253D&md5=6b906ae227f6b6f17bbaede4b59f3e85</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-9-261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-9-261%26sid%3Dliteratum%253Aachs%26aulast%3DMarker%26aufirst%3DD.%2BF.%26aulast%3DPuccini%26aufirst%3DJ.%2BM.%26aulast%3DMockus%26aufirst%3DT.%2BE.%26aulast%3DBarbieri%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DS.%2BM.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DLRRK2%2520kinase%2520inhibition%2520prevents%2520pathological%2520microglial%2520phagocytosis%2520in%2520response%2520to%2520HIV-1%2520Tat%2520protein%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2012%26volume%3D9%26spage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Kiebala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span> </span><span class="NLM_article-title">Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e18633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e18633&author=M.+Kiebalaauthor=S.+B.+Maggirwar&title=Ibudilast%2C+a+pharmacologic+phosphodiesterase+inhibitor%2C+prevents+human+immunodeficiency+virus-1+Tat-mediated+activation+of+microglial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiebala%26aufirst%3DM.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26atitle%3DIbudilast%252C%2520a%2520pharmacologic%2520phosphodiesterase%2520inhibitor%252C%2520prevents%2520human%2520immunodeficiency%2520virus-1%2520Tat-mediated%2520activation%2520of%2520microglial%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De18633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Sui, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sniderhan, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span> </span><span class="NLM_article-title">Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implication in HIV type 1 dementia</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">3226</span><span class="NLM_x">–</span> <span class="NLM_lpage">3236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=3226-3236&author=Z.+Suiauthor=L.+F.+Sniderhanauthor=G.+Schifittoauthor=R.+P.+Phippsauthor=H.+A.+Gelbardauthor=S.+Dewhurstauthor=S.+B.+Maggirwar&title=Functional+synergy+between+CD40+ligand+and+HIV-1+Tat+contributes+to+inflammation%3A+implication+in+HIV+type+1+dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DSniderhan%26aufirst%3DL.%2BF.%26aulast%3DSchifitto%26aufirst%3DG.%26aulast%3DPhipps%26aufirst%3DR.%2BP.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26atitle%3DFunctional%2520synergy%2520between%2520CD40%2520ligand%2520and%2520HIV-1%2520Tat%2520contributes%2520to%2520inflammation%253A%2520implication%2520in%2520HIV%2520type%25201%2520dementia%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D3226%26epage%3D3236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 42 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yelena Mostinski, Guus J. J. E. Heynen, Maria Pascual López-Alberca, Jerome Paul, Sandra Miksche, Silke Radetzki, David Schaller, Elena Shanina, Carola Seyffarth, Yuliya Kolomeets, Nandor Ziebart, Judith de Schryver, Sylvia Oestreich, Martin Neuenschwander, Yvette Roske, Udo Heinemann, Christoph Rademacher, Andrea Volkamer, Jens Peter von Kries, Walter Birchmeier, <span class="NLM_string-name hlFld-ContribAuthor">Marc Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14780-14804. <a href="https://doi.org/10.1021/acs.jmedchem.0c01265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BPyrazolones%252Bto%252BAzaindoles%25253A%252BEvolution%252Bof%252BActive-Site%252BSHP2%252BInhibitors%252BBased%252Bon%252BScaffold%252BHopping%252Band%252BBioisosteric%252BReplacement%26aulast%3DMostinski%26aufirst%3DYelena%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D19112020%26volume%3D63%26issue%3D23%26spage%3D14780%26epage%3D14804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ulf Bremberg, Johan Eriksson-Bajtner, Fredrik Lehmann, Viveca Oltner, Ellen Sölver, <span class="NLM_string-name hlFld-ContribAuthor">Johan Wennerberg</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Synthesis of Kinase Inhibitor AKN028. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (10)
                                     , 1360-1364. <a href="https://doi.org/10.1021/acs.oprd.8b00092" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00092%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BSynthesis%252Bof%252BKinase%252BInhibitor%252BAKN028%26aulast%3DBremberg%26aufirst%3DUlf%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03042018%26date%3D17092018%26volume%3D22%26issue%3D10%26spage%3D1360%26epage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Athena F.  Phoa</span>, <span class="hlFld-ContribAuthor ">Ramzi H.  Abbassi</span>, <span class="hlFld-ContribAuthor ">Monira  Hoque</span>, <span class="hlFld-ContribAuthor ">Tristan A.  Reekie</span>, <span class="hlFld-ContribAuthor ">Josep S.  Font</span>, <span class="hlFld-ContribAuthor ">Renae M.  Ryan</span>, <span class="hlFld-ContribAuthor ">Brett W.  Stringer</span>, <span class="hlFld-ContribAuthor ">Bryan W.  Day</span>, <span class="hlFld-ContribAuthor ">Terrance G.  Johns</span>, <span class="hlFld-ContribAuthor ">Lenka  Munoz</span>, and <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 2052-2070. <a href="https://doi.org/10.1021/acs.jmedchem.6b01840" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01840%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BOptimization%252Band%252BPharmacological%252BEvaluation%252Bof%252BInhibitors%252BTargeting%252BDual-Specificity%252BTyrosine%252BPhosphorylation-Regulated%252BKinases%252B%252528DYRK%252529%252Band%252BCDC-like%252Bkinases%252B%252528CLK%252529%252Bin%252BGlioblastoma%26aulast%3DZhou%26aufirst%3DQingqing%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D16122016%26date%3D28022017%26date%3D09032017%26date%3D16022017%26volume%3D60%26issue%3D5%26spage%3D2052%26epage%3D2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prakash  Kannaboina</span>, <span class="hlFld-ContribAuthor ">K. Anil  Kumar</span>, and <span class="hlFld-ContribAuthor ">Parthasarathi  Das</span>  . </span><span class="cited-content_cbyCitation_article-title">Site-Selective Intermolecular Oxidative C-3 Alkenylation of 7-Azaindoles at Room Temperature. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (5)
                                     , 900-903. <a href="https://doi.org/10.1021/acs.orglett.5b03429" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b03429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b03429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b03429%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSite-Selective%252BIntermolecular%252BOxidative%252BC-3%252BAlkenylation%252Bof%252B7-Azaindoles%252Bat%252BRoom%252BTemperature%26aulast%3DKannaboina%26aufirst%3DPrakash%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D07122015%26date%3D04022016%26date%3D04032016%26volume%3D18%26issue%3D5%26spage%3D900%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stéphanie  Gourdain</span>, <span class="hlFld-ContribAuthor ">Julien  Dairou</span>, <span class="hlFld-ContribAuthor ">Clément  Denhez</span>, <span class="hlFld-ContribAuthor ">Linh Chi  Bui</span>, <span class="hlFld-ContribAuthor ">Fernando  Rodrigues-Lima</span>, <span class="hlFld-ContribAuthor ">Nathalie  Janel</span>, <span class="hlFld-ContribAuthor ">Jean M.  Delabar</span>, <span class="hlFld-ContribAuthor ">Kevin  Cariou</span>, and <span class="hlFld-ContribAuthor ">Robert H.  Dodd</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of DANDYs, New 3,5-Diaryl-7-azaindoles Demonstrating Potent DYRK1A Kinase Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (23)
                                     , 9569-9585. <a href="https://doi.org/10.1021/jm401049v" title="DOI URL">https://doi.org/10.1021/jm401049v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401049v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401049v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BDANDYs%25252C%252BNew%252B3%25252C5-Diaryl-7-azaindoles%252BDemonstrating%252BPotent%252BDYRK1A%252BKinase%252BInhibitory%252BActivity%26aulast%3DGourdain%26aufirst%3DSt%25C3%25A9phanie%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D11072013%26date%3D19112013%26date%3D12122013%26date%3D04112013%26volume%3D56%26issue%3D23%26spage%3D9569%26epage%3D9585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua-fu  Zhao</span>, <span class="hlFld-ContribAuthor ">Chang-peng  Wu</span>, <span class="hlFld-ContribAuthor ">Xiu-ming  Zhou</span>, <span class="hlFld-ContribAuthor ">Peng-yu  Diao</span>, <span class="hlFld-ContribAuthor ">Yan-wen  Xu</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Xian-jian  Huang</span>, <span class="hlFld-ContribAuthor ">Wen-lan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhong-ping  Chen</span>, <span class="hlFld-ContribAuthor ">Guo-dong  Huang</span>, <span class="hlFld-ContribAuthor ">Wei-ping  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell International</span><span> <strong>2021,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12935-020-01728-4" title="DOI URL">https://doi.org/10.1186/s12935-020-01728-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12935-020-01728-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12935-020-01728-4%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%2520International%26atitle%3DSynergism%252Bbetween%252Bthe%252Bphosphatidylinositol%252B3-kinase%252Bp110%2525CE%2525B2%252Bisoform%252Binhibitor%252BAZD6482%252Band%252Bthe%252Bmixed%252Blineage%252Bkinase%252B3%252Binhibitor%252BURMC-099%252Bon%252Bthe%252Bblockade%252Bof%252Bglioblastoma%252Bcell%252Bmotility%252Band%252Bfocal%252Badhesion%252Bformation%26aulast%3DZhao%26aufirst%3DHua-fu%26date%3D2021%26date%3D2021%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huaqian  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Minglong  Qiao</span>, <span class="hlFld-ContribAuthor ">Jiawen  Hu</span>, <span class="hlFld-ContribAuthor ">Chunmei  Li</span>, <span class="hlFld-ContribAuthor ">Chenze  Qi</span>, <span class="hlFld-ContribAuthor ">Furen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient domino strategy for synthesis of 3‐substituted 1,5‐dihydro
              
                ‐4
                H
              
              ‐pyrrolo[3,2‐
              c
              ]pyridin‐4‐one derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>24 </em><a href="https://doi.org/10.1002/jhet.4339" title="DOI URL">https://doi.org/10.1002/jhet.4339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DEfficient%252Bdomino%252Bstrategy%252Bfor%252Bsynthesis%252Bof%252B3%2525E2%252580%252590substituted%252B1%25252C5%2525E2%252580%252590dihydro%252B%2525E2%252580%2525904%252BH%252B%2525E2%252580%252590pyrrolo%25255B3%25252C2%2525E2%252580%252590%252Bc%252B%25255Dpyridin%2525E2%252580%2525904%2525E2%252580%252590one%252Bderivatives%26aulast%3DChen%26aufirst%3DHuaqian%26date%3D2021%26date%3D2021%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Sunil Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Basabi  Rana</span>, <span class="hlFld-ContribAuthor ">Ajay  Rana</span>. </span><span class="cited-content_cbyCitation_article-title">The regulatory function of mixed lineage kinase 3 in tumor and host immunity. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>219 </em>, 107704. <a href="https://doi.org/10.1016/j.pharmthera.2020.107704" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107704%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DThe%252Bregulatory%252Bfunction%252Bof%252Bmixed%252Blineage%252Bkinase%252B3%252Bin%252Btumor%252Band%252Bhost%252Bimmunity%26aulast%3DKumar%26aufirst%3DSandeep%26date%3D2021%26volume%3D219%26spage%3D107704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah E.  Kohrt</span>, <span class="hlFld-ContribAuthor ">Wisam N.  Awadallah</span>, <span class="hlFld-ContribAuthor ">Robert A.  Phillips</span>, <span class="hlFld-ContribAuthor ">Thomas C.  Case</span>, <span class="hlFld-ContribAuthor ">Renjie  Jin</span>, <span class="hlFld-ContribAuthor ">Jagpreet S.  Nanda</span>, <span class="hlFld-ContribAuthor ">Xiuping  Yu</span>, <span class="hlFld-ContribAuthor ">Peter E.  Clark</span>, <span class="hlFld-ContribAuthor ">Yajun  Yi</span>, <span class="hlFld-ContribAuthor ">Robert J.  Matusik</span>, <span class="hlFld-ContribAuthor ">Philip D.  Anderson</span>, <span class="hlFld-ContribAuthor ">Magdalena M.  Grabowska</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells
              In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2021,</strong> <em>20 </em>
                                    (2)
                                     , 398-409. <a href="https://doi.org/10.1158/1535-7163.MCT-20-0244" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-20-0244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-20-0244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-20-0244%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DIdentification%252Bof%252BGenes%252BRequired%252Bfor%252BEnzalutamide%252BResistance%252Bin%252BCastration-Resistant%252BProstate%252BCancer%252BCells%252BIn%252BVitro%26aulast%3DKohrt%26aufirst%3DSarah%2BE.%26date%3D2021%26date%3D2020%26volume%3D20%26issue%3D2%26spage%3D398%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damoder Reddy  Motati</span>, <span class="hlFld-ContribAuthor ">Radhika  Amaradhi</span>, <span class="hlFld-ContribAuthor ">Thota  Ganesh</span>. </span><span class="cited-content_cbyCitation_article-title">Azaindole therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115830. <a href="https://doi.org/10.1016/j.bmc.2020.115830" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115830%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAzaindole%252Btherapeutic%252Bagents%26aulast%3DMotati%26aufirst%3DDamoder%2BReddy%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melle  Holwerda</span>, <span class="hlFld-ContribAuthor ">Philip  V’kovski</span>, <span class="hlFld-ContribAuthor ">Manon  Wider</span>, <span class="hlFld-ContribAuthor ">Volker  Thiel</span>, <span class="hlFld-ContribAuthor ">Ronald  Dijkman</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In Vitro. </span><span class="cited-content_cbyCitation_journal-name">Microorganisms</span><span> <strong>2020,</strong> <em>8 </em>
                                    (12)
                                     , 1872. <a href="https://doi.org/10.3390/microorganisms8121872" title="DOI URL">https://doi.org/10.3390/microorganisms8121872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/microorganisms8121872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmicroorganisms8121872%26sid%3Dliteratum%253Aachs%26jtitle%3DMicroorganisms%26atitle%3DIdentification%252Bof%252Ban%252BAntiviral%252BCompound%252Bfrom%252Bthe%252BPandemic%252BResponse%252BBox%252Bthat%252BEfficiently%252BInhibits%252BSARS-CoV-2%252BInfection%252BIn%252BVitro%26aulast%3DHolwerda%26aufirst%3DMelle%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D12%26spage%3D1872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junyan  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Deng</span>, <span class="hlFld-ContribAuthor ">Qing  Liu</span>, <span class="hlFld-ContribAuthor ">Yusheng  Huang</span>, <span class="hlFld-ContribAuthor ">Weitao  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Lu  Zhang</span>, <span class="hlFld-ContribAuthor ">Birong  Liang</span>, <span class="hlFld-ContribAuthor ">Jiaqi  He</span>, <span class="hlFld-ContribAuthor ">Zixin  Chen</span>, <span class="hlFld-ContribAuthor ">Cui  Yan</span>, <span class="hlFld-ContribAuthor ">Zhongqi  Yang</span>, <span class="hlFld-ContribAuthor ">Shaoxiang  Xian</span>, <span class="hlFld-ContribAuthor ">Lingjun  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2020,</strong> <em>11 </em>
                                    (7)
                                     <a href="https://doi.org/10.1038/s41419-020-02777-3" title="DOI URL">https://doi.org/10.1038/s41419-020-02777-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-020-02777-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-020-02777-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DPyroptosis%252Band%252Bferroptosis%252Binduced%252Bby%252Bmixed%252Blineage%252Bkinase%252B3%252B%252528MLK3%252529%252Bsignaling%252Bin%252Bcardiomyocytes%252Bare%252Bessential%252Bfor%252Bmyocardial%252Bfibrosis%252Bin%252Bresponse%252Bto%252Bpressure%252Boverload%26aulast%3DWang%26aufirst%3DJunyan%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Ravikanth  Velagapudi</span>, <span class="hlFld-ContribAuthor ">Cuicui  Kong</span>, <span class="hlFld-ContribAuthor ">Ramona M.  Rodriguiz</span>, <span class="hlFld-ContribAuthor ">William C.  Wetsel</span>, <span class="hlFld-ContribAuthor ">Ting  Yang</span>, <span class="hlFld-ContribAuthor ">Miles  Berger</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">Carol A.  Colton</span>, <span class="hlFld-ContribAuthor ">Niccolò  Terrando</span>. </span><span class="cited-content_cbyCitation_article-title">Neurovascular and immune mechanisms that regulate postoperative delirium superimposed on dementia. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's & Dementia</span><span> <strong>2020,</strong> <em>16 </em>
                                    (5)
                                     , 734-749. <a href="https://doi.org/10.1002/alz.12064" title="DOI URL">https://doi.org/10.1002/alz.12064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/alz.12064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Falz.12064%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520%2526%2520Dementia%26atitle%3DNeurovascular%252Band%252Bimmune%252Bmechanisms%252Bthat%252Bregulate%252Bpostoperative%252Bdelirium%252Bsuperimposed%252Bon%252Bdementia%26aulast%3DWang%26aufirst%3DPing%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D734%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen A.  Gallo</span>, <span class="hlFld-ContribAuthor ">Edmund  Ellsworth</span>, <span class="hlFld-ContribAuthor ">Hayden  Stoub</span>, <span class="hlFld-ContribAuthor ">Susan E.  Conrad</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>207 </em>, 107457. <a href="https://doi.org/10.1016/j.pharmthera.2019.107457" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.107457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.107457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.107457%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTherapeutic%252Bpotential%252Bof%252Btargeting%252Bmixed%252Blineage%252Bkinases%252Bin%252Bcancer%252Band%252Binflammation%26aulast%3DGallo%26aufirst%3DKathleen%2BA.%26date%3D2020%26volume%3D207%26spage%3D107457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pieter H.  Bos</span>, <span class="hlFld-ContribAuthor ">Emily R.  Lowry</span>, <span class="hlFld-ContribAuthor ">Jonathon  Costa</span>, <span class="hlFld-ContribAuthor ">Sebastian  Thams</span>, <span class="hlFld-ContribAuthor ">Alejandro  Garcia-Diaz</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>, <span class="hlFld-ContribAuthor ">Hynek  Wichterle</span>, <span class="hlFld-ContribAuthor ">Brent R.  Stockwell</span>. </span><span class="cited-content_cbyCitation_article-title">Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting Agents. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (12)
                                     , 1703-1715.e37. <a href="https://doi.org/10.1016/j.chembiol.2019.10.005" title="DOI URL">https://doi.org/10.1016/j.chembiol.2019.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2019.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2019.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DDevelopment%252Bof%252BMAP4%252BKinase%252BInhibitors%252Bas%252BMotor%252BNeuron-Protecting%252BAgents%26aulast%3DBos%26aufirst%3DPieter%2BH.%26date%3D2019%26volume%3D26%26issue%3D12%26spage%3D1703%26epage%3D1715.e37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patrick  Miller-Rhodes</span>, <span class="hlFld-ContribAuthor ">Cuicui  Kong</span>, <span class="hlFld-ContribAuthor ">Gurpreet S.  Baht</span>, <span class="hlFld-ContribAuthor ">Priyanka  Saminathan</span>, <span class="hlFld-ContribAuthor ">Ramona M.  Rodriguiz</span>, <span class="hlFld-ContribAuthor ">William C.  Wetsel</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">Niccolò  Terrando</span>. </span><span class="cited-content_cbyCitation_article-title">The broad spectrum mixed-lineage kinase 3 inhibitor URMC-099 prevents acute microgliosis and cognitive decline in a mouse model of perioperative neurocognitive disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2019,</strong> <em>16 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-019-1582-5" title="DOI URL">https://doi.org/10.1186/s12974-019-1582-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-019-1582-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-019-1582-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DThe%252Bbroad%252Bspectrum%252Bmixed-lineage%252Bkinase%252B3%252Binhibitor%252BURMC-099%252Bprevents%252Bacute%252Bmicrogliosis%252Band%252Bcognitive%252Bdecline%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bperioperative%252Bneurocognitive%252Bdisorders%26aulast%3DMiller-Rhodes%26aufirst%3DPatrick%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Xu</span>, <span class="hlFld-ContribAuthor ">Min  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Chi</span>, <span class="hlFld-ContribAuthor ">Xiuying  Liu</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Tianli  Lin</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, . </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2019,</strong> <em>93 </em>
                                    (18)
                                     <a href="https://doi.org/10.1128/JVI.00758-19" title="DOI URL">https://doi.org/10.1128/JVI.00758-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.00758-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.00758-19%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DHigh-Throughput%252BScreening%252BIdentifies%252BMixed-Lineage%252BKinase%252B3%252Bas%252Ba%252BKey%252BHost%252BRegulatory%252BFactor%252Bin%252BZika%252BVirus%252BInfection%26aulast%3DXu%26aufirst%3DHua%26date%3D2019%26volume%3D93%26issue%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth M.  Kline</span>, <span class="hlFld-ContribAuthor ">Laura M.  Butkovich</span>, <span class="hlFld-ContribAuthor ">Joshua M.  Bradner</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chang</span>, <span class="hlFld-ContribAuthor ">Harris  Gelbard</span>, <span class="hlFld-ContribAuthor ">Val  Goodfellow</span>, <span class="hlFld-ContribAuthor ">W. Michael  Caudle</span>, <span class="hlFld-ContribAuthor ">Malú G.  Tansey</span>. </span><span class="cited-content_cbyCitation_article-title">The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss. </span><span class="cited-content_cbyCitation_journal-name">Experimental Neurology</span><span> <strong>2019,</strong> <em>318 </em>, 157-164. <a href="https://doi.org/10.1016/j.expneurol.2019.05.002" title="DOI URL">https://doi.org/10.1016/j.expneurol.2019.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.expneurol.2019.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.expneurol.2019.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Neurology%26atitle%3DThe%252Bsecond%252Bgeneration%252Bmixed%252Blineage%252Bkinase-3%252B%252528MLK3%252529%252Binhibitor%252BCLFB-1134%252Bprotects%252Bagainst%252Bneurotoxin-induced%252Bnigral%252Bdopaminergic%252Bneuron%252Bloss%26aulast%3DKline%26aufirst%3DElizabeth%2BM.%26date%3D2019%26volume%3D318%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyanka  Saminathan</span>, <span class="hlFld-ContribAuthor ">Bhavesh D.  Kevadiya</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Marker</span>, <span class="hlFld-ContribAuthor ">Howard E.  Gendelman</span>, <span class="hlFld-ContribAuthor ">Santhi  Gorantla</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>. </span><span class="cited-content_cbyCitation_article-title">Broad Spectrum Mixed Lineage Kinase Type 3 Inhibition and HIV-1 Persistence in Macrophages. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroimmune Pharmacology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (1)
                                     , 44-51. <a href="https://doi.org/10.1007/s11481-018-09829-8" title="DOI URL">https://doi.org/10.1007/s11481-018-09829-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11481-018-09829-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11481-018-09829-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroimmune%2520Pharmacology%26atitle%3DBroad%252BSpectrum%252BMixed%252BLineage%252BKinase%252BType%252B3%252BInhibition%252Band%252BHIV-1%252BPersistence%252Bin%252BMacrophages%26aulast%3DSaminathan%26aufirst%3DPriyanka%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D1%26spage%3D44%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 386-453. <a href="https://doi.org/10.1002/cmdc.201800755" title="DOI URL">https://doi.org/10.1002/cmdc.201800755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800755%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DUnpacking%252Bthe%252BPathogen%252BBox%2525E2%252580%252594An%252BOpen%252BSource%252BTool%252Bfor%252BFighting%252BNeglected%252BTropical%252BDisease%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D386%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy D.  Calamaras</span>, <span class="hlFld-ContribAuthor ">Robert A.  Baumgartner</span>, <span class="hlFld-ContribAuthor ">Mark J.  Aronovitz</span>, <span class="hlFld-ContribAuthor ">Angela L.  McLaughlin</span>, <span class="hlFld-ContribAuthor ">Kelly  Tam</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Richards</span>, <span class="hlFld-ContribAuthor ">Craig W.  Cooper</span>, <span class="hlFld-ContribAuthor ">Nathan  Li</span>, <span class="hlFld-ContribAuthor ">Wendy E.  Baur</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Qiao</span>, <span class="hlFld-ContribAuthor ">Guang-Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Roger J.  Davis</span>, <span class="hlFld-ContribAuthor ">Navin K.  Kapur</span>, <span class="hlFld-ContribAuthor ">Richard H.  Karas</span>, <span class="hlFld-ContribAuthor ">Robert M.  Blanton</span>. </span><span class="cited-content_cbyCitation_article-title">Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Heart and Circulatory Physiology</span><span> <strong>2019,</strong> <em>316 </em>
                                    (1)
                                     , H145-H159. <a href="https://doi.org/10.1152/ajpheart.00029.2018" title="DOI URL">https://doi.org/10.1152/ajpheart.00029.2018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpheart.00029.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpheart.00029.2018%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Heart%2520and%2520Circulatory%2520Physiology%26atitle%3DMixed%252Blineage%252Bkinase-3%252Bprevents%252Bcardiac%252Bdysfunction%252Band%252Bstructural%252Bremodeling%252Bwith%252Bpressure%252Boverload%26aulast%3DCalamaras%26aufirst%3DTimothy%2BD.%26date%3D2019%26volume%3D316%26issue%3D1%26spage%3DH145%26epage%3DH159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomomi  Kiyota</span>, <span class="hlFld-ContribAuthor ">Jatin  Machhi</span>, <span class="hlFld-ContribAuthor ">Yaman  Lu</span>, <span class="hlFld-ContribAuthor ">Bhagyalaxmi  Dyavarshetty</span>, <span class="hlFld-ContribAuthor ">Maryam  Nemati</span>, <span class="hlFld-ContribAuthor ">Gang  Zhang</span>, <span class="hlFld-ContribAuthor ">R. Lee  Mosley</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">Howard E.  Gendelman</span>. </span><span class="cited-content_cbyCitation_article-title">URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2018,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-018-1172-y" title="DOI URL">https://doi.org/10.1186/s12974-018-1172-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-018-1172-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-018-1172-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DURMC-099%252Bfacilitates%252Bamyloid-%2525CE%2525B2%252Bclearance%252Bin%252Ba%252Bmurine%252Bmodel%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKiyota%26aufirst%3DTomomi%26date%3D2018%26date%3D2018%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Shi</span>, <span class="hlFld-ContribAuthor ">Mary  Mader</span>. </span><span class="cited-content_cbyCitation_article-title">Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (11)
                                     , 1981-1991. <a href="https://doi.org/10.1016/j.bmcl.2018.05.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain%252Bpenetrant%252Bkinase%252Binhibitors%25253A%252BLearning%252Bfrom%252Bkinase%252Bneuroscience%252Bdiscovery%26aulast%3DShi%26aufirst%3DYuan%26date%3D2018%26volume%3D28%26issue%3D11%26spage%3D1981%26epage%3D1991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Marker</span>, <span class="hlFld-ContribAuthor ">Timothy  Fitzgerald</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>. </span><span class="cited-content_cbyCitation_article-title">HAND Adjunctive Therapies: Reversing Neuronal Injury. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 599-604. <a href="https://doi.org/10.1007/978-1-4939-7101-5_217" title="DOI URL">https://doi.org/10.1007/978-1-4939-7101-5_217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7101-5_217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7101-5_217%26sid%3Dliteratum%253Aachs%26atitle%3DHAND%252BAdjunctive%252BTherapies%25253A%252BReversing%252BNeuronal%252BInjury%26aulast%3DMarker%26aufirst%3DDaniel%2BF.%26date%3D2018%26date%3D2018%26spage%3D599%26epage%3D604%26pub%3DSpringer%2520New%2520York%26atitle%3DEncyclopedia%252Bof%252BAIDS%26aulast%3DHope%26aufirst%3DThomas%2BJ.%26date%3D2018%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masashi  Okada</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Takeda</span>, <span class="hlFld-ContribAuthor ">Hirotsugu  Sakaki</span>, <span class="hlFld-ContribAuthor ">Kenta  Kuramoto</span>, <span class="hlFld-ContribAuthor ">Shuhei  Suzuki</span>, <span class="hlFld-ContribAuthor ">Tomomi  Sanomachi</span>, <span class="hlFld-ContribAuthor ">Keita  Togashi</span>, <span class="hlFld-ContribAuthor ">Shizuka  Seino</span>, <span class="hlFld-ContribAuthor ">Chifumi  Kitanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (55)
                                     , 94872-94882. <a href="https://doi.org/10.18632/oncotarget.22033" title="DOI URL">https://doi.org/10.18632/oncotarget.22033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.22033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.22033%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRepositioning%252BCEP-1347%25252C%252Ba%252Bchemical%252Bagent%252Boriginally%252Bdeveloped%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%25252C%252Bas%252Ban%252Banti-cancer%252Bstem%252Bcell%252Bdrug%26aulast%3DOkada%26aufirst%3DMasashi%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D55%26spage%3D94872%26epage%3D94882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyoko  Tomita</span>, <span class="hlFld-ContribAuthor ">Rohit  Kohli</span>, <span class="hlFld-ContribAuthor ">Brittany L.  MacLaurin</span>, <span class="hlFld-ContribAuthor ">Petra  Hirsova</span>, <span class="hlFld-ContribAuthor ">Qianqian  Guo</span>, <span class="hlFld-ContribAuthor ">Luz H. Gutierrez  Sanchez</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">Burns C.  Blaxall</span>, <span class="hlFld-ContribAuthor ">Samar H.  Ibrahim</span>. </span><span class="cited-content_cbyCitation_article-title">Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2017,</strong> <em>2 </em>
                                    (15)
                                     <a href="https://doi.org/10.1172/jci.insight.94488" title="DOI URL">https://doi.org/10.1172/jci.insight.94488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.94488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.94488%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DMixed-lineage%252Bkinase%252B3%252Bpharmacological%252Binhibition%252Battenuates%252Bmurine%252Bnonalcoholic%252Bsteatohepatitis%26aulast%3DTomita%26aufirst%3DKyoko%26date%3D2017%26volume%3D2%26issue%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of pyrrolopyridines derivatives: a patent and literature review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (5)
                                     , 591-606. <a href="https://doi.org/10.1080/13543776.2017.1280465" title="DOI URL">https://doi.org/10.1080/13543776.2017.1280465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1280465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1280465%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Badvances%252Bof%252Bpyrrolopyridines%252Bderivatives%25253A%252Ba%252Bpatent%252Band%252Bliterature%252Breview%26aulast%3DEl-Gamal%26aufirst%3DMohammed%2BI.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D591%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clémence  Feneyrolles</span>, <span class="hlFld-ContribAuthor ">Léa  Guiet</span>, <span class="hlFld-ContribAuthor ">Mathilde  Singer</span>, <span class="hlFld-ContribAuthor ">Nathalie  Van Hijfte</span>, <span class="hlFld-ContribAuthor ">Bénédicte  Daydé-Cazals</span>, <span class="hlFld-ContribAuthor ">Bénédicte  Fauvel</span>, <span class="hlFld-ContribAuthor ">Gwénaël  Chevé</span>, <span class="hlFld-ContribAuthor ">Abdelaziz  Yasri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovering novel 7-azaindole-based series as potent AXL kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 862-866. <a href="https://doi.org/10.1016/j.bmcl.2017.01.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovering%252Bnovel%252B7-azaindole-based%252Bseries%252Bas%252Bpotent%252BAXL%252Bkinase%252Binhibitors%26aulast%3DFeneyrolles%26aufirst%3DCl%25C3%25A9mence%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D862%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Divya Prakash  Gnanadhas</span>, <span class="hlFld-ContribAuthor ">Prasanta K.  Dash</span>, <span class="hlFld-ContribAuthor ">Brady  Sillman</span>, <span class="hlFld-ContribAuthor ">Aditya N.  Bade</span>, <span class="hlFld-ContribAuthor ">Zhiyi  Lin</span>, <span class="hlFld-ContribAuthor ">Diana L.  Palandri</span>, <span class="hlFld-ContribAuthor ">Nagsen  Gautam</span>, <span class="hlFld-ContribAuthor ">Yazen  Alnouti</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">JoEllyn  McMillan</span>, <span class="hlFld-ContribAuthor ">R. Lee  Mosley</span>, <span class="hlFld-ContribAuthor ">Benson  Edagwa</span>, <span class="hlFld-ContribAuthor ">Howard E.  Gendelman</span>, <span class="hlFld-ContribAuthor ">Santhi  Gorantla</span>. </span><span class="cited-content_cbyCitation_article-title">Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2017,</strong> <em>127 </em>
                                    (3)
                                     , 857-873. <a href="https://doi.org/10.1172/JCI90025" title="DOI URL">https://doi.org/10.1172/JCI90025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI90025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI90025%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DAutophagy%252Bfacilitates%252Bmacrophage%252Bdepots%252Bof%252Bsustained-release%252Bnanoformulated%252Bantiretroviral%252Bdrugs%26aulast%3DGnanadhas%26aufirst%3DDivya%2BPrakash%26date%3D2017%26volume%3D127%26issue%3D3%26spage%3D857%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiguo  Dong</span>, <span class="hlFld-ContribAuthor ">Christine M.  Embury</span>, <span class="hlFld-ContribAuthor ">Yaman  Lu</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Whitmire</span>, <span class="hlFld-ContribAuthor ">Bhagyalaxmi  Dyavarshetty</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">Howard E.  Gendelman</span>, <span class="hlFld-ContribAuthor ">Tomomi  Kiyota</span>. </span><span class="cited-content_cbyCitation_article-title">The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroinflammation</span><span> <strong>2016,</strong> <em>13 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12974-016-0646-z" title="DOI URL">https://doi.org/10.1186/s12974-016-0646-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12974-016-0646-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12974-016-0646-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroinflammation%26atitle%3DThe%252Bmixed-lineage%252Bkinase%252B3%252Binhibitor%252BURMC-099%252Bfacilitates%252Bmicroglial%252Bamyloid-%2525CE%2525B2%252Bdegradation%26aulast%3DDong%26aufirst%3DWeiguo%26date%3D2016%26date%3D2016%26volume%3D13%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suresh  Narva</span>, <span class="hlFld-ContribAuthor ">Surendar  Chitti</span>, <span class="hlFld-ContribAuthor ">Bhaskara Rao  Bala</span>, <span class="hlFld-ContribAuthor ">Mallika  Alvala</span>, <span class="hlFld-ContribAuthor ">Nishant  Jain</span>, <span class="hlFld-ContribAuthor ">Venkata Gowri Chandra Sekhar  Kondapalli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of pyrrolo[2,3- b ]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>114 </em>, 220-231. <a href="https://doi.org/10.1016/j.ejmech.2016.02.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.02.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.02.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrrolo%25255B2%25252C3-%252Bb%252B%25255Dpyridine%252Banalogues%252Bas%252Bantiproliferative%252Bagents%252Band%252Btheir%252Binteraction%252Bwith%252Bcalf%252Bthymus%252BDNA%26aulast%3DNarva%26aufirst%3DSuresh%26date%3D2016%26volume%3D114%26spage%3D220%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph  D'Attoma</span>, <span class="hlFld-ContribAuthor ">Grégoire  Cozien</span>, <span class="hlFld-ContribAuthor ">Pierre Louis  Brun</span>, <span class="hlFld-ContribAuthor ">Yves  Robin</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bostyn</span>, <span class="hlFld-ContribAuthor ">Frédéric  Buron</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>. </span><span class="cited-content_cbyCitation_article-title">Fast functionalization of (7-aza)indoles using continuous flow processes. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2016,</strong> <em>1 </em>
                                    (3)
                                     , 338-342. <a href="https://doi.org/10.1002/slct.201600012" title="DOI URL">https://doi.org/10.1002/slct.201600012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201600012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201600012%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DFast%252Bfunctionalization%252Bof%252B%2525287-aza%252529indoles%252Busing%252Bcontinuous%252Bflow%252Bprocesses%26aulast%3DD%2527Attoma%26aufirst%3DJoseph%26date%3D2016%26date%3D2016%26volume%3D1%26issue%3D3%26spage%3D338%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramon  Yarza</span>, <span class="hlFld-ContribAuthor ">Silvia  Vela</span>, <span class="hlFld-ContribAuthor ">Maite  Solas</span>, <span class="hlFld-ContribAuthor ">Maria J.  Ramirez</span>. </span><span class="cited-content_cbyCitation_article-title">c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2016,</strong> <em>6 </em><a href="https://doi.org/10.3389/fphar.2015.00321" title="DOI URL">https://doi.org/10.3389/fphar.2015.00321</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2015.00321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2015.00321%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3Dc-Jun%252BN-terminal%252BKinase%252B%252528JNK%252529%252BSignaling%252Bas%252Ba%252BTherapeutic%252BTarget%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DYarza%26aufirst%3DRamon%26date%3D2016%26date%3D2016%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Zhang</span>, <span class="hlFld-ContribAuthor ">Dongwei  Guo</span>, <span class="hlFld-ContribAuthor ">Prasanta K.  Dash</span>, <span class="hlFld-ContribAuthor ">Mariluz  Araínga</span>, <span class="hlFld-ContribAuthor ">Jayme L.  Wiederin</span>, <span class="hlFld-ContribAuthor ">Nicole A.  Haverland</span>, <span class="hlFld-ContribAuthor ">Jaclyn  Knibbe-Hollinger</span>, <span class="hlFld-ContribAuthor ">Andrea  Martinez-Skinner</span>, <span class="hlFld-ContribAuthor ">Pawel  Ciborowski</span>, <span class="hlFld-ContribAuthor ">Val S.  Goodfellow</span>, <span class="hlFld-ContribAuthor ">Tadeusz A.  Wysocki</span>, <span class="hlFld-ContribAuthor ">Beata J.  Wysocki</span>, <span class="hlFld-ContribAuthor ">Larisa Y.  Poluektova</span>, <span class="hlFld-ContribAuthor ">Xin-Ming  Liu</span>, <span class="hlFld-ContribAuthor ">JoEllyn M.  McMillan</span>, <span class="hlFld-ContribAuthor ">Santhi  Gorantla</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">Howard E.  Gendelman</span>. </span><span class="cited-content_cbyCitation_article-title">The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine: Nanotechnology, Biology and Medicine</span><span> <strong>2016,</strong> <em>12 </em>
                                    (1)
                                     , 109-122. <a href="https://doi.org/10.1016/j.nano.2015.09.009" title="DOI URL">https://doi.org/10.1016/j.nano.2015.09.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nano.2015.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nano.2015.09.009%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%253A%2520Nanotechnology%252C%2520Biology%2520and%2520Medicine%26atitle%3DThe%252Bmixed%252Blineage%252Bkinase-3%252Binhibitor%252BURMC-099%252Bimproves%252Btherapeutic%252Boutcomes%252Bfor%252Blong-acting%252Bantiretroviral%252Btherapy%26aulast%3DZhang%26aufirst%3DGang%26date%3D2016%26volume%3D12%26issue%3D1%26spage%3D109%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshihiko  Tashima</span>. </span><span class="cited-content_cbyCitation_article-title">Intriguing possibilities and beneficial aspects of transporter-conscious drug design. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4119-4131. <a href="https://doi.org/10.1016/j.bmc.2015.06.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIntriguing%252Bpossibilities%252Band%252Bbeneficial%252Baspects%252Bof%252Btransporter-conscious%252Bdrug%252Bdesign%26aulast%3DTashima%26aufirst%3DToshihiko%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4119%26epage%3D4131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Marker</span>, <span class="hlFld-ContribAuthor ">Timothy  Fitzgerald</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>. </span><span class="cited-content_cbyCitation_article-title">HAND Adjunctive Therapies: Reversing Neuronal Injury. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 1-6. <a href="https://doi.org/10.1007/978-1-4614-9610-6_217-1" title="DOI URL">https://doi.org/10.1007/978-1-4614-9610-6_217-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-9610-6_217-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-9610-6_217-1%26sid%3Dliteratum%253Aachs%26atitle%3DHAND%252BAdjunctive%252BTherapies%25253A%252BReversing%252BNeuronal%252BInjury%26aulast%3DMarker%26aufirst%3DDaniel%2BF.%26date%3D2015%26date%3D2015%26spage%3D1%26epage%3D6%26pub%3DSpringer%2520New%2520York%26atitle%3DEncyclopedia%252Bof%252BAIDS%26aulast%3DHope%26aufirst%3DThomas%2BJ.%26date%3D2014%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Howard E.  Gendelman</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>. </span><span class="cited-content_cbyCitation_article-title">Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in HIV and AIDS</span><span> <strong>2014,</strong> <em>9 </em>
                                    (6)
                                     , 585-590. <a href="https://doi.org/10.1097/COH.0000000000000111" title="DOI URL">https://doi.org/10.1097/COH.0000000000000111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/COH.0000000000000111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCOH.0000000000000111%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520HIV%2520and%2520AIDS%26atitle%3DAdjunctive%252Band%252Blong-acting%252Bnanoformulated%252Bantiretroviral%252Btherapies%252Bfor%252BHIV-associated%252Bneurocognitive%252Bdisorders%26aulast%3DGendelman%26aufirst%3DHoward%2BE.%26date%3D2014%26volume%3D9%26issue%3D6%26spage%3D585%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun Hyoe  Rhoo</span>, <span class="hlFld-ContribAuthor ">Megan  Granger</span>, <span class="hlFld-ContribAuthor ">Joynita  Sur</span>, <span class="hlFld-ContribAuthor ">Changyong  Feng</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">Stephen  Dewhurst</span>, <span class="hlFld-ContribAuthor ">Oksana  Polesskaya</span>, . </span><span class="cited-content_cbyCitation_article-title">Pharmacologic Inhibition of MLK3 Kinase Activity Blocks the In Vitro Migratory Capacity of Breast Cancer Cells but Has No Effect on Breast Cancer Brain Metastasis in a Mouse Xenograft Model. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (9)
                                     , e108487. <a href="https://doi.org/10.1371/journal.pone.0108487" title="DOI URL">https://doi.org/10.1371/journal.pone.0108487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0108487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0108487%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DPharmacologic%252BInhibition%252Bof%252BMLK3%252BKinase%252BActivity%252BBlocks%252Bthe%252BIn%252BVitro%252BMigratory%252BCapacity%252Bof%252BBreast%252BCancer%252BCells%252Bbut%252BHas%252BNo%252BEffect%252Bon%252BBreast%252BCancer%252BBrain%252BMetastasis%252Bin%252Ba%252BMouse%252BXenograft%252BModel%26aulast%3DRhoo%26aufirst%3DKun%2BHyoe%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D9%26spage%3De108487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oksana  Polesskaya</span>, <span class="hlFld-ContribAuthor ">Christopher  Wong</span>, <span class="hlFld-ContribAuthor ">Luis  Lebron</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Harris A.  Gelbard</span>, <span class="hlFld-ContribAuthor ">Val  Goodfellow</span>, <span class="hlFld-ContribAuthor ">Minsoo  Kim</span>, <span class="hlFld-ContribAuthor ">John L.  Daiss</span>, <span class="hlFld-ContribAuthor ">Stephen  Dewhurst</span>. </span><span class="cited-content_cbyCitation_article-title">MLK3 regulates fMLP-stimulated neutrophil motility. </span><span class="cited-content_cbyCitation_journal-name">Molecular Immunology</span><span> <strong>2014,</strong> <em>58 </em>
                                    (2)
                                     , 214-222. <a href="https://doi.org/10.1016/j.molimm.2013.11.016" title="DOI URL">https://doi.org/10.1016/j.molimm.2013.11.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molimm.2013.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molimm.2013.11.016%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Immunology%26atitle%3DMLK3%252Bregulates%252BfMLP-stimulated%252Bneutrophil%252Bmotility%26aulast%3DPolesskaya%26aufirst%3DOksana%26date%3D2014%26volume%3D58%26issue%3D2%26spage%3D214%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  McCoull</span>, <span class="hlFld-ContribAuthor ">Edward J.  Hennessy</span>, <span class="hlFld-ContribAuthor ">Kevin  Blades</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Box</span>, <span class="hlFld-ContribAuthor ">Claudio  Chuaqui</span>, <span class="hlFld-ContribAuthor ">James E.  Dowling</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Davies</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Frederick W.  Goldberg</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Howe</span>, <span class="hlFld-ContribAuthor ">Paul D.  Kemmitt</span>, <span class="hlFld-ContribAuthor ">Gillian M.  Lamont</span>, <span class="hlFld-ContribAuthor ">Katrina  Madden</span>, <span class="hlFld-ContribAuthor ">Claire  McWhirter</span>, <span class="hlFld-ContribAuthor ">Jeffrey G.  Varnes</span>, <span class="hlFld-ContribAuthor ">Richard A.  Ward</span>, <span class="hlFld-ContribAuthor ">Jason D.  Williams</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and optimisation of 7-azaindole PAK1 inhibitors with improved potency and kinase selectivity. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (10)
                                     , 1533-1539. <a href="https://doi.org/10.1039/C4MD00280F" title="DOI URL">https://doi.org/10.1039/C4MD00280F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00280F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00280F%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DIdentification%252Band%252Boptimisation%252Bof%252B7-azaindole%252BPAK1%252Binhibitors%252Bwith%252Bimproved%252Bpotency%252Band%252Bkinase%252Bselectivity%26aulast%3DMcCoull%26aufirst%3DWilliam%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D10%26spage%3D1533%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of known potent MLK3 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Potent and drug-like 7-azaindole MLK3 inhibitors selected for initial profiling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Optimization design path to compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of HIV Tat stimulated cytokine release in human monocytes with compound <b>1</b> at 100, 300, and 1000 nM concentrations (NT = no treatment).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Intraperitoneal (ip) compound <b>1</b> treatment prevents HIV-1 Tat mediated increase in JNK phosphorylation in vivo in brain tissue ipsilateral to stereotactically injected Tat. (A) Immunoblots of the expression of pJNK and α-tubulin in brain tissue of mice stereotactically injected with saline (Sa) vehicle and no treatment or Sa+ systemic administration of <b>1</b> or stereotaxic injection of HIV-1 Tat and no treatment or stereotaxic injection of Tat with systemic administration of <b>1</b>. (B) Densitometric analyses of the optical density of bands in (A), normalized to the expression of α tubulin in each experimental replicate. * = <i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Potential binding site interactions analysis for MLK1 and compound <b>1</b> based on manual docking and minimization studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Percent inhibition profiles in the DiscoverRx ScanMax kinome scan for compounds <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NIS, acetone; (b) NaH, <i>p</i>-TSA, THF; (c) indole-5-boronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, MeCN, aq 2 M Na<sub>2</sub>CO<sub>3</sub>; (d) 4-formylphenyl boronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, MeCN, aq 2 M Na<sub>2</sub>CO<sub>3</sub>; (e) 1-methylpiperazine, Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>; (f) aq 5N NaOH, CH<sub>2</sub>Cl<sub>2</sub>, acetone.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 7-azaindole-5-boronic acid pinacol ester, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, MeCN, aq 1 M Na<sub>2</sub>CO<sub>3</sub>; (b) NaH, <i>p</i>-toluene sulfonyl chloride, DMF; (c) 4-formylphenyl boronic acid, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, MeCN, aq 1 M Na<sub>2</sub>CO<sub>3</sub>; (d) 1-methyl piperazine, Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>; (e) NaOH, MeOH.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/medium/jm-2013-01094t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Screening Hit <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm401094t/production/images/large/jm-2013-01094t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401094t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (b) EtOH, DIEA, 80 °C; (c) CDI, THF, 65 °C; (d) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CH<sub>3</sub>CN, H<sub>2</sub>O, 150 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i78">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 63 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Marker, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantz Marker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loweth, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muly, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodfellow, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">9998</span><span class="NLM_x">–</span> <span class="NLM_lpage">10010</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1523%2FJNEUROSCI.0598-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslKmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=9998-10010&author=D.+F.+Markerauthor=M.+E.+Tremblayauthor=J.+M.+Pucciniauthor=J.+Barbieriauthor=M.+A.+Gantz+Markerauthor=C.+J.+Lowethauthor=E.+C.+Mulyauthor=S.+M.+Luauthor=V.+S.+Goodfellowauthor=S.+Dewhurstauthor=H.+A.+Gelbard&title=The+new+small-molecule+mixed-lineage+kinase+3+inhibitor+URMC-099+is+neuroprotective+and+anti-inflammatory+in+models+of+human+immunodeficiency+virus-associated+neurocognitive+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive disorders</span></div><div class="casAuthors">Marker, Daniel F.; Tremblay, Marie-Eve; Puccini, Jenna M.; Barbieri, Justin; Marker, Mary A. Gantz; Loweth, Colin J.; Muly, E. Chris; Lu, Shao-Ming; Goodfellow, Val S.; Dewhurst, Stephen; Gelbard, Harris A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9998-10010</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Human immunodeficiency virus (HIV)-assocd. neurocognitive disorders (HAND) is a significant source of disability in the HIV-infected population.  Even with stringent adherence to anti-retroviral therapy, >50% of patients living with HIV-1 will develop HAND.  Because suppression of viral replication alone is not enough to stop HAND progression, there is a need for an adjunctive neuroprotective therapy in this population.  To this end, we have developed a small-mol. brain-penetrant inhibitor with activity against mixed-lineage kinase 3 (MLK3), named URMC-099.  MLK3 activation is assocd. with many of the pathol. hallmarks of HAND and therefore represents a prime target for adjunctive therapy based on small-mol. kinase inhibition.  Here we demonstrate the anti-inflammatory and neuroprotective effects of URMC-099 in multiple murine and rodent models of HAND.  In vitro, URMC-099 treatment reduced inflammatory cytokine prodn. by HIV-1 Tat-exposed microglia and prevented destruction and phagocytosis of cultured neuronal axons by these cells.  In vivo, URMC-099 treatment reduced inflammatory cytokine prodn., protected neuronal architecture, and altered the morphol. and ultrastructural response of microglia to HIV-1 Tat exposure.  In conclusion, these data provide compelling in vitro and in vivo evidence to investigate the utility of URMC-099 in other models of HAND with the goal of advancement to an adjunctive therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNCsZZAzOfCrVg90H21EOLACvtfcHk0lgT90Rh1HbYAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslKmsrw%253D&md5=683f118425138b2ef7447e4a34c87636</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0598-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0598-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DMarker%26aufirst%3DD.%2BF.%26aulast%3DTremblay%26aufirst%3DM.%2BE.%26aulast%3DPuccini%26aufirst%3DJ.%2BM.%26aulast%3DBarbieri%26aufirst%3DJ.%26aulast%3DGantz%2BMarker%26aufirst%3DM.%2BA.%26aulast%3DLoweth%26aufirst%3DC.%2BJ.%26aulast%3DMuly%26aufirst%3DE.%2BC.%26aulast%3DLu%26aufirst%3DS.%2BM.%26aulast%3DGoodfellow%26aufirst%3DV.%2BS.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DThe%2520new%2520small-molecule%2520mixed-lineage%2520kinase%25203%2520inhibitor%2520URMC-099%2520is%2520neuroprotective%2520and%2520anti-inflammatory%2520in%2520models%2520of%2520human%2520immunodeficiency%2520virus-associated%2520neurocognitive%2520disorders%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D9998%26epage%3D10010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Heaton, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCutchan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letendre, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corkran, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duarte, N. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clifford, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgello, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mindt, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelman, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennema-Notestine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jernigan, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, I.</span><span> </span><span class="NLM_article-title">HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors</span> <span class="citation_source-journal">J NeuroVirol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1007%2Fs13365-010-0006-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=21174240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVyrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=3-16&author=R.+K.+Heatonauthor=D.+R.+Franklinauthor=R.+J.+Ellisauthor=J.+A.+McCutchanauthor=S.+L.+Letendreauthor=S.+Leblancauthor=S.+H.+Corkranauthor=N.+A+Duarteauthor=D.+B.+Cliffordauthor=S.+P.+Woodsauthor=A.+C.+Collierauthor=C.+M.+Marraauthor=S.+Morgelloauthor=M.+R.+Mindtauthor=M.+J+Taylorauthor=T.+D.+Marcotteauthor=J.+H.+Atkinsonauthor=T.+Wolfsonauthor=B.+B.+Gelmanauthor=J.+C.+McArthurauthor=D.+M.+Simpsonauthor=I.+Abramsonauthor=A.+Gamstauthor=C.+Fennema-Notestineauthor=T.+L.+Jerniganauthor=J.+Wongauthor=I.+Grant&title=HIV-associated+neurocognitive+disorders+before+and+during+the+era+of+combination+antiretroviral+therapy%3A+differences+in+rates%2C+nature%2C+and+predictors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors</span></div><div class="casAuthors">Heaton, Robert K.; Franklin, Donald R.; Ellis, Ronald J.; McCutchan, J. Allen; Letendre, Scott L.; LeBlanc, Shannon; Corkran, Stephanie H.; Duarte, Nichole A.; Clifford, David B.; Woods, Steven P.; Collier, Ann C.; Marra, Christina M.; Morgello, Susan; Mindt, Monica Rivera; Taylor, Michael J.; Marcotte, Thomas D.; Atkinson, J. Hampton; Wolfson, Tanya; Gelman, Benjamin B.; McArthur, Justin C.; Simpson, David M.; Abramson, Ian; Gamst, Anthony; Fennema-Notestine, Christine; Jernigan, Terry L.; Wong, Joseph; Grant, Igor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of NeuroVirology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-16</span>CODEN:
                <span class="NLM_cas:coden">JNVIFK</span>;
        ISSN:<span class="NLM_cas:issn">1355-0284</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and mortality with HIV infection, but high rates of HIV-assocd. neurocognitive disorders (HAND) continue to be reported.  Because large HIV-infected (HIV+) and uninfected (HIV-) groups have not been studied with similar methods in the pre-CART and CART eras, it is unclear whether CART has changed the prevalence, nature, and clin. correlates of HAND.  We used comparable methods of subject screening and assessments to classify neurocognitive impairment (NCI) in large groups of HIV + and HIV - participants from the pre-CART era (1988-1995; N = 857) and CART era (2000-2007; N = 937).  Impairment rate increased with successive disease stages (CDC stages A, B, and C) in both eras: 25, 42, and 52% in pre-CART era and 36, 40, and 45% in CART era.  In the medically asymptomatic stage (CDC-A), NCI was significantly more common in the CART era.  Low nadir CD4 predicted NCI in both eras, whereas degree of current immunosuppression, estd. duration of infection, and viral suppression in CSF (on treatment) were related to impairment only pre-CART.  Pattern of NCI also differed: pre-CART had more impairment in motor skills, cognitive speed, and verbal fluency, whereas CART era involved more memory (learning) and executive function impairment.  High rates of mild NCI persist at all stages of HIV infection, despite improved viral suppression and immune reconstitution with CART.  The consistent assocn. of NCI with nadir CD4 across eras suggests that earlier treatment to prevent severe immunosuppression may also help prevent HAND.  Clin. trials targeting HAND prevention should specifically examine timing of ART initiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonCaVzD1EKJrVg90H21EOLACvtfcHk0ljFzd2UHp3aUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVyrtb8%253D&md5=7e59a0c46d8b250b6b14c54ee9b34149</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs13365-010-0006-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13365-010-0006-1%26sid%3Dliteratum%253Aachs%26aulast%3DHeaton%26aufirst%3DR.%2BK.%26aulast%3DFranklin%26aufirst%3DD.%2BR.%26aulast%3DEllis%26aufirst%3DR.%2BJ.%26aulast%3DMcCutchan%26aufirst%3DJ.%2BA.%26aulast%3DLetendre%26aufirst%3DS.%2BL.%26aulast%3DLeblanc%26aufirst%3DS.%26aulast%3DCorkran%26aufirst%3DS.%2BH.%26aulast%3DDuarte%26aufirst%3DN.%2BA%26aulast%3DClifford%26aufirst%3DD.%2BB.%26aulast%3DWoods%26aufirst%3DS.%2BP.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26aulast%3DMarra%26aufirst%3DC.%2BM.%26aulast%3DMorgello%26aufirst%3DS.%26aulast%3DMindt%26aufirst%3DM.%2BR.%26aulast%3DTaylor%26aufirst%3DM.%2BJ%26aulast%3DMarcotte%26aufirst%3DT.%2BD.%26aulast%3DAtkinson%26aufirst%3DJ.%2BH.%26aulast%3DWolfson%26aufirst%3DT.%26aulast%3DGelman%26aufirst%3DB.%2BB.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DSimpson%26aufirst%3DD.%2BM.%26aulast%3DAbramson%26aufirst%3DI.%26aulast%3DGamst%26aufirst%3DA.%26aulast%3DFennema-Notestine%26aufirst%3DC.%26aulast%3DJernigan%26aufirst%3DT.%2BL.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DI.%26atitle%3DHIV-associated%2520neurocognitive%2520disorders%2520before%2520and%2520during%2520the%2520era%2520of%2520combination%2520antiretroviral%2520therapy%253A%2520differences%2520in%2520rates%252C%2520nature%252C%2520and%2520predictors%26jtitle%3DJ%2520NeuroVirol.%26date%3D2011%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiebala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polesskaya, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">392</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=392-398&author=H.+A.+Gelbardauthor=S.+Dewhurstauthor=S.+B.+Maggirwarauthor=M.+Kiebalaauthor=O.+Polesskayaauthor=H.+E.+Gendelman&title=Rebuilding+synaptic+architecture+in+HIV-1+associated+neurocognitive+disease%3A+a+therapeutic+strategy+based+on+modulation+of+mixed+lineage+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DKiebala%26aufirst%3DM.%26aulast%3DPolesskaya%26aufirst%3DO.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DRebuilding%2520synaptic%2520architecture%2520in%2520HIV-1%2520associated%2520neurocognitive%2520disease%253A%2520a%2520therapeutic%2520strategy%2520based%2520on%2520modulation%2520of%2520mixed%2520lineage%2520kinase%26jtitle%3DNeurotherapeutics%26date%3D2010%26volume%3D7%26spage%3D392%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gallo, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. L.</span><span> </span><span class="NLM_article-title">Mixed-lineage kinase control of JNK and p38 pathways</span> <span class="citation_source-journal">Nature Rev. Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnrm906" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=663-672&author=K.+A.+Galloauthor=G.+L.+Johnson&title=Mixed-lineage+kinase+control+of+JNK+and+p38+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm906%26sid%3Dliteratum%253Aachs%26aulast%3DGallo%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26atitle%3DMixed-lineage%2520kinase%2520control%2520of%2520JNK%2520and%2520p38%2520pathways%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D663%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Silva, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuan, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakic, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, R. E.</span><span> </span><span class="NLM_article-title">Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson’s disease</span> <span class="citation_source-journal">Mov. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">653</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=653-664&author=R.+M.+Silvaauthor=C.+Y.+Kuanauthor=P.+Rakicauthor=R.+E.+Burke&title=Mixed+lineage+kinase-c-jun+N-terminal+kinase+signaling+pathway%3A+a+new+therapeutic+target+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DR.%2BM.%26aulast%3DKuan%26aufirst%3DC.%2BY.%26aulast%3DRakic%26aufirst%3DP.%26aulast%3DBurke%26aufirst%3DR.%2BE.%26atitle%3DMixed%2520lineage%2520kinase-c-jun%2520N-terminal%2520kinase%2520signaling%2520pathway%253A%2520a%2520new%2520therapeutic%2520target%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2005%26volume%3D20%26spage%3D653%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wang, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besirli, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.,  Jr.</span><span> </span><span class="NLM_article-title">Mixed-lineage kinases: a target for the prevention of neurodegeneration</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=451-474&author=L.+H.+Wangauthor=C.+G.+Besirliauthor=E.+M.+Johnson&title=Mixed-lineage+kinases%3A+a+target+for+the+prevention+of+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%2BH.%26aulast%3DBesirli%26aufirst%3DC.%2BG.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26atitle%3DMixed-lineage%2520kinases%253A%2520a%2520target%2520for%2520the%2520prevention%2520of%2520neurodegeneration%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2004%26volume%3D44%26spage%3D451%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, J. L.</span><span> </span><span class="NLM_article-title">Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">25302</span><span class="NLM_x">–</span> <span class="NLM_lpage">25308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=25302-25308&author=A.+C.+Maroneyauthor=J.+P.+Finnauthor=T.+J.+Connorsauthor=J.+T.+Durkinauthor=T.+Angelesauthor=G.+Gessnerauthor=Z.+Xuauthor=S.+L.+Meyerauthor=M.+J.+Savageauthor=L.+A.+Greeneauthor=R.+W.+Scottauthor=J.+L.+Vaught&title=Cep-1347+%28KT7515%29%2C+a+semisynthetic+inhibitor+of+the+mixed+lineage+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DFinn%26aufirst%3DJ.%2BP.%26aulast%3DConnors%26aufirst%3DT.%2BJ.%26aulast%3DDurkin%26aufirst%3DJ.%2BT.%26aulast%3DAngeles%26aufirst%3DT.%26aulast%3DGessner%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMeyer%26aufirst%3DS.%2BL.%26aulast%3DSavage%26aufirst%3DM.%2BJ.%26aulast%3DGreene%26aufirst%3DL.%2BA.%26aulast%3DScott%26aufirst%3DR.%2BW.%26aulast%3DVaught%26aufirst%3DJ.%2BL.%26atitle%3DCep-1347%2520%2528KT7515%2529%252C%2520a%2520semisynthetic%2520inhibitor%2520of%2520the%2520mixed%2520lineage%2520kinase%2520family%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D25302%26epage%3D25308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Handley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasaiyaah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollara, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chain, B. M.</span><span> </span><span class="NLM_article-title">Expression and function of mixed lineage kinases in dendritic cells</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1093%2Fintimm%2Fdxm050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWmtLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=923-933&author=M.+E.+Handleyauthor=J.+Rasaiyaahauthor=J.+Barnettauthor=M.+Thakkerauthor=G.+Pollaraauthor=D.+R.+Katzauthor=B.+M.+Chain&title=Expression+and+function+of+mixed+lineage+kinases+in+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and function of mixed lineage kinases in dendritic cells</span></div><div class="casAuthors">Handley, Matthew E.; Rasaiyaah, Jane; Barnett, James; Thakker, Manish; Pollara, Gabriele; Katz, David R.; Chain, Benjamin M.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">923-933</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Dendritic cells (DCs) sense the presence of conserved microbial structures in their local microenvironment via specific pattern recognition receptors (PRRs).  This leads to a program of changes, which include migration and activation, and enables them to induce adaptive T cell immunity.  Mitogen-activated protein kinases (MAPKs) are implicated in this response, but the pathways leading from PRR ligation to MAPK activation, and hence DC activation, are not fully understood.  Recent studies in the nervous system have suggested that the mixed lineage kinase (MLK) family of MAPK kinase kinase proteins may be involved as an intermediary step between PRRs and MAPKs.  Therefore, in this study, we have used a well-established DC model to explore the role of MLKs in these cells.  MRNA for MLKs 2, 3, 4 and DLK and protein for MLKs 2, 3 and DLK are found in DC.  DC activation in response to model PRR ligands, such as LPS or poly (I:C), is accompanied by phosphorylation of MLK3.  In contrast, another known PRR ligand, zymosan, induces little MLK3 phosphorylation.  Inhibition of MLK activity using a pharmacol. inhibitor, CEP11004, blocks p38 and Jun N-terminal kinase (JNK) MAPK activation in response to LPS and poly (I:C), but not zymosan.  The inhibition is assocd. with a block in DC activation as measured by cell-surface marker expression and cytokine secretion.  Thus, MLKs are expressed in DC, and are implicated in DC activation, and the involvement of MLKs appears to be selective, depending on the nature of the DC stimulus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRGrsS0Q0JTrVg90H21EOLACvtfcHk0liW_qb3OE_hOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWmtLvO&md5=0ad68705b9d5a01b38d37fd3e8972b25</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxm050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxm050%26sid%3Dliteratum%253Aachs%26aulast%3DHandley%26aufirst%3DM.%2BE.%26aulast%3DRasaiyaah%26aufirst%3DJ.%26aulast%3DBarnett%26aufirst%3DJ.%26aulast%3DThakker%26aufirst%3DM.%26aulast%3DPollara%26aufirst%3DG.%26aulast%3DKatz%26aufirst%3DD.%2BR.%26aulast%3DChain%26aufirst%3DB.%2BM.%26atitle%3DExpression%2520and%2520function%2520of%2520mixed%2520lineage%2520kinases%2520in%2520dendritic%2520cells%26jtitle%3DInt.%2520Immunol.%26date%3D2007%26volume%3D19%26spage%3D923%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Handley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasaiyaah, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chain, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, D. R.</span><span> </span><span class="NLM_article-title">Mixed lineage kinases (MLKs): a role in dendritic cells, inflammation and immunity?</span> <span class="citation_source-journal">Int. J. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1111%2Fj.1365-2613.2007.00531.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslWjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2007&pages=111-126&author=M.+E.+Handleyauthor=J.+Rasaiyaahauthor=B.+M.+Chainauthor=D.+R.+Katz&title=Mixed+lineage+kinases+%28MLKs%29%3A+a+role+in+dendritic+cells%2C+inflammation+and+immunity%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinases (MLKs): a role in dendritic cells, inflammation and immunity?</span></div><div class="casAuthors">Handley, Matthew E.; Rasaiyaah, Jane; Chain, Benjamin M.; Katz, David R.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Experimental Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-126</span>CODEN:
                <span class="NLM_cas:coden">IJEPEI</span>;
        ISSN:<span class="NLM_cas:issn">0959-9673</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">This review summarizes current knowledge about the mixed lineage kinases (MLKs) and explores their potential role in inflammation and immunity.  MLKs were identified initially as signalling mols. in the nervous system.  They were also shown to play a role in the cell cycle.  Further studies documented three groups of MLKs, and showed that they may be activated via the c-Jun NH2 terminal kinase (JNK) pathway, and by Rho GTPases.  The biochem. of the MLKs has been investigated in considerable detail.  Homodimerization and heterodimerization can occur, and both autophosphorylation and autoinhibition are seen.  The interaction between MLKs and JNK interacting protein (JIP) scaffolds, and the resultant effects on mitogen activated protein kinases, have been identified.  Clearly, there is some redundancy within the MLK pathway(s), since mice which lack the MLK3 mol. are not abnormal.  However, using a combination of biochem. anal. and pharmacol. inhibitors, several recent studies in vitro have suggested that MLKs are not only expressed in cells of the immune system (as well as in the nervous system), but also may be implicated selectively in the signalling pathway that follows on toll-like receptor ligation in innate sentinel cells, such as the dendritic cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHhh8Ep53ApbVg90H21EOLACvtfcHk0liW_qb3OE_hOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslWjtrc%253D&md5=5b5bd1d3bbe4baf015bc9ce202c72480</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2613.2007.00531.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2613.2007.00531.x%26sid%3Dliteratum%253Aachs%26aulast%3DHandley%26aufirst%3DM.%2BE.%26aulast%3DRasaiyaah%26aufirst%3DJ.%26aulast%3DChain%26aufirst%3DB.%2BM.%26aulast%3DKatz%26aufirst%3DD.%2BR.%26atitle%3DMixed%2520lineage%2520kinases%2520%2528MLKs%2529%253A%2520a%2520role%2520in%2520dendritic%2520cells%252C%2520inflammation%2520and%2520immunity%253F%26jtitle%3DInt.%2520J.%2520Exp.%2520Pathol.%26date%3D2007%26volume%3D88%26spage%3D111%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jaeschke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. J.</span><span> </span><span class="NLM_article-title">Metabolic stress signaling mediated by mixed-lineage kinases</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=498-508&author=A.+Jaeschkeauthor=R.+J.+Davis&title=Metabolic+stress+signaling+mediated+by+mixed-lineage+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaeschke%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DR.%2BJ.%26atitle%3DMetabolic%2520stress%2520signaling%2520mediated%2520by%2520mixed-lineage%2520kinases%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D498%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sathyanarayana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundu, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzivion, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, A.</span><span> </span><span class="NLM_article-title">Activation of the drosophila MLK by ceramide reveals TNF-alpha and ceramide as agonists of mammalian MLK3</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1527</span><span class="NLM_x">–</span> <span class="NLM_lpage">1533</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=1527-1533&author=P.+Sathyanarayanaauthor=M.+K.+Barthwalauthor=C.+N.+Kunduauthor=M.+E.+Laneauthor=A.+Bergmannauthor=G.+Tzivionauthor=A.+Rana&title=Activation+of+the+drosophila+MLK+by+ceramide+reveals+TNF-alpha+and+ceramide+as+agonists+of+mammalian+MLK3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSathyanarayana%26aufirst%3DP.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DKundu%26aufirst%3DC.%2BN.%26aulast%3DLane%26aufirst%3DM.%2BE.%26aulast%3DBergmann%26aufirst%3DA.%26aulast%3DTzivion%26aufirst%3DG.%26aulast%3DRana%26aufirst%3DA.%26atitle%3DActivation%2520of%2520the%2520drosophila%2520MLK%2520by%2520ceramide%2520reveals%2520TNF-alpha%2520and%2520ceramide%2520as%2520agonists%2520of%2520mammalian%2520MLK3%26jtitle%3DMol.%2520Cell%26date%3D2002%26volume%3D10%26spage%3D1527%26epage%3D1533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Leung, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassam, N.</span><span> </span><span class="NLM_article-title">Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">32408</span><span class="NLM_x">–</span> <span class="NLM_lpage">32415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=32408-32415&author=I.+W.+Leungauthor=N.+Lassam&title=Dimerization+via+tandem+leucine+zippers+is+essential+for+the+activation+of+the+mitogen-activated+protein+kinase+kinase+kinase%2C+MLK-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DI.%2BW.%26aulast%3DLassam%26aufirst%3DN.%26atitle%3DDimerization%2520via%2520tandem%2520leucine%2520zippers%2520is%2520essential%2520for%2520the%2520activation%2520of%2520the%2520mitogen-activated%2520protein%2520kinase%2520kinase%2520kinase%252C%2520MLK-3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D32408%26epage%3D32415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Leung, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassam, N.</span><span> </span><span class="NLM_article-title">The kinase activation loop is the key to mixed lineage kinase-3 activation via both autophosphorylation and hematopoietic progenitor kinase 1 phosphorylation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=1961-1967&author=I.+W.+Leungauthor=N.+Lassam&title=The+kinase+activation+loop+is+the+key+to+mixed+lineage+kinase-3+activation+via+both+autophosphorylation+and+hematopoietic+progenitor+kinase+1+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeung%26aufirst%3DI.%2BW.%26aulast%3DLassam%26aufirst%3DN.%26atitle%3DThe%2520kinase%2520activation%2520loop%2520is%2520the%2520key%2520to%2520mixed%2520lineage%2520kinase-3%2520activation%2520via%2520both%2520autophosphorylation%2520and%2520hematopoietic%2520progenitor%2520kinase%25201%2520phosphorylation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D1961%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sui, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sniderhan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reisinger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litzburg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span> </span><span class="NLM_article-title">Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2006&pages=702-711&author=Z.+Suiauthor=S.+Fanauthor=L.+Sniderhanauthor=E.+Reisingerauthor=A.+Litzburgauthor=G.+Schifittoauthor=H.+A.+Gelbardauthor=S.+Dewhurstauthor=S.+B.+Maggirwar&title=Inhibition+of+mixed+lineage+kinase+3+prevents+HIV-1+Tat-mediated+neurotoxicity+and+monocyte+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DS.%26aulast%3DSniderhan%26aufirst%3DL.%26aulast%3DReisinger%26aufirst%3DE.%26aulast%3DLitzburg%26aufirst%3DA.%26aulast%3DSchifitto%26aufirst%3DG.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26atitle%3DInhibition%2520of%2520mixed%2520lineage%2520kinase%25203%2520prevents%2520HIV-1%2520Tat-mediated%2520neurotoxicity%2520and%2520monocyte%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D177%26spage%3D702%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">New, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-<i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors by a NFkappaB-independent mechanism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">17852</span><span class="NLM_x">–</span> <span class="NLM_lpage">17858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=17852-17858&author=D.+R.+Newauthor=S.+B.+Maggirwarauthor=L.+G.+Epsteinauthor=S.+Dewhurstauthor=H.+A.+Gelbard&title=HIV-1+Tat+induces+neuronal+death+via+tumor+necrosis+factor-alpha+and+activation+of+non-N-methyl-d-aspartate+receptors+by+a+NFkappaB-independent+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNew%26aufirst%3DD.%2BR.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DEpstein%26aufirst%3DL.%2BG.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DHIV-1%2520Tat%2520induces%2520neuronal%2520death%2520via%2520tumor%2520necrosis%2520factor-alpha%2520and%2520activation%2520of%2520non-N-methyl-d-aspartate%2520receptors%2520by%2520a%2520NFkappaB-independent%2520mechanism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D17852%26epage%3D17858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS</span> <span class="citation_source-journal">J. Neuroimmune Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1007%2Fs11481-006-9051-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADC%252BD2sjgtlGntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=93-96&author=S.+Dewhurstauthor=S.+B.+Maggirwarauthor=G.+Schifittoauthor=H.+E.+Gendelmanauthor=H.+A.+Gelbard&title=Glycogen+synthase+kinase+3+beta+%28GSK-3+beta%29+as+a+therapeutic+target+in+neuroAIDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS</span></div><div class="casAuthors">Dewhurst Stephen; Maggirwar Sanjay B; Schifitto Giovanni; Gendelman Howard E; Gelbard Harris A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Highly active antiretroviral therapy (HAART) has made a significant impact on the lives of people living with HIV-1 infection.  The incidence of neurologic disease associated with HIV-1 infection of the CNS plummeted between 1996-2000, but unfortunately the number of people currently HIV-1 infected (i.e., prevalence) with associated cognitive impairment has been steadily rising.  While the reasons for this may be multifactorial, the implication is clear: there is a pressing need for adjunctive therapy directed at reversing or preventing damage to vulnerable pathways in the central nervous system (CNS) from HIV-1 infection.  Using a team of preclinical and clinical investigators, we have focused our efforts on defining how proinflammatory mediators and secretory neurotoxins from HIV-1 disrupt signaling of the survival-regulating enzyme, glycogen synthase kinase 3 beta (GSK-3beta).  In a series of studies initiated using in vitro, then in vivo models of HIV-1-associated dementia (HAD), we have demonstrated the ability of the mood stabilizing and anticonvulsant drug, sodium valproate (VPA), that inhibits GSK-3beta activity and other downstream mediators, to reverse HIV-1-induced damage to synaptic pathways in the CNS.  Based on these results, we successfully performed pharmacokinetic and safety and tolerability trials with VPA in a cohort of HIV-1-infected patients with neurologic disease.  VPA was well tolerated in this population and secondary measures of brain metabolism, as evidenced by an increase in N-acetyl aspartate/creatine (NAA/Cr), further suggested that VPA may improve gray matter integrity in brain regions damaged by HIV-1.  These findings highlight the therapeutic potential of GSK-3beta blockade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQYLomxCS5MYCXXDYhVZBdlfW6udTcc2eYftybFdEgu9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjgtlGntw%253D%253D&md5=32a04eb612b189d1abfe4dc241df68cd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs11481-006-9051-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11481-006-9051-1%26sid%3Dliteratum%253Aachs%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DSchifitto%26aufirst%3DG.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520beta%2520%2528GSK-3%2520beta%2529%2520as%2520a%2520therapeutic%2520target%2520in%2520neuroAIDS%26jtitle%3DJ.%2520Neuroimmune%2520Pharmacol.%26date%3D2007%26volume%3D2%26spage%3D93%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mishra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barthwal, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondarva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">30393</span><span class="NLM_x">–</span> <span class="NLM_lpage">30405</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=30393-30405&author=R.+Mishraauthor=M.+K.+Barthwalauthor=G.+Sondarvaauthor=B.+Ranaauthor=L.+Wongauthor=M.+Chatterjeeauthor=J.+R.+Woodgettauthor=A.+Rana&title=Glycogen+synthase+kinase-3beta+induces+neuronal+cell+death+via+direct+phosphorylation+of+mixed+lineage+kinase+3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DR.%26aulast%3DBarthwal%26aufirst%3DM.%2BK.%26aulast%3DSondarva%26aufirst%3DG.%26aulast%3DRana%26aufirst%3DB.%26aulast%3DWong%26aufirst%3DL.%26aulast%3DChatterjee%26aufirst%3DM.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26aulast%3DRana%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase-3beta%2520induces%2520neuronal%2520cell%2520death%2520via%2520direct%2520phosphorylation%2520of%2520mixed%2520lineage%2520kinase%25203%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D30393%26epage%3D30405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewcock, J. W.</span><span> </span><span class="NLM_article-title">ACS Chemical Neuroscience Spotlight on CEP-1347</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000793" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWiurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=3-4&author=Z.+K.+Sweeneyauthor=J.+W.+Lewcock&title=ACS+Chemical+Neuroscience+Spotlight+on+CEP-1347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">ACS Chemical Neuroscience Spotlight on CEP-1347</span></div><div class="casAuthors">Sweeney, Zachary K.; Lewcock, Joseph W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-4</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6ot-9NHLazbVg90H21EOLACvtfcHk0lhasxI_hw6ZxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWiurzE&md5=f2364649af4f96ac72753fbba21557f7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcn1000793&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000793%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26aulast%3DLewcock%26aufirst%3DJ.%2BW.%26atitle%3DACS%2520Chemical%2520Neuroscience%2520Spotlight%2520on%2520CEP-1347%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D3%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lhasxI_hw6ZxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Falsig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pörzgen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotharius, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leist, M.</span><span> </span><span class="NLM_article-title">Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">2762</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2004&pages=2762-2770&author=J.+Falsigauthor=P.+P%C3%B6rzgenauthor=J.+Lothariusauthor=M.+Leist&title=Specific+modulation+of+astrocyte+inflammation+by+inhibition+of+mixed+lineage+kinases+with+CEP-1347"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFalsig%26aufirst%3DJ.%26aulast%3DP%25C3%25B6rzgen%26aufirst%3DP.%26aulast%3DLotharius%26aufirst%3DJ.%26aulast%3DLeist%26aufirst%3DM.%26atitle%3DSpecific%2520modulation%2520of%2520astrocyte%2520inflammation%2520by%2520inhibition%2520of%2520mixed%2520lineage%2520kinases%2520with%2520CEP-1347%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D173%26spage%3D2762%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diebold, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josef, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husten, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holskin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almo, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathiasen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozyczko-Coyne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saporito, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl [3,4-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetraphydropyridine models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5680</span><span class="NLM_x">–</span> <span class="NLM_lpage">5689</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8005838" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5680-5689&author=R.+L.+Hudkinsauthor=J.+L.+Dieboldauthor=M.+Taoauthor=K.+A.+Josefauthor=C.+H.+Parkauthor=T.+S.+Angelesauthor=L.+D.+Aimoneauthor=J.+Hustenauthor=M.+A.+Atorauthor=S.+L.+Meyerauthor=B.+P.+Holskinauthor=J.+T.+Durkinauthor=A.+A.+Fedorovauthor=E.+V.+Fedorovauthor=S.+C.+Almoauthor=J.+R.+Mathiasenauthor=D.+Bozyczko-Coyneauthor=M.+S.+Saporitoauthor=R.+W.+Scottauthor=J.+P.+Mallamo&title=Mixed-lineage+kinase+1+and+mixed-lineage+kinase+3+subtype-selective+dihydronaphthyl+%5B3%2C4-a%5Dpyrrolo%5B3%2C4-c%5Dcarbazole-5-ones%3A+optimization%2C+mixed-lineage+kinase+1+crystallography%2C+and+oral+in+vivo+activity+in+1-methyl-4-phenyltetraphydropyridine+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm8005838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8005838%26sid%3Dliteratum%253Aachs%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DDiebold%26aufirst%3DJ.%2BL.%26aulast%3DTao%26aufirst%3DM.%26aulast%3DJosef%26aufirst%3DK.%2BA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DHusten%26aufirst%3DJ.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DMeyer%26aufirst%3DS.%2BL.%26aulast%3DHolskin%26aufirst%3DB.%2BP.%26aulast%3DDurkin%26aufirst%3DJ.%2BT.%26aulast%3DFedorov%26aufirst%3DA.%2BA.%26aulast%3DFedorov%26aufirst%3DE.%2BV.%26aulast%3DAlmo%26aufirst%3DS.%2BC.%26aulast%3DMathiasen%26aufirst%3DJ.%2BR.%26aulast%3DBozyczko-Coyne%26aufirst%3DD.%26aulast%3DSaporito%26aufirst%3DM.%2BS.%26aulast%3DScott%26aufirst%3DR.%2BW.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DMixed-lineage%2520kinase%25201%2520and%2520mixed-lineage%2520kinase%25203%2520subtype-selective%2520dihydronaphthyl%2520%255B3%252C4-a%255Dpyrrolo%255B3%252C4-c%255Dcarbazole-5-ones%253A%2520optimization%252C%2520mixed-lineage%2520kinase%25201%2520crystallography%252C%2520and%2520oral%2520in%2520vivo%2520activity%2520in%25201-methyl-4-phenyltetraphydropyridine%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5680%26epage%3D5689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lotharius, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falsig, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Beek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dringen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brundin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leist, M.</span><span> </span><span class="NLM_article-title">Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6329</span><span class="NLM_x">–</span> <span class="NLM_lpage">6342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1523%2FJNEUROSCI.1746-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=16000623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtF2ksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6329-6342&author=J.+Lothariusauthor=J.+Falsigauthor=J.+van+Beekauthor=S.+Payneauthor=R.+Dringenauthor=P.+Brundinauthor=M.+Leist&title=Progressive+degeneration+of+human+mesencephalic+neuron-derived+cells+triggered+by+dopamine-dependent+oxidative+stress+is+dependent+on+the+mixed-lineage+kinase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway</span></div><div class="casAuthors">Lotharius, Julie; Falsig, Jeppe; van Beek, Johan; Payne, Sarah; Dringen, Ralf; Brundin, Patrik; Leist, Marcel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6329-6342</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Models of Parkinson's disease (PD) based on selective neuronal death have been used to study pathogenic mechanisms underlying nigral cell death and in some instances to develop symptomatic therapies.  For validation of putative neuroprotectants, a model is desirable in which the events leading to neurodegeneration replicate those occurring in the disease.  We developed a human in vitro model of PD based on the assumption that dysregulated cytoplasmic dopamine levels trigger cell loss in this disorder.  Differentiated human mesencephalic neuron-derived cells were exposed to methamphetamine (METH) to promote cytoplasmic dopamine accumulation.  In the presence of elevated iron concns., as obsd. in PD, increased cytosolic dopamine led to oxidative stress, c-Jun N-terminal kinase (JNK) pathway activation, neurite degeneration, and eventually apoptosis.  We examd. the role of the mixed-lineage kinases (MLKs) in this complex degenerative cascade by using the potent inhibitor 3,9-bis[(ethylthio)methyl]-K-252a (CEP1347).  Inhibition of MLKs not only prevented FeCl2+/METH-induced JNK activation and apoptosis but also early events such as neurite degeneration and oxidative stress.  This broad neuroprotective action of CEP1347 was assocd. with increased expression of an oxidative stress-response modulator, activating transcription factor 4.  As a functional consequence, transcription of the cystine/glutamate and glycine transporters, cellular cystine uptake and intracellular levels of the redox buffer glutathione were augmented.  In conclusion, this new human model of parkinsonian neurodegeneration has the potential to yield new insights into neurorestorative therapeutics and suggests that enhancement of cytoprotective mechanisms, in addn. to blockade of apoptosis, may be essential for disease modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqavEJ7HFAQ5rVg90H21EOLACvtfcHk0lhjp7OILiZc3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtF2ksb4%253D&md5=51fab9639a0de3e6029ec86e7c62bae5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1746-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1746-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DLotharius%26aufirst%3DJ.%26aulast%3DFalsig%26aufirst%3DJ.%26aulast%3Dvan%2BBeek%26aufirst%3DJ.%26aulast%3DPayne%26aufirst%3DS.%26aulast%3DDringen%26aufirst%3DR.%26aulast%3DBrundin%26aufirst%3DP.%26aulast%3DLeist%26aufirst%3DM.%26atitle%3DProgressive%2520degeneration%2520of%2520human%2520mesencephalic%2520neuron-derived%2520cells%2520triggered%2520by%2520dopamine-dependent%2520oxidative%2520stress%2520is%2520dependent%2520on%2520the%2520mixed-lineage%2520kinase%2520pathway%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6329%26epage%3D6342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Saporito, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carswell, S.</span><span> </span><span class="NLM_article-title">CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=9918541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADyaK1MXpvFOisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=1999&pages=421-427&author=M.+S.+Saporitoauthor=E.+M.+Brownauthor=M.+S.+Millerauthor=S.+Carswell&title=CEP-1347%2FKT-7515%2C+an+inhibitor+of+c-jun+N-terminal+kinase+activation%2C+attenuates+the+1-methyl-4-phenyl+tetrahydropyridine-mediated+loss+of+nigrostriatal+dopaminergic+neurons+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo</span></div><div class="casAuthors">Saporito, Michael S.; Brown, Ellen M.; Miller, Matthew S.; Carswell, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-427</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have identified a bis-ethylthiomethyl analog of K-252a, CEP-1347/KT-7515, that promotes neuronal survival in culture and in vivo.  The neuronal survival properties of CEP-1347/KT-7515 may be related to its ability to inhibit the activation of c-jun N-terminal kinase, a key kinase in some forms of stress-induced neuronal death and perhaps apoptosis.  There is evidence that the selective nigrostriatal dopaminergic neurotoxin, MPTP, produces neuronal apoptosis in culture and in adult mice.  Thus, our studies were designed to det. if CEP-1347/KT-7515 could protect dopaminergic neurons from MPTP-mediated neurotoxicity.  CEP-1347/KT-7515 was assessed for neuroprotective activity in a low dose MPTP model (20 mg/kg) where there was a 50% loss of striatal dopaminergic terminals in the absence of substantia nigra neuronal loss, and a high dose (40 mg/kg) MPTP model where there was a complete loss of dopaminergic terminals and 80% loss of dopaminergic cell bodies.  In the low dose MPTP model, CEP-1347/KT-7515 (0.3 mg/kg/day) attenuated the MPTP-mediated loss of striatal dopaminergic terminals by 50%.  In the high dose model, CEP-1347/KT-7515 ameliorated the loss of dopaminergic cell bodies by 50% and partially preserved striatal dopaminergic terminals.  CEP-1347/KT-7515 did not inhibit monoamine oxidase B or the dopamine transporter, suggesting that the neuroprotective effects of CEP-1347/KT-7515 occur down-stream of the metabolic conversion of MPTP to MPP+ and accumulation of MPP+ into dopaminergic neurons.  These data implicate a c-jun N-terminal kinase signaling system in MPTP-mediated dopaminergic degeneration and suggest that CEP-1347/KT-7515 may have potential as a treatment for Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsVZsdmWMSYbVg90H21EOLACvtfcHk0liuPulBxV4SsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXpvFOisA%253D%253D&md5=118b9beb6f0d924aab55e1a474e78951</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaporito%26aufirst%3DM.%2BS.%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMiller%26aufirst%3DM.%2BS.%26aulast%3DCarswell%26aufirst%3DS.%26atitle%3DCEP-1347%252FKT-7515%252C%2520an%2520inhibitor%2520of%2520c-jun%2520N-terminal%2520kinase%2520activation%252C%2520attenuates%2520the%25201-methyl-4-phenyl%2520tetrahydropyridine-mediated%2520loss%2520of%2520nigrostriatal%2520dopaminergic%2520neurons%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D288%26spage%3D421%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mathiasen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saporito, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghadge, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holskin, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusko, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozyczko-Coyne, D.</span><span> </span><span class="NLM_article-title">Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1003</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2Fj.brainres.2003.11.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=15019567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFaitr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1003&publication_year=2004&pages=86-97&author=J.+R.+Mathiasenauthor=B.+A.+McKennaauthor=M.+S.+Saporitoauthor=G.+D.+Ghadgeauthor=R.+P.+Roosauthor=B.+P.+Holskinauthor=Z.+L.+Wuauthor=S.+P.+Truskoauthor=T.+C.+Connorsauthor=A.+C.+Maroneyauthor=B.+A.+Thomasauthor=J.+C.+Thomasauthor=D.+Bozyczko-Coyne&title=Inhibition+of+mixed+lineage+kinase+3+attenuates+MPP%2B-induced+neurotoxicity+in+SH-SY5Y+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells</span></div><div class="casAuthors">Mathiasen, Joanne R.; McKenna, Beth Ann W.; Saporito, Michael S.; Ghadge, Ghanashyam D.; Roos, Raymond P.; Holskin, Beverly P.; Wu, Zhi-Liang; Trusko, Stephen P.; Connors, Thomas C.; Maroney, Anna C.; Thomas, Beth Ann; Thomas, Jeffrey C.; Bozyczko-Coyne, Donna</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1003</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">86-97</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The neuropathol. of Parkinson's Disease has been modeled in exptl. animals following MPTP treatment and in dopaminergic cells in culture treated with the MPTP neurotoxic metabolite, MPP+.  MPTP through MPP+ activates the stress-activated c-Jun N-terminal kinase (JNK) pathway in mice and SH-SY5Y neuroblastoma cells.  Recently, it was demonstrated that CEP-1347/KT7515 attenuated MPTP-induced nigrostriatal dopaminergic neuron degeneration in mice, as well as MPTP-induced JNK phosphorylation.  Presumably, CEP-1347 acts through inhibition of at least one upstream kinase within the mixed lineage kinase (MLK) family since it has been shown to inhibit MLK 1, 2 and 3 in vitro.  Activation of the MLK family leads to JNK activation.  In this study, the potential role of MLK and the JNK pathway was examd. in MPP+-induced cell death of differentiated SH-SY5Y cells using CEP-1347 as a pharmacol. probe and dominant neg. adenoviral constructs to MLKs.  CEP-1347 inhibited MPP+-induced cell death and the morphol. features of apoptosis.  CEP-1347 also prevented MPP+-induced JNK activation in SH-SY5Y cells.  Endogenous MLK 3 expression was demonstrated in SH-SY5Y cells through protein levels and RT-PCR.  Adenoviral infection of SH-SY5Y cells with a dominant neg. MLK 3 construct attenuated the MPP+-mediated increase in activated JNK levels and inhibited neuronal death following MPP+ addn. compared to cultures infected with a control construct.  Adenoviral dominant neg. constructs of two other MLK family members (MLK 2 and DLK) did not protect against MPP+-induced cell death.  These studies show that inhibition of the MLK 3/JNK pathway attenuates MPP+-mediated SH-SY5Y cell death in culture and supports the mechanism of action of CEP-1347 as an MLK family inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWMfFo7PHTlrVg90H21EOLACvtfcHk0liuPulBxV4SsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFaitr0%253D&md5=f82cbb2b5c6f2b3b765ee1f58cbccbfd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2003.11.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2003.11.073%26sid%3Dliteratum%253Aachs%26aulast%3DMathiasen%26aufirst%3DJ.%2BR.%26aulast%3DMcKenna%26aufirst%3DB.%2BA.%26aulast%3DSaporito%26aufirst%3DM.%2BS.%26aulast%3DGhadge%26aufirst%3DG.%2BD.%26aulast%3DRoos%26aufirst%3DR.%2BP.%26aulast%3DHolskin%26aufirst%3DB.%2BP.%26aulast%3DWu%26aufirst%3DZ.%2BL.%26aulast%3DTrusko%26aufirst%3DS.%2BP.%26aulast%3DConnors%26aufirst%3DT.%2BC.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DThomas%26aufirst%3DB.%2BA.%26aulast%3DThomas%26aufirst%3DJ.%2BC.%26aulast%3DBozyczko-Coyne%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520mixed%2520lineage%2520kinase%25203%2520attenuates%2520MPP%252B-induced%2520neurotoxicity%2520in%2520SH-SY5Y%2520cells%26jtitle%3DBrain%2520Res.%26date%3D2004%26volume%3D1003%26spage%3D86%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bodner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span> </span><span class="NLM_article-title">Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2Fj.expneurol.2004.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2004&pages=246-253&author=A.+Bodnerauthor=P.+T.+Tothauthor=R.+J.+Miller&title=Activation+of+c-Jun+N-terminal+kinase+mediates+gp120IIIB-+and+nucleoside+analogue-induced+sensory+neuron+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of c-Jun N-terminal kinase mediates gp120IIIB- and nucleoside analogue-induced sensory neuron toxicity</span></div><div class="casAuthors">Bodner, Amos; Toth, Peter T.; Miller, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-253</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Peripheral neuropathy is the most common neurol. symptom in patients with acquired immunodeficiency syndrome (AIDS).  Here, we examine possible mechanisms of gp120 and nucleoside reverse transcriptase inhibitors (NRTIs) in the pathogenesis of AIDS peripheral neuropathy.  Neonatal dorsal root ganglion (DRG) neurons were found to undergo apoptosis in response to chronic treatment with gp120IIIB, an effect enhanced by the co-application of hCD4, as well as upon exposure to the nucleoside reverse transcriptase inhibitor (NRTI), 2',3'-dideoxyinosine (ddI).  DRG neurons were rescued from the neurotoxic effects of these agents by CEP-1347, an inhibitor of the mixed lineage kinases (MLKs), upstream activators of the c-Jun N-terminal kinase (JNK) signaling pathway.  In addn., gp120- or ddI-mediated toxicity were also inhibited by neuronal expression of dominant neg. versions of the MLKs.  Our results suggest that both gp120 and the NRTIs cause sensory neuron apoptosis through the activation of the JNK pathway, and that CEP-1347-like compds. may serve as a therapeutic option in patients with AIDS-assocd. peripheral neuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0rJtGYlG1YrVg90H21EOLACvtfcHk0ljIUQL9VdvPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFygtL0%253D&md5=ef951667e4c1fc67f380951a95742127</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2004.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2004.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DBodner%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DP.%2BT.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DActivation%2520of%2520c-Jun%2520N-terminal%2520kinase%2520mediates%2520gp120IIIB-%2520and%2520nucleoside%2520analogue-induced%2520sensory%2520neuron%2520toxicity%26jtitle%3DExp.%2520Neurol.%26date%3D2004%26volume%3D188%26spage%3D246%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bodner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maroney, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghadge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span> </span><span class="NLM_article-title">Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1424</span><span class="NLM_x">–</span> <span class="NLM_lpage">1434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1046%2Fj.1471-4159.2002.01088.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsV2hs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=1424-1434&author=A.+Bodnerauthor=A.+C.+Maroneyauthor=J.+P.+Finnauthor=G.+Ghadgeauthor=R.+Roosauthor=R.+J.+Miller&title=Mixed+lineage+kinase+3+mediates+gp120IIIB-induced+neurotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity</span></div><div class="casAuthors">Bodner, Amos; Maroney, Anna C.; Finn, James P.; Ghadge, Ghanashyam; Roos, Raymond; Miller, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1424-1434</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Overexpression of gp120, the major coat protein of the HIV-1 virus, in central glial cells, or treatment of neurons with gp120 in culture, produces apoptotic neuronal death.  Here the authors demonstrate that CEP-1347 (KT7515), an inhibitor of mixed lineage kinase 3 (MLK3), an upstream activator of JNK, inhibits gp120IIIB-induced apoptosis of hippocampal neurons.  Furthermore, expression of wild type MLK3 in hippocampal pyramidal neurons enhanced gp120IIIB-induced neurotoxicity, whereas expression of a dominant neg. MLK3 protected neurons from the toxic effects of the glycoprotein.  These results indicate a role for MLK3 signaling in gp120IIIB-induced neuronal death, and suggest potential clin. utility of CEP-1347 in inhibiting the progression of AIDS dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkGW6_iGg5LVg90H21EOLACvtfcHk0ljIUQL9VdvPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsV2hs74%253D&md5=706f55838667df62fb58a675c5d02f1d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01088.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01088.x%26sid%3Dliteratum%253Aachs%26aulast%3DBodner%26aufirst%3DA.%26aulast%3DMaroney%26aufirst%3DA.%2BC.%26aulast%3DFinn%26aufirst%3DJ.%2BP.%26aulast%3DGhadge%26aufirst%3DG.%26aulast%3DRoos%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DMixed%2520lineage%2520kinase%25203%2520mediates%2520gp120IIIB-induced%2520neurotoxicity%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D82%26spage%3D1424%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Eggert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dash, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorantla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluektova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Neuroprotective activities of CEP-1347 in models of neuroAIDS</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x">, </span> <span class="NLM_fpage">746</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=746-756&author=D.+Eggertauthor=P.+K.+Dashauthor=S.+Gorantlaauthor=H.+Douauthor=G.+Schifittoauthor=S.+B.+Maggirwarauthor=S.+Dewhurstauthor=L.+Poluektovaauthor=H.+A.+Gelbardauthor=H.+E.+Gendelman&title=Neuroprotective+activities+of+CEP-1347+in+models+of+neuroAIDS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEggert%26aufirst%3DD.%26aulast%3DDash%26aufirst%3DP.%2BK.%26aulast%3DGorantla%26aufirst%3DS.%26aulast%3DDou%26aufirst%3DH.%26aulast%3DSchifitto%26aufirst%3DG.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DPoluektova%26aufirst%3DL.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DNeuroprotective%2520activities%2520of%2520CEP-1347%2520in%2520models%2520of%2520neuroAIDS%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D184%26spage%3D746%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span>Parkinson Study Group PRECEPT Investigators. <span> </span><span class="NLM_article-title">Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease</span>.  <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1480</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Parkinson+Study+Group+PRECEPT+Investigators.+Mixed+lineage+kinase+inhibitor+CEP-1347+fails+to+delay+disability+in+early+Parkinson+disease.+Neurology+2007%2C+69%2C+1480%E2%80%931490."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DMixed%2520lineage%2520kinase%2520inhibitor%2520CEP-1347%2520fails%2520to%2520delay%2520disability%2520in%2520early%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2007%26volume%3D69%26spage%3D1480%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Difrancesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochreiter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span> </span><span class="NLM_article-title">Pharmacokinetic interaction of CEP-1347 and atazanavir in HIV-infected patients</span> <span class="citation_source-journal">J. Neurovirol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=254-60&author=Q.+Maauthor=H.+A.+Gelbardauthor=S.+B.+Maggirwarauthor=S.+Dewhurstauthor=H.+E.+Gendelmanauthor=D.+R.+Petersonauthor=R.+Difrancescoauthor=J.+S.+Hochreiterauthor=G.+D.+Morseauthor=G.+Schifitto&title=Pharmacokinetic+interaction+of+CEP-1347+and+atazanavir+in+HIV-infected+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26aulast%3DPeterson%26aufirst%3DD.%2BR.%26aulast%3DDifrancesco%26aufirst%3DR.%26aulast%3DHochreiter%26aufirst%3DJ.%2BS.%26aulast%3DMorse%26aufirst%3DG.%2BD.%26aulast%3DSchifitto%26aufirst%3DG.%26atitle%3DPharmacokinetic%2520interaction%2520of%2520CEP-1347%2520and%2520atazanavir%2520in%2520HIV-infected%2520patients%26jtitle%3DJ.%2520Neurovirol.%26date%3D2013%26volume%3D3%26spage%3D254%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span>StarDrop: Guiding Decisions in Drug Discovery; <span class="NLM_publisher-name">Optibrium Ltd.</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.optibrium.com/stardrop/" class="extLink">http://www.optibrium.com/stardrop/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=StarDrop%3A+Guiding+Decisions+in+Drug+Discovery%3B+Optibrium+Ltd.%3A+Cambridge%2C+UK%2C+2013%3B+http%3A%2F%2Fwww.optibrium.com%2Fstardrop%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DStarDrop%253A%2520Guiding%2520Decisions%2520in%2520Drug%2520Discovery%26pub%3DOptibrium%2520Ltd%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Dash, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorantla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knibbe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makarov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boska, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poluektova, L. Y.</span><span> </span><span class="NLM_article-title">Loss of neuronal integrity during progressive HIV-1 infection of humanized mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">3148</span><span class="NLM_x">–</span> <span class="NLM_lpage">3157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1523%2FJNEUROSCI.5473-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=21368026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtVaht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=3148-3157&author=P.+K.+Dashauthor=S.+Gorantlaauthor=H.+E.+Gendelmanauthor=J.+Knibbeauthor=G.+P.+Casaleauthor=E.+Makarovauthor=A.+A.+Epsteinauthor=H.+A.+Gelbardauthor=M.+D.+Boskaauthor=L.+Y.+Poluektova&title=Loss+of+neuronal+integrity+during+progressive+HIV-1+infection+of+humanized+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of neuronal integrity during progressive HIV-1 infection of humanized mice</span></div><div class="casAuthors">Dash, Prasanta K.; Gorantla, Santhi; Gendelman, Howard E.; Knibbe, Jaclyn; Casale, George P.; Makarov, Edward; Epstein, Adrian A.; Gelbard, Harris A.; Boska, Michael D.; Poluektova, Larisa Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3148-3157</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuronal damage induced by ongoing human immunodeficiency virus type 1 (HIV-1) infection was investigated in humanized NOD/scid-IL-2Rγnullc mice transplanted at birth with human CD34-pos. hematopoietic stem cells.  Mice infected at 5 mo of age and followed for up to 15 wk maintained significant plasma viral loads and showed reduced nos. of CD4+ T-cells.  Prospective serial proton magnetic resonance spectroscopy tests showed selective redns. in cortical N-acetyl aspartate in infected animals.  Diffusion tensor imaging revealed structural changes in cortical gray matter.  Postmortem immunofluorescence brain tissue examns. for neuronal and glial markers, captured by multispectral imaging microscopy and quantified by morphometric and fluorescence emission, showed regional redn. of neuronal soma and synaptic architectures.  This was evidenced by loss of microtubule-assocd. protein 2, synaptophysin, and neurofilament antigens.  This study is the first, to our knowledge, demonstrating lost neuronal integrity after HIV-1 infection in humanized mice.  As such, the model permits studies of the relationships between ongoing viral replication and virus-assocd. neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTHkYAVHLi67Vg90H21EOLACvtfcHk0lggJZ_UvLHgjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtVaht7g%253D&md5=1e099151579fba50c6cc58d43174d7b3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5473-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5473-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DDash%26aufirst%3DP.%2BK.%26aulast%3DGorantla%26aufirst%3DS.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26aulast%3DKnibbe%26aufirst%3DJ.%26aulast%3DCasale%26aufirst%3DG.%2BP.%26aulast%3DMakarov%26aufirst%3DE.%26aulast%3DEpstein%26aufirst%3DA.%2BA.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DBoska%26aufirst%3DM.%2BD.%26aulast%3DPoluektova%26aufirst%3DL.%2BY.%26atitle%3DLoss%2520of%2520neuronal%2520integrity%2520during%2520progressive%2520HIV-1%2520infection%2520of%2520humanized%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D3148%26epage%3D3157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Genis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernton, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzenko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keane, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrachi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volsky, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gendelman, H. E.</span><span> </span><span class="NLM_article-title">Cytokins and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage–astroglia interactions: implications for the neuropathogenesis of HIV disease</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=1992&pages=1703-1718&author=P.+Genisauthor=M.+Jettauthor=E.+W.+Berntonauthor=T.+Boyleauthor=H.+A.+Gelbardauthor=K.+Dzenkoauthor=R.+W.+Keaneauthor=L.+Resnickauthor=Y.+Mizrachiauthor=D.+J.+Volskyauthor=L.+G.+Epsteinauthor=H.+E.+Gendelman&title=Cytokins+and+arachidonic+metabolites+produced+during+human+immunodeficiency+virus+%28HIV%29-infected+macrophage%E2%80%93astroglia+interactions%3A+implications+for+the+neuropathogenesis+of+HIV+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGenis%26aufirst%3DP.%26aulast%3DJett%26aufirst%3DM.%26aulast%3DBernton%26aufirst%3DE.%2BW.%26aulast%3DBoyle%26aufirst%3DT.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DDzenko%26aufirst%3DK.%26aulast%3DKeane%26aufirst%3DR.%2BW.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DMizrachi%26aufirst%3DY.%26aulast%3DVolsky%26aufirst%3DD.%2BJ.%26aulast%3DEpstein%26aufirst%3DL.%2BG.%26aulast%3DGendelman%26aufirst%3DH.%2BE.%26atitle%3DCytokins%2520and%2520arachidonic%2520metabolites%2520produced%2520during%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529-infected%2520macrophage%25E2%2580%2593astroglia%2520interactions%253A%2520implications%2520for%2520the%2520neuropathogenesis%2520of%2520HIV%2520disease%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1992%26volume%3D176%26spage%3D1703%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wesselingh, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyor, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, D. E.</span><span> </span><span class="NLM_article-title">Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1002%2Fana.410330604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADyaK3s3ntVClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1993&pages=576-582&author=S.+L.+Wesselinghauthor=C.+Powerauthor=J.+D.+Glassauthor=W.+R.+Tyorauthor=J.+C.+McArthurauthor=J.+M.+Farberauthor=J.+W.+Griffinauthor=D.+E.+Griffin&title=Intracerebral+cytokine+messenger+RNA+expression+in+acquired+immunodeficiency+syndrome+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia</span></div><div class="casAuthors">Wesselingh S L; Power C; Glass J D; Tyor W R; McArthur J C; Farber J M; Griffin J W; Griffin D E</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">576-82</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">The pathogenesis of the dementia associated with human immunodeficiency virus (HIV) infection is unclear, but has been postulated to be due to indirect effects of HIV infection including the local production of cytokines.  To determine which cytokines are produced in the nervous system and to identify any correlations with dementia, cytokine and HIV messenger RNA expression was analyzed by reverse transcriptase-polymerase chain reaction in the brains from 24 HIV-infected patients with and without dementia and 9 HIV-uninfected control subjects.  Levels of tumor necrosis factor-alpha messenger RNA were significantly higher and levels of interleukin (IL)-4 messenger RNA were significantly lower in demented compared to nondemented HIV-infected patients.  Demented patients also had lower IL-1 beta levels than did nondemented patients.  No significant differences were detected in the amounts of leukemia inhibitory factor, IL-6, transforming growth factor-beta 1 and -beta 2, monokine induced by gamma interferon-2 (MIG-2), or interferon-gamma messenger RNAs.  IL-10 and IL-2 messenger RNAs were undetectable in all brains examined.  Cytokine messenger RNA levels in nondemented HIV-positive patients were similar to those in HIV-negative control subjects.  HIV transcripts were more abundant in subcortical white matter than in the basal ganglia, cortex, or deep white matter.  Our findings suggest a possible role for tumor necrosis factor-alpha in the development of neurological dysfunction.  Increased levels of tumor necrosis factor-alpha messenger RNA were not associated with increased levels of IL-1 beta messenger RNA, suggesting differential regulation of these monokines in acquired immunodeficiency syndrome dementia.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6gZt_4NNPoQvupmecNw_lfW6udTcc2eaZ_KT2K9R1N7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3ntVClsA%253D%253D&md5=b2955d77cbb5d826144d4f9fd973a1bf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fana.410330604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410330604%26sid%3Dliteratum%253Aachs%26aulast%3DWesselingh%26aufirst%3DS.%2BL.%26aulast%3DPower%26aufirst%3DC.%26aulast%3DGlass%26aufirst%3DJ.%2BD.%26aulast%3DTyor%26aufirst%3DW.%2BR.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DFarber%26aufirst%3DJ.%2BM.%26aulast%3DGriffin%26aufirst%3DJ.%2BW.%26aulast%3DGriffin%26aufirst%3DD.%2BE.%26atitle%3DIntracerebral%2520cytokine%2520messenger%2520RNA%2520expression%2520in%2520acquired%2520immunodeficiency%2520syndrome%2520dementia%26jtitle%3DAnn.%2520Neurol.%26date%3D1993%26volume%3D33%26spage%3D576%26epage%3D582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Tyor, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, D. E.</span><span> </span><span class="NLM_article-title">Cytokine expression in the brain during the acquired immunodeficiency syndrome</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1002%2Fana.410310402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADyaK383msVKqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1992&pages=349-360&author=W.+R.+Tyorauthor=J.+D.+Glassauthor=J.+W.+Griffinauthor=P.+S.+Beckerauthor=J.+C.+McArthurauthor=L.+Bezmanauthor=D.+E.+Griffin&title=Cytokine+expression+in+the+brain+during+the+acquired+immunodeficiency+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine expression in the brain during the acquired immunodeficiency syndrome</span></div><div class="casAuthors">Tyor W R; Glass J D; Griffin J W; Becker P S; McArthur J C; Bezman L; Griffin D E</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-60</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">The pathogenesis of central nervous system (CNS) disease in acquired immunodeficiency syndrome (AIDS) is poorly understood but may be related to specific effects of the immune system.  Cytokines such as tumor necrosis factor and interleukin-1 may have toxic effects on CNS cells and have been postulated to contribute to the pathogenesis of the neurological complications of human immunodeficiency virus (HIV) infection.  To characterize viral and immunological activity in the CNS, frozen specimens taken at autopsy from the cerebral cortex and white matter of HIV-seropositive and -seronegative individuals were stained immunocytochemically for mononuclear cells, major histocompatibility complex (MHC) antigens, HIV, astrocytes, and the cytokines interleukin-1 and -6, tumor necrosis factor-alpha and -beta, and interferon gamma.  Levels of soluble CD4, CD8, and interleukin-2 receptor, as well as interferon gamma, tumor necrosis factor-alpha, beta 2-microglobulin, neopterin, and interleukin-6 and -1 beta were assayed in the cerebrospinal fluid and plasma of many of these individuals during life.  The HIV-seropositive group included individuals without neurological disease, those with CNS opportunistic infections, and those with HIV encephalopathy.  Perivascular cells, consisting primarily of macrophages with some CD4+ and CD8+ T cells and rare B cells, were consistently MHC class II positive.  MHC class II antigen was also present on microglial cells, which were frequently positive for tumor necrosis factor-alpha.  HIV p24 antigen, when present, was found on macrophages and microglia.  Endothelial cells were frequently positive for interleukin-1 and interferon gamma and less frequently for tumor necrosis factor and interleukin-6.  There were gliosis and significant increases in MHC class II antigen, interleukin-1, and tumor necrosis factor-alpha in HIV-positive patients compared to HIV-negative brains.  Cerebrospinal fluid from most of the patients tested had increased levels of tumor necrosis factor, beta 2-microglobulin, and neopterin.  There was no correlation in HIV-positive individuals between levels of cytokines and the presence or absence of CNS disease.  These data indicate that there is a relative state of "immune activation" in the brains of HIV-positive compared to HIV-negative individuals, and suggest a potential role for the immune system in the pathogenesis of HIV encephalopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWgysHNiySORe4jJGKT5N0fW6udTcc2eaZ_KT2K9R1N7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383msVKqtw%253D%253D&md5=9e94fa380431a954bf8b50b97737f86c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fana.410310402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410310402%26sid%3Dliteratum%253Aachs%26aulast%3DTyor%26aufirst%3DW.%2BR.%26aulast%3DGlass%26aufirst%3DJ.%2BD.%26aulast%3DGriffin%26aufirst%3DJ.%2BW.%26aulast%3DBecker%26aufirst%3DP.%2BS.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DBezman%26aufirst%3DL.%26aulast%3DGriffin%26aufirst%3DD.%2BE.%26atitle%3DCytokine%2520expression%2520in%2520the%2520brain%2520during%2520the%2520acquired%2520immunodeficiency%2520syndrome%26jtitle%3DAnn.%2520Neurol.%26date%3D1992%26volume%3D31%26spage%3D349%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wesselingh, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, D. E.</span><span> </span><span class="NLM_article-title">Cytokine dysregulation in HIV-associated neurological disease</span> <span class="citation_source-journal">Adv. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2FS0960-5428%2806%2980258-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADyaK2M7nvFCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=199-206&author=S.+L.+Wesselinghauthor=J.+Glassauthor=J.+C.+McArthurauthor=J.+W.+Griffinauthor=D.+E.+Griffin&title=Cytokine+dysregulation+in+HIV-associated+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokine dysregulation in HIV-associated neurological disease</span></div><div class="casAuthors">Wesselingh S L; Glass J; McArthur J C; Griffin J W; Griffin D E</div><div class="citationInfo"><span class="NLM_cas:title">Advances in neuroimmunology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-206</span>
        ISSN:<span class="NLM_cas:issn">0960-5428</span>.
    </div><div class="casAbstract">AIDS is associated with three major neurological syndromes: dementia (HIVD), vacuolar myelopathy (VM) and plainful sensory neuropathy (PSN).  The pathogenesis of these conditions remains unclear although they all demonstrate a marked increase in macrophage number and activation despite systemic immunosuppression.  It was therefore of interest to determine the profile of cytokine and HIV expression in brain, spinal cord and peripheral nerves of AIDS patients with AD, VM and PSN, as compared to AIDS patients without neurological disease and seronegative controls.  RNA was extracted from brain, spinal cord and peripheral nerve and RT/PCR for cytokine and HIV mRNA was performed.  In situ RT/PCR was performed to determine the number and type of cells expressing cytokine message and this was compared to the number of cells containing HIV DNA detected with in situ PCR.  We found a consistent profile of increased TNF alpha and decreased IFN gamma and IL4 in all three syndromes compared to AIDS patients without neurological disease.  IL1 did not increase in parallel with TNF alpha IL10 was decreased in the VM tissue.  HIV transcripts were increased in the AD brains compared to non-demented controls but were detected only occasionally in spinal cord and not at all in peripheral nerve.  Preliminary data from in situ RT/PCR suggests that a large number of cells are expressing.  TNF alpha but only a small number are infected with HIV.(ABSTRACT TRUNCATED AT 250 WORDS)</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThUbQG7zCGRwMthz5_Rx5rfW6udTcc2eaZ_KT2K9R1N7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7nvFCjuw%253D%253D&md5=cb3cc28a4c89a816858a27117e9e7344</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FS0960-5428%2806%2980258-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-5428%252806%252980258-5%26sid%3Dliteratum%253Aachs%26aulast%3DWesselingh%26aufirst%3DS.%2BL.%26aulast%3DGlass%26aufirst%3DJ.%26aulast%3DMcArthur%26aufirst%3DJ.%2BC.%26aulast%3DGriffin%26aufirst%3DJ.%2BW.%26aulast%3DGriffin%26aufirst%3DD.%2BE.%26atitle%3DCytokine%2520dysregulation%2520in%2520HIV-associated%2520neurological%2520disease%26jtitle%3DAdv.%2520Neuroimmunol.%26date%3D1994%26volume%3D4%26spage%3D199%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Chico, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Eldik, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, D. M.</span><span> </span><span class="NLM_article-title">Targeting protein kinases in central nervous system disorders</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=892-909&author=L.+K.+Chicoauthor=L.+J.+Van+Eldikauthor=D.+M.+Watterson&title=Targeting+protein+kinases+in+central+nervous+system+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChico%26aufirst%3DL.%2BK.%26aulast%3DVan%2BEldik%26aufirst%3DL.%2BJ.%26aulast%3DWatterson%26aufirst%3DD.%2BM.%26atitle%3DTargeting%2520protein%2520kinases%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D892%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>Cardiac Toxicity hERG; <span class="NLM_publisher-name">Cerep</span>: <span class="NLM_publisher-loc">Celle L’Evescault, France</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.cerep.fr/cerep/users/pages/downloads/Documents/Marketing/Pharmacology%20&amp;%20ADME/Application%20notes/Cardiac%20toxicity%20hERG-2012.pdf" class="extLink">http://www.cerep.fr/cerep/users/pages/downloads/Documents/Marketing/Pharmacology%20&%20ADME/Application%20notes/Cardiac%20toxicity%20hERG-2012.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cardiac+Toxicity+hERG%3B+Cerep%3A+Celle+L%E2%80%99Evescault%2C+France%2C+2012%3B+http%3A%2F%2Fwww.cerep.fr%2Fcerep%2Fusers%2Fpages%2Fdownloads%2FDocuments%2FMarketing%2FPharmacology%2520%26%2520ADME%2FApplication%2520notes%2FCardiac%2520toxicity%2520hERG-2012.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DCardiac%2520Toxicity%2520hERG%26pub%3DCerep%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Weiss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, J. W.</span><span> </span><span class="NLM_article-title">HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood–brain barrier and up-regulates CCR5 expression on human monocytes</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">2953</span><span class="NLM_x">–</span> <span class="NLM_lpage">2959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=2953-2959&author=J.+M.+Weissauthor=A.+Nathauthor=E.+O.+Majorauthor=J.+W.+Berman&title=HIV-1+Tat+induces+monocyte+chemoattractant+protein-1-mediated+monocyte+transmigration+across+a+model+of+the+human+blood%E2%80%93brain+barrier+and+up-regulates+CCR5+expression+on+human+monocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DJ.%2BM.%26aulast%3DNath%26aufirst%3DA.%26aulast%3DMajor%26aufirst%3DE.%2BO.%26aulast%3DBerman%26aufirst%3DJ.%2BW.%26atitle%3DHIV-1%2520Tat%2520induces%2520monocyte%2520chemoattractant%2520protein-1-mediated%2520monocyte%2520transmigration%2520across%2520a%2520model%2520of%2520the%2520human%2520blood%25E2%2580%2593brain%2520barrier%2520and%2520up-regulates%2520CCR5%2520expression%2520on%2520human%2520monocytes%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D2953%26epage%3D2959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Gonzalez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovin, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mummidi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamshad, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telles, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deucher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">SBologna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, S. K.</span><span> </span><span class="NLM_article-title">HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">13795</span><span class="NLM_x">–</span> <span class="NLM_lpage">13800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=13795-13800&author=E.+Gonzalezauthor=B.+H.+Rovinauthor=L.+Senauthor=G.+Cookeauthor=R.+Dhandaauthor=S.+Mummidiauthor=H.+Kulkarniauthor=M.+J.+Bamshadauthor=V.+Tellesauthor=S.+A.+Andersonauthor=E.+A.+Walterauthor=K.+T.+Stephanauthor=M.+Deucherauthor=A.+Manganoauthor=R.+SBolognaauthor=S.+S.+Ahujaauthor=M.+J.+Dolanauthor=S.+K.+Ahuja&title=HIV-1+infection+and+AIDS+dementia+are+influenced+by+a+mutant+MCP-1+allele+linked+to+increased+monocyte+infiltration+of+tissues+and+MCP-1+levels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DE.%26aulast%3DRovin%26aufirst%3DB.%2BH.%26aulast%3DSen%26aufirst%3DL.%26aulast%3DCooke%26aufirst%3DG.%26aulast%3DDhanda%26aufirst%3DR.%26aulast%3DMummidi%26aufirst%3DS.%26aulast%3DKulkarni%26aufirst%3DH.%26aulast%3DBamshad%26aufirst%3DM.%2BJ.%26aulast%3DTelles%26aufirst%3DV.%26aulast%3DAnderson%26aufirst%3DS.%2BA.%26aulast%3DWalter%26aufirst%3DE.%2BA.%26aulast%3DStephan%26aufirst%3DK.%2BT.%26aulast%3DDeucher%26aufirst%3DM.%26aulast%3DMangano%26aufirst%3DA.%26aulast%3DSBologna%26aufirst%3DR.%26aulast%3DAhuja%26aufirst%3DS.%2BS.%26aulast%3DDolan%26aufirst%3DM.%2BJ.%26aulast%3DAhuja%26aufirst%3DS.%2BK.%26atitle%3DHIV-1%2520infection%2520and%2520AIDS%2520dementia%2520are%2520influenced%2520by%2520a%2520mutant%2520MCP-1%2520allele%2520linked%2520to%2520increased%2520monocyte%2520infiltration%2520of%2520tissues%2520and%2520MCP-1%2520levels%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D13795%26epage%3D13800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Mankowski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queen, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zink, M. C.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid markers that predict SIV CNS disease</span> <span class="citation_source-journal">J Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2Fj.jneuroim.2004.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVaqsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2004&pages=66-70&author=J.+L.+Mankowskiauthor=S.+E.+Queenauthor=J.+E.+Clementsauthor=M.+C.+Zink&title=Cerebrospinal+fluid+markers+that+predict+SIV+CNS+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid markers that predict SIV CNS disease</span></div><div class="casAuthors">Mankowski, J. L.; Queen, S. E.; Clements, J. E.; Zink, M. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">66-70</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Predictive cerebrospinal fluid markers would provide valuable tools for tracking the development and progression of HIV CNS disease.  In this study, expression of IL-6, MCP-1, and viral RNA in cerebrospinal fluid collected from SIV-inoculated macaques during acute, asymptomatic, and terminal stages of infection was quantitated to det. whether one or several of these parameters paralleled the severity of SIV encephalitis.  Animals that developed moderate to severe SIV encephalitis had significantly elevated levels of CSF IL-6, MCP-1, and SIV RNA during asymptomatic infection and persisting through terminal disease as compared to animals developing mild or no CNS disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAK4LjQm8oFbVg90H21EOLACvtfcHk0lj6SQr-JuXOlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVaqsLjM&md5=b8d4d0312079a1c533b766908480ae74</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2004.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2004.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DMankowski%26aufirst%3DJ.%2BL.%26aulast%3DQueen%26aufirst%3DS.%2BE.%26aulast%3DClements%26aufirst%3DJ.%2BE.%26aulast%3DZink%26aufirst%3DM.%2BC.%26atitle%3DCerebrospinal%2520fluid%2520markers%2520that%2520predict%2520SIV%2520CNS%2520disease%26jtitle%3DJ%2520Neuroimmunol.%26date%3D2004%26volume%3D157%26spage%3D66%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Li, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borodyansky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardee, A. B.</span><span> </span><span class="NLM_article-title">Tat protein induces self-perpetuating permissivity for productive HIV-1 infection</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">8116</span><span class="NLM_x">–</span> <span class="NLM_lpage">8120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=8116-8120&author=C.+J.+Liauthor=Y.+Uedaauthor=B.+Shiauthor=L.+Borodyanskyauthor=L.+Huangauthor=Y.+Z.+Liauthor=A.+B.+Pardee&title=Tat+protein+induces+self-perpetuating+permissivity+for+productive+HIV-1+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BJ.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DB.%26aulast%3DBorodyansky%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%2BZ.%26aulast%3DPardee%26aufirst%3DA.%2BB.%26atitle%3DTat%2520protein%2520induces%2520self-perpetuating%2520permissivity%2520for%2520productive%2520HIV-1%2520infection%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26spage%3D8116%26epage%3D8120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ganju, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groopman, J. E.</span><span> </span><span class="NLM_article-title">Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi’s sarcoma cells</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">6131</span><span class="NLM_x">–</span> <span class="NLM_lpage">6137</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFGltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1998&pages=6131-6137&author=R.+K.+Ganjuauthor=N.+Munshiauthor=B.+C.+Nairauthor=Z.+Y.+Liuauthor=P.+Gillauthor=J.+E.+Groopman&title=Human+immunodeficiency+virus+tat+modulates+the+Flk-1%2FKDR+receptor%2C+mitogen-activated+protein+kinases%2C+and+components+of+focal+adhesion+in+Kaposi%E2%80%99s+sarcoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Human immunodeficiency virus Tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells</span></div><div class="casAuthors">Ganju, Ramesh K.; Munshi, Neru; Nair, B. C.; Liu, Zhong-Ying; Gill, Parkash; Groopman, Jerome E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">6131-6137</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Kaposi's sarcoma (KS) spindle cell growth and spread have been reported to be modulated by various cytokines as well as the human immunodeficiency virus (HIV) gene product Tat.  Recently, HIV-1 Tat has been shown to act like a cytokine and bind to the Flk-1/KDR receptor for the vascular endothelial growth factor A (VEGF-A), which is expressed by KS cells.  The authors have characterized signal transduction pathways stimulated by HIV-1 Tat upon its binding to surface receptors on KS cells.  The authors obsd. that stimulation in KS 38 spindle cells resulted in tyrosine phosphorylation and activation of the Flk-1/KDR receptor.  The authors also report that HIV-1 Tat treatment enhanced the phosphorylation and assocn. of proteins found in focal adhesions, such as the related adhesion focal tyrosine kinase RAFTK, paxillin, and p130cas.  Further characterization revealed the activation of mitogen-activated protein kinase, c-Jun amino-terminal kinase (JNK), and Src kinase.  HIV-1 Tat contains a basic domain which can interact with growth factor tyrosine kinase receptors and a classical RGD sequence which may bind to and activate the surface integrin receptors for fibronectin and vitronectin.  The authors obsd. that stimulation of KS cells with basic as well as RGD sequence-contg. Tat peptides resulted in enhanced phosphorylation of RAFTK and activation of MAP kinase.  These studies reveal that Tat stimulation activates a no. of signal transduction pathways that are assocd. with cell growth and migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopiH57t1sHdbVg90H21EOLACvtfcHk0lifkOO4lOG77Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFGltbw%253D&md5=6f69f3d6a221cef72616dffaf0c4fbc3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGanju%26aufirst%3DR.%2BK.%26aulast%3DMunshi%26aufirst%3DN.%26aulast%3DNair%26aufirst%3DB.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BY.%26aulast%3DGill%26aufirst%3DP.%26aulast%3DGroopman%26aufirst%3DJ.%2BE.%26atitle%3DHuman%2520immunodeficiency%2520virus%2520tat%2520modulates%2520the%2520Flk-1%252FKDR%2520receptor%252C%2520mitogen-activated%2520protein%2520kinases%252C%2520and%2520components%2520of%2520focal%2520adhesion%2520in%2520Kaposi%25E2%2580%2599s%2520sarcoma%2520cells%26jtitle%3DJ.%2520Virol.%26date%3D1998%26volume%3D72%26spage%3D6131%26epage%3D6137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manna, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khawan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span> </span><span class="NLM_article-title">HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=1998&pages=776-781&author=A.+Kumarauthor=S.+K.+Mannaauthor=S.+Khawanauthor=B.+B.+Aggarwal&title=HIV-Tat+protein+activates+c-Jun+N-terminal+kinase+and+activator+protein-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DManna%26aufirst%3DS.%2BK.%26aulast%3DKhawan%26aufirst%3DS.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DHIV-Tat%2520protein%2520activates%2520c-Jun%2520N-terminal%2520kinase%2520and%2520activator%2520protein-1%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D161%26spage%3D776%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Singh, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Hage, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutz, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, K. F.</span><span> </span><span class="NLM_article-title">Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2005&pages=781-790&author=I.+N.+Singhauthor=N.+El-Hageauthor=M.+E.+Campbellauthor=S.+E.+Lutzauthor=P.+E.+Knappauthor=A.+Nathauthor=K.+F.+Hauser&title=Differential+involvement+of+p38+and+JNK+MAP+kinases+in+HIV-1+Tat+and+gp120-induced+apoptosis+and+neurite+degeneration+in+striatal+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DI.%2BN.%26aulast%3DEl-Hage%26aufirst%3DN.%26aulast%3DCampbell%26aufirst%3DM.%2BE.%26aulast%3DLutz%26aufirst%3DS.%2BE.%26aulast%3DKnapp%26aufirst%3DP.%2BE.%26aulast%3DNath%26aufirst%3DA.%26aulast%3DHauser%26aufirst%3DK.%2BF.%26atitle%3DDifferential%2520involvement%2520of%2520p38%2520and%2520JNK%2520MAP%2520kinases%2520in%2520HIV-1%2520Tat%2520and%2520gp120-induced%2520apoptosis%2520and%2520neurite%2520degeneration%2520in%2520striatal%2520neurons%26jtitle%3DNeuroscience%26date%3D2005%26volume%3D135%26spage%3D781%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Davies, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tournier, C.</span><span> </span><span class="NLM_article-title">Exploring the function of the JNK (c-Jun N-terminal kinase) signaling pathway in physiological and pathological processes to design novel therapeutic strategies</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1042%2FBST20110641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=85-89&author=C.+Daviesauthor=C.+Tournier&title=Exploring+the+function+of+the+JNK+%28c-Jun+N-terminal+kinase%29+signaling+pathway+in+physiological+and+pathological+processes+to+design+novel+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies</span></div><div class="casAuthors">Davies, Clare; Tournier, Cathy</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-89</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  JNK (c-Jun N-terminal kinase) is a member of the MAPK (mitogen-activated protein kinase) family that regulates a range of biol. processes implicated in tumorigenesis and neurodegenerative disorders.  For example, genetic studies have demonstrated that the removal of specific Jnk genes can reduce neuronal death assocd. with cerebral ischemia.  As such, targeting JNK signalling constitutes an obvious opportunity for therapeutic intervention.  However, MAPK inhibitors can display toxic effects.  Consequently, dual-specificity MKKs (MAPK kinases) may represent more attractive targets.  In particular, evidence that blocking JNK activation by removing MKK4 offers an effective therapy to treat pathol. conditions has started to emerge.  MKK4 was the first JNK activator identified.  The remaining level of JNK activity in cells lacking MKK4 expression led to the discovery of a second activator of JNK, named MKK7.  Distinct phenotypic abnormalities assocd. with the targeted deletion of Mkk4 and Mkk7 in mice have revealed that MKK4 and MKK7 have non-redundant function in vivo.  Further insights into the specific functions of the JNK activators in cancer cells and in neurons will be of crit. importance to validate MKK4 and MKK7 as promising drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE5YUaVM80x7Vg90H21EOLACvtfcHk0liQ3xjOminLjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqurk%253D&md5=23da2741d00c642daf9d90f9f1c85e80</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1042%2FBST20110641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20110641%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DTournier%26aufirst%3DC.%26atitle%3DExploring%2520the%2520function%2520of%2520the%2520JNK%2520%2528c-Jun%2520N-terminal%2520kinase%2529%2520signaling%2520pathway%2520in%2520physiological%2520and%2520pathological%2520processes%2520to%2520design%2520novel%2520therapeutic%2520strategies%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2012%26volume%3D40%26spage%3D85%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Santiago, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefano, M.</span><span> </span><span class="NLM_article-title">Medicinal Chemistry and the Molecular Operating Environment (MOE): application of QSAR and molecular docking to drug discovery</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.2174%2F156802608786786624" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1555-1572&author=V.+Santiagoauthor=C.+Giorgioauthor=M.+Stefano&title=Medicinal+Chemistry+and+the+Molecular+Operating+Environment+%28MOE%29%3A+application+of+QSAR+and+molecular+docking+to+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F156802608786786624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608786786624%26sid%3Dliteratum%253Aachs%26aulast%3DSantiago%26aufirst%3DV.%26aulast%3DGiorgio%26aufirst%3DC.%26aulast%3DStefano%26aufirst%3DM.%26atitle%3DMedicinal%2520Chemistry%2520and%2520the%2520Molecular%2520Operating%2520Environment%2520%2528MOE%2529%253A%2520application%2520of%2520QSAR%2520and%2520molecular%2520docking%2520to%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1555%26epage%3D1572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Braselmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurcevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1124%2Fjpet.106.109058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=16946104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yltL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=998-1008&author=S.+Braselmannauthor=V.+Taylorauthor=H.+Zhaoauthor=S.+Wangauthor=C.+Sylvainauthor=M.+Baluomauthor=K.+Quauthor=E.+Herlaarauthor=A.+Lauauthor=C.+Youngauthor=B.+R.+Wongauthor=S.+Lovelauthor=T.+Sunauthor=G.+Parkauthor=A.+Argadeauthor=S.+Jurcevicauthor=P.+Pineauthor=R.+Singhauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+S.+Masuda&title=R406%2C+an+orally+available+spleen+tyrosine+kinase+inhibitor+blocks+fc+receptor+signaling+and+reduces+immune+complex-mediated+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation</span></div><div class="casAuthors">Braselmann, Sylvia; Taylor, Vanessa; Zhao, Haoran; Wang, Su; Sylvain, Catherine; Baluom, Muhammad; Qu, Kunbin; Herlaar, Ellen; Lau, Angela; Young, Chi; Wong, Brian R.; Lovell, Scott; Sun, Thomas; Park, Gary; Argade, Ankush; Jurcevic, Stipo; Pine, Polly; Singh, Rajinder; Grossbard, Elliott B.; Payan, Donald G.; Masuda, Esteban S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">998-1008</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent compelling evidence has lead to renewed interest in the role of antibodies and immune complexes in the pathogenesis of several autoimmune disorders, such as rheumatoid arthritis.  These immune complexes, consisting of autoantibodies to self-antigens, can mediate inflammatory responses largely through binding and activating the Ig Fc receptors (FcRs).  Using cell-based structure activity relationships with cultured human mast cells, we have identified the small mol. R406 [N4-(2,2-dimethyl-3-oxo-4H-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2- (3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine] as a potent inhibitor of IgE (IgE)- and IgG-mediated activation of Fc receptor signaling (EC50 for degranulation = 56-64 nM).  Here we show that the primary target for R406 is the spleen tyrosine kinase (Syk), which plays a key role in the signaling of activating Fc receptors and the B-cell receptor (BCR).  R406 inhibited phosphorylation of Syk substrate linker for activation of T cells in mast cells and B-cell linker protein/SLP65 in B cells.  R406 bound to the ATP binding pocket of Syk and inhibited its kinase activity as an ATP-competitive inhibitor (Ki = 30 nM).  Furthermore, R406 blocked Syk-dependent FcR-mediated activation of monocytes/macrophages and neutrophils and BCR-mediated activation of B lymphocytes.  R406 was selective as assessed using a large panel of Syk-independent cell-based assays representing both specific and general signaling pathways.  Consistent with Syk inhibition, oral administration of R406 to mice reduced immune complex-mediated inflammation in a reverse-passive Arthus reaction and two antibody-induced arthritis models.  Finally, we report a first-in-human study showing that R406 is orally bioavailable, achieving exposures capable of inhibiting Syk-dependent IgE-mediated basophil activation.  Collectively, the results show R406 potential for modulating Syk activity in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohoeT9BJQAyLVg90H21EOLACvtfcHk0liQ3xjOminLjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yltL7P&md5=18fea516041ea075d2123158f321a186</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.109058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.109058%26sid%3Dliteratum%253Aachs%26aulast%3DBraselmann%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DK.%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DB.%2BR.%26aulast%3DLovel%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DArgade%26aufirst%3DA.%26aulast%3DJurcevic%26aufirst%3DS.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DR406%252C%2520an%2520orally%2520available%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520fc%2520receptor%2520signaling%2520and%2520reduces%2520immune%2520complex-mediated%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D998%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellow, G. W.</span><span> </span><span class="NLM_article-title">Selectivity of kinase inhibitor fragments</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5131</span><span class="NLM_x">–</span> <span class="NLM_lpage">5143</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200349b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5131-5143&author=P.+Bamboroughauthor=M.+J.+Brownauthor=J.+A.+Christopherauthor=C.+Chungauthor=G.+W.+Mellow&title=Selectivity+of+kinase+inhibitor+fragments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm200349b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200349b%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DM.%2BJ.%26aulast%3DChristopher%26aufirst%3DJ.%2BA.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DMellow%26aufirst%3DG.%2BW.%26atitle%3DSelectivity%2520of%2520kinase%2520inhibitor%2520fragments%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5131%26epage%3D5143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhardauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lhCmouSwETLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhard%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lhCmouSwETLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNature%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, K.</span><span> </span><span class="NLM_article-title">The challenge of selecting protein kinase assays for lead discovery optimization</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1517%2F17460441.3.6.607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=19662101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotVyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=607-621&author=H.+Maauthor=S.+Deaconauthor=K.+Horiuchi&title=The+challenge+of+selecting+protein+kinase+assays+for+lead+discovery+optimization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of selecting protein kinase assays for lead discovery optimization</span></div><div class="casAuthors">Ma, Haiching; Deacon, Sean; Horiuchi, Kurumi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">607-621</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Protein kinases represent one of the most promising groups of drug targets owing to their involvement in such pathol. conditions as cancer, inflammatory diseases, neural disorders, and metab. problems.  In the last few years, numerous pharmaceutical and biotech companies have established kinase high-throughput screening (HTS) programs, and the reagent and service industries for kinase assay platforms, kits, and profiling services have begun to thrive.  Objective: The plethora of different assay formats available today poses a great challenge to scientists who want to select a technol. that will be cost efficient, convenient to use, and have low false pos. and false neg. rates.  Methods: In the current review, we summarize the most commonly used kinase assay methods in the drug discovery process, present the advantages and disadvantages of each of these methods, and discuss the challenges of discovering kinase inhibitors by using these technologies.  Conclusions: The decision of selecting the assay formats for HTS or service platform for profiling should take into account not only the final goals of the screens but also the limitation of resources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-z-puxv_a7Vg90H21EOLACvtfcHk0ljjM8NzFv4xVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotVyrt70%253D&md5=d01a65a4560c5edb357f02c788631c69</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1517%2F17460441.3.6.607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.3.6.607%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DDeacon%26aufirst%3DS.%26aulast%3DHoriuchi%26aufirst%3DK.%26atitle%3DThe%2520challenge%2520of%2520selecting%2520protein%2520kinase%2520assays%2520for%2520lead%2520discovery%2520optimization%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D607%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kaneko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionne, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauer, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakata, C.</span><span> </span><span class="NLM_article-title">Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1863</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970031d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1863-1869&author=M.+Kanekoauthor=Y.+Saitoauthor=H.+Saitoauthor=T.+Matsumotoauthor=Y.+Matsudaauthor=J.+L.+Vaughtauthor=C.+A.+Dionneauthor=T.+S.+Angelesauthor=M.+A.+Glicksmanauthor=N.+T.+Neffauthor=D.+P.+Rotellaauthor=J.+C.+Kauerauthor=J.+P.+Mallamoauthor=R.+L.+Hudkinsauthor=C.+Murakata&title=Neurotrophic+3%2C9-bis%5B%28alkylthio%29methyl%5D-and-bis%28alkoxymethyl%29-K-252a+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm970031d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970031d%26sid%3Dliteratum%253Aachs%26aulast%3DKaneko%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DVaught%26aufirst%3DJ.%2BL.%26aulast%3DDionne%26aufirst%3DC.%2BA.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DNeff%26aufirst%3DN.%2BT.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DKauer%26aufirst%3DJ.%2BC.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DMurakata%26aufirst%3DC.%26atitle%3DNeurotrophic%25203%252C9-bis%255B%2528alkylthio%2529methyl%255D-and-bis%2528alkoxymethyl%2529-K-252a%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1863%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Olaharski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzaludo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K.</span><span> </span><span class="NLM_article-title">Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1000446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=e1000446&author=A.+J.+Olaharskiauthor=N.+Gonzaludoauthor=H.+Bitterauthor=D.+Goldsteinauthor=S.+Kirchnerauthor=H.+Uppalauthor=K.+Kolaja&title=Identification+of+a+kinase+profile+that+predicts+chromosome+damage+induced+by+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlaharski%26aufirst%3DA.%2BJ.%26aulast%3DGonzaludo%26aufirst%3DN.%26aulast%3DBitter%26aufirst%3DH.%26aulast%3DGoldstein%26aufirst%3DD.%26aulast%3DKirchner%26aufirst%3DS.%26aulast%3DUppal%26aufirst%3DH.%26aulast%3DKolaja%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520a%2520kinase%2520profile%2520that%2520predicts%2520chromosome%2520damage%2520induced%2520by%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3De1000446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901132v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1413-1437&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Selectively Nonselective Kinase Inhibition: Striking the Right Balance</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1413-1437</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Marketed kinase inhibitors (MKIs) can deliver superior efficacy compared to inhibitors with high specificity for a single kinase, and the recent introduction of several MKIs to the market opens the door to a new era of safer and effective anticancer therapy.  The key to combining high efficacy with acceptable safety is to inhibit multiple targets in a selectively nonselective fashion.  Strategies for intentionally designing MKIs are emerging, but the field is still in its infancy and we are as medicinal chemists currently on the steepest part of the learning curve.  MTDD can be time-consuming and expensive, and we need to become more proficient first at identifying disease-relevant target combinations and second at discovering MKIs that combine optimal physicochem. and biol. properties.  Bold and innovative medicinal chem. strategies are required to tackle "difficult combinations" where the disease rationale is compelling but where it is a struggle to combine all the desired attributes of an oral MKI drug into a single mol.  At present it is unclear to what extent MKIs with highly tuned selectivity profiles can be rationally designed, particularly for targets that are unrelated by sequence.  In addn. to the well-known selectivity challenge, the physicochem. property profiles of AT P-competitive MKIs can be inherently challenging and limited scope for patentability can also be a serious hindrance.  On the plus side, the amt. of kinase-specific structural information is growing very rapidly, and ultimately this may reveal distinct features and design rules that enable a medicinal chemist to rationally modify and refine the profile of MKIs.  In addn., increasing SAR knowledge is emerging from large scale panel screening with the binding profiles starting to reveal to medicinal chemists how chem. structure affects cross-reactivity across large parts of the kinome.  The merit of MKIs compared with single kinase inhibitors is a subject of controversy in drug discovery that is unlikely to be resolved in the near future.  At the start of a new MTDD project, a rigorous debate needs to take place as to whether it makes more sense to seek a combination of highly selective agents or a DML.  Many factors need to be taken into account in this decision such as the no., similarity, and promiscuity of the targets in the profile and the disease area.  Conformational plasticity and the occurrence of multiple binding modes complicate the in silico prediction of kinase polypharmacol. based solely upon protein structure.  The use of ligand-based similarity to assess the feasibility of a given combination can add real value.  Currently, serendipity plays a significant role in MKI discovery and many, if not most, MKIs have been discovered by chance during the search for selective inhibitors.  Medicinal chemists need to be alert to the possibilities when a surprising combination is found by chance.  To exploit such serendipity, you need a good appreciation of when you have a sufficiently high quality starting compd. and then you need to be able to make and test sufficient analogs to explore your new disease-based hypothesis.  MKIs are costly to develop and are consequently priced at a premium level, so they will need to show clear improvements in order to get reimbursement.  There have already been problems with reimbursement for some MKIs in some markets due to concerns from funding bodies over insufficient efficacy.  The true value of MKIs relative to other anticancer drugs still has to be established, and the results from recent clin. trials have been mixed.  Despite the broad activity profile of many MKIs, the patient response can be inconsistent and unpredictable.  The identification of predictive biomarkers of response or resistance is a crit. step to ascertain which specific combination of targets produces a significant clin. benefit with respect to specific tumor types.  More clin. feedback is needed to facilitate the design of the next generation of inhibitors with more precisely defined profiles.  Although it might seem immeasurably distant at the present time, the ultimate goal should be to derive the prerequisite knowledge and tools so that MTDD becomes a rational endeavor rather than a black box approach that relies upon serendipity.  This will help banish claims that MKIs are merely dirty, nonspecific drugs with insufficient specificity for treating a wider range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-L-NWmtdikbVg90H21EOLACvtfcHk0liNYVMPrfzggg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWmtbfF&md5=3c915b5debf9d005993c8ad31c68bc2e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901132v%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1413%26epage%3D1437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Grunwald, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levis, M. J.</span><span> </span><span class="NLM_article-title">FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance</span> <span class="citation_source-journal">Int. J. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1007%2Fs12185-013-1334-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXps1ynt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2013&pages=683-694&author=M.+R.+Grunwaldauthor=M.+J.+Levis&title=FLT3+inhibitors+for+acute+myeloid+leukemia%3A+a+review+of+their+efficacy+and+mechanisms+of+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance</span></div><div class="casAuthors">Grunwald, Michael R.; Levis, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Hematology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">683-694</span>CODEN:
                <span class="NLM_cas:coden">IJHEEY</span>;
        ISSN:<span class="NLM_cas:issn">0925-5710</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">A review.  Since the Food and Drug Administration approval of imatinib for treatment of chronic myeloid leukemia in 2001, tyrosine kinase inhibitors (TKIs) have become a mainstay in the care of many malignancies.  In acute myeloid leukemia (AML), activating mutations in the FMS-like tyrosine kinase 3 (FLT3) gene result in survival and proliferation of leukemic blasts and are assocd. with adverse prognosis.  Therefore, the FLT3 receptor is an appealing target for inhibition.  Multiple small mol. TKIs are currently in development for FLT3-mutated AML, and agents are beginning to show promising efficacy.  In other malignancies, the development of resistance to TKIs during the course of therapy has proven to be a challenge, and thus far, in clin. trials of FLT3 TKIs, resistance to inhibition represents a significant barrier to successful FLT3 inhibition.  Understanding the mechanisms of resistance and overcoming these obstacles to target inhibition will be central to the success of these agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLGvQhRtVOcLVg90H21EOLACvtfcHk0liNYVMPrfzggg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXps1ynt7Y%253D&md5=f760866dbcd953c09143e0290fbffe3c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2Fs12185-013-1334-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12185-013-1334-8%26sid%3Dliteratum%253Aachs%26aulast%3DGrunwald%26aufirst%3DM.%2BR.%26aulast%3DLevis%26aufirst%3DM.%2BJ.%26atitle%3DFLT3%2520inhibitors%2520for%2520acute%2520myeloid%2520leukemia%253A%2520a%2520review%2520of%2520their%2520efficacy%2520and%2520mechanisms%2520of%2520resistance%26jtitle%3DInt.%2520J.%2520Hematol.%26date%3D2013%26volume%3D97%26spage%3D683%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">DeBoy, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegla, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cudrici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whartenby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P. A.</span><span> </span><span class="NLM_article-title">FLT-3 expression and function on microglia in multiple sclerosis</span> <span class="citation_source-journal">Exp. Mol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1016%2Fj.yexmp.2010.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A280%3ADC%252BC3cfgvVWksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2010&pages=109-116&author=C.+A.+DeBoyauthor=H.+Rusauthor=C.+Teglaauthor=C.+Cudriciauthor=M.+V.+Jonesauthor=C.+A.+Pardoauthor=D.+Smallauthor=K.+A.+Whartenbyauthor=P.+A.+Calabresi&title=FLT-3+expression+and+function+on+microglia+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">FLT-3 expression and function on microglia in multiple sclerosis</span></div><div class="casAuthors">DeBoy Cynthia A; Rus Horea; Tegla Cosmin; Cudrici Cornelia; Jones Melina V; Pardo Carlos A; Small Donald; Whartenby Katharine A; Calabresi Peter A</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and molecular pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammatory cell infiltration and resident microglial activation within the central nervous system (CNS) are pathological events in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).  While MS therapies target the peripheral immune system, no treatment is currently known to also modulate microglia.  FMS-like tyrosine-3 (FLT-3) is expressed on hematopoietic and dendritic cells.  We reported that FLT-3 inhibition ameliorates early actively induced EAE by predominantly modulating dendritic cell function as compared to microglia.  We demonstrate in this report that FLT-3 is expressed in perivascular cuffs, brain parenchyma and in non-lesioned gray and white matter within MS brain but not in these regions within control brain.  Furthermore, we demonstrate that FLT-3 is expressed on two populations of cells within MS brain; one which expresses the dendritic cell marker CD209, and the other which does not, suggesting that FLT-3 within MS brain is expressed on infiltrating dendritic cells and a non-dendritic cell such as microglia.  Additionally, we report that FLT-3 inhibition in murine microglia blocks, in a dose-dependent manner, IFN-γ-induced expression of MHC class II and CD86, and LPS-induced secretion of IL-6.  These data suggest that FLT-3 is involved in microglial cells' capacity to respond to environmental cues to function as antigen presenting cells and mediate CNS inflammation.  Furthermore these data suggest that FLT-3 may be a therapeutic target on microglia to mitigate CNS inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCpUbo7qjyD1UIs6wFK5xJfW6udTcc2eYZ3pYYlTzKyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfgvVWksg%253D%253D&md5=2d9f1bbf587ed9bf1f317ecc2d96d90e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.yexmp.2010.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexmp.2010.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DDeBoy%26aufirst%3DC.%2BA.%26aulast%3DRus%26aufirst%3DH.%26aulast%3DTegla%26aufirst%3DC.%26aulast%3DCudrici%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DM.%2BV.%26aulast%3DPardo%26aufirst%3DC.%2BA.%26aulast%3DSmall%26aufirst%3DD.%26aulast%3DWhartenby%26aufirst%3DK.%2BA.%26aulast%3DCalabresi%26aufirst%3DP.%2BA.%26atitle%3DFLT-3%2520expression%2520and%2520function%2520on%2520microglia%2520in%2520multiple%2520sclerosis%26jtitle%3DExp.%2520Mol.%2520Pathol.%26date%3D2010%26volume%3D89%26spage%3D109%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">Comprehensive analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1038%2Fnbt.1990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm401094t&amp;key=22037378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=1046-1051&author=M.+I.+Davisauthor=J.+P.+Huntauthor=S.+Herrgardauthor=P.+Ciceriauthor=L.+M.+Wodickaauthor=G.+Pallaresauthor=M.+Hockerauthor=D.+K.+Treiberauthor=P.+P.+Zarrinkar&title=Comprehensive+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Davis, Mindy I.; Hunt, Jeremy P.; Herrgard, Sanna; Ciceri, Pietro; Wodicka, Lisa M.; Pallares, Gabriel; Hocker, Michael; Treiber, Daniel K.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1046-1051</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We tested the interaction of 72 kinase inhibitors with 442 kinases covering >80% of the human catalytic protein kinome.  Our data show that, as a class, type II inhibitors are more selective than type I inhibitors, but that there are important exceptions to this trend.  The data further illustrate that selective inhibitors have been developed against the majority of kinases targeted by the compds. tested.  Anal. of the interaction patterns reveals a class of 'group-selective' inhibitors broadly active against a single subfamily of kinases, but selective outside that subfamily.  The data set suggests compds. to use as tools to study kinases for which no dedicated inhibitors exist.  It also provides a foundation for further exploring kinase inhibitor biol. and toxicity, as well as for studying the structural basis of the obsd. interaction patterns.  Our findings will help to realize the direct enabling potential of genomics for drug development and basic research about cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEZnKVs6Xt5rVg90H21EOLACvtfcHk0lgepagKMLQbCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyisrrK&md5=67639f702cb48ffb2c60e9a250f0df5e</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1990%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DHocker%26aufirst%3DM.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DComprehensive%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNature%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D1046%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Santos, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Manero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Extrov, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=1131-1136&author=F.+P.+Santosauthor=H.+M.+Kantarjianauthor=N.+Jainauthor=T.+Manshouriauthor=D.+A.+Thomasauthor=G.+Garcia-Maneroauthor=D.+Kennedyauthor=Z.+Extrovauthor=J.+Cortesauthor=S.+Verstovsek&title=Phase+2+study+of+CEP-701%2C+an+orally+available+JAK2+inhibitor%2C+in+patients+with+primary+or+post-polycythemia+vera%2Fessential+thrombocythemia+myelofibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DF.%2BP.%26aulast%3DKantarjian%26aufirst%3DH.%2BM.%26aulast%3DJain%26aufirst%3DN.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DD.%2BA.%26aulast%3DGarcia-Manero%26aufirst%3DG.%26aulast%3DKennedy%26aufirst%3DD.%26aulast%3DExtrov%26aufirst%3DZ.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPhase%25202%2520study%2520of%2520CEP-701%252C%2520an%2520orally%2520available%2520JAK2%2520inhibitor%252C%2520in%2520patients%2520with%2520primary%2520or%2520post-polycythemia%2520vera%252Fessential%2520thrombocythemia%2520myelofibrosis%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Olaharski, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzaludo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabka, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaja, K.</span><span> </span><span class="NLM_article-title">Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors</span> <span class="citation_source-journal">Toxicol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1093%2Ftoxsci%2Fkfq258" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2010&pages=226-275&author=A.+J.+Olaharskiauthor=H.+Bitterauthor=N.+Gonzaludoauthor=R.+Kondruauthor=D.+M.+Goldsteinauthor=T.+S.+Zabkaauthor=H.+Linauthor=T.+Singerauthor=K.+Kolaja&title=Modeling+bone+marrow+toxicity+using+kinase+structural+motifs+and+the+inhibition+profiles+of+small+molecular+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1093%2Ftoxsci%2Fkfq258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Ftoxsci%252Fkfq258%26sid%3Dliteratum%253Aachs%26aulast%3DOlaharski%26aufirst%3DA.%2BJ.%26aulast%3DBitter%26aufirst%3DH.%26aulast%3DGonzaludo%26aufirst%3DN.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DZabka%26aufirst%3DT.%2BS.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DSinger%26aufirst%3DT.%26aulast%3DKolaja%26aufirst%3DK.%26atitle%3DModeling%2520bone%2520marrow%2520toxicity%2520using%2520kinase%2520structural%2520motifs%2520and%2520the%2520inhibition%2520profiles%2520of%2520small%2520molecular%2520kinase%2520inhibitors%26jtitle%3DToxicol.%2520Sci.%26date%3D2010%26volume%3D118%26spage%3D226%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Tsika, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span> </span><span class="NLM_article-title">Mechanisms of LRRK2-mediated neurodegeneration</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1007%2Fs11910-012-0265-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsF2jsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=251-260&author=E.+Tsikaauthor=D.+J.+Moore&title=Mechanisms+of+LRRK2-mediated+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of LRRK2-Mediated Neurodegeneration</span></div><div class="casAuthors">Tsika, Elpida; Moore, Darren J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neurology and Neuroscience Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">CNNRBS</span>;
        ISSN:<span class="NLM_cas:issn">1534-6293</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene represent the most common cause of familial Parkinson's disease (PD), whereas common variation at the LRRK2 locus is assocd. with an increased risk of idiopathic PD.  Considerable progress has been made toward understanding the biol. functions of LRRK2 and the mol. mechanisms underlying the pathogenic effects of disease-assocd. mutations.  The development of neuronal culture models and transgenic or viral-based rodent models have proved useful for identifying a no. of emerging pathways implicated in LRRK2-dependent neuronal damage, including the microtubule network, actin cytoskeleton, autophagy, mitochondria, vesicular trafficking, and protein quality control.  However, many important questions remain to be posed and answered.  Elucidating the mol. mechanisms and pathways underlying LRRK2-mediated neurodegeneration is crit. for the identification of new mol. targets for therapeutic intervention in PD.  In this review we discuss recent advances and unanswered questions in understanding the pathophysiol. of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5tcBB2SWeZbVg90H21EOLACvtfcHk0ljgxoyv0dGDsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2jsb0%253D&md5=0d2a3d62fb96d6b8b9f0bae6ddcf7c11</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1007%2Fs11910-012-0265-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-012-0265-8%26sid%3Dliteratum%253Aachs%26aulast%3DTsika%26aufirst%3DE.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26atitle%3DMechanisms%2520of%2520LRRK2-mediated%2520neurodegeneration%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2012%26volume%3D12%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Marker, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mockus, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieri, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span> </span><span class="NLM_article-title">LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm401094t&amp;key=10.1186%2F1742-2094-9-261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm401094t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=261&author=D.+F.+Markerauthor=J.+M.+Pucciniauthor=T.+E.+Mockusauthor=J.+Barbieriauthor=S.+M.+Luauthor=H.+A.+Gelbard&title=LRRK2+kinase+inhibition+prevents+pathological+microglial+phagocytosis+in+response+to+HIV-1+Tat+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein</span></div><div class="casAuthors">Marker, Daniel F.; Puccini, Jenna M.; Mockus, Taryn E.; Barbieri, Justin; Lu, Shao-Ming; Gelbard, Harris A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Human Immunodeficiency Virus-1 (HIV-1) assocd. neurocognitive disorders (HANDs) are accompanied by significant morbidity, which persists despite the use of combined antiretroviral therapy (cART).  While activated microglia play a role in pathogenesis, changes in their immune effector functions, including phagocytosis and proinflammatory signaling pathways, are not well understood.  We have identified leucine-rich repeat kinase 2 (LRRK2) as a novel regulator of microglial phagocytosis and activation in an in vitro model of HANDs, and hypothesize that LRRK2 kinase inhibition will attenuate microglial activation during HANDs.  Methods: We treated BV-2 immortalized mouse microglia cells with the HIV-1 trans activator of transcription (Tat) protein in the absence or presence of LRRK2 kinase inhibitor (LRRK2i).  We used Western blot, qRT-PCR, immunocytochem. and latex bead engulfment assays to analyze LRRK2 protein levels, proinflammatory cytokine and phagocytosis receptor expression, LRRK2 cellular distribution and phagocytosis, resp.  Finally, we utilized ex vivo microfluidic chambers contg. primary hippocampal neurons and BV-2 microglia cells to investigate microglial phagocytosis of neuronal axons.  Results: We found that Tat-treatment of BV-2 cells induced kinase activity assocd. phosphorylation of serine 935 on LRRK2 and caused the formation of cytoplasmic LRRK2 inclusions.  LRRK2i decreased Tat-induced phosphorylation of serine 935 on LRRK2 and inhibited the formation of Tat-induced cytoplasmic LRRK2 inclusions.  LRRK2i also decreased Tat-induced process extension in BV-2 cells.  Furthermore, LRRK2i attenuated Tat-induced cytokine expression and latex bead engulfment.  We examd. relevant cellular targets in microfluidic chambers and found that Tat-treated BV-2 microglia cells cleared axonal arbor and engulfed neuronal elements, whereas saline treated controls did not.  LRRK2i was found to protect axons in the presence of Tat-activated microglia, as well as AnnexinV, a phosphatidylserine-binding protein.  In addn., LRRK2i decreased brain-specific angiogenesis inhibitor 1 (BAI1) receptor expression on BV-2 cells after Tat-treatment, a key receptor in phosphatidylserine-mediated phagocytosis.  Conclusion: Taken together, these results implicate LRRK2 as a key player in microglial inflammation and, in particular, in the phagocytosis of neuronal elements.  These studies show that LRRK2 kinase inhibition may prove an effective therapeutic strategy for HANDs, as well as other neuroinflammatory conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoKzmyQBRIXLVg90H21EOLACvtfcHk0ljgxoyv0dGDsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyju7g%253D&md5=6b906ae227f6b6f17bbaede4b59f3e85</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-9-261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-9-261%26sid%3Dliteratum%253Aachs%26aulast%3DMarker%26aufirst%3DD.%2BF.%26aulast%3DPuccini%26aufirst%3DJ.%2BM.%26aulast%3DMockus%26aufirst%3DT.%2BE.%26aulast%3DBarbieri%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DS.%2BM.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26atitle%3DLRRK2%2520kinase%2520inhibition%2520prevents%2520pathological%2520microglial%2520phagocytosis%2520in%2520response%2520to%2520HIV-1%2520Tat%2520protein%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2012%26volume%3D9%26spage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Kiebala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span> </span><span class="NLM_article-title">Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e18633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e18633&author=M.+Kiebalaauthor=S.+B.+Maggirwar&title=Ibudilast%2C+a+pharmacologic+phosphodiesterase+inhibitor%2C+prevents+human+immunodeficiency+virus-1+Tat-mediated+activation+of+microglial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiebala%26aufirst%3DM.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26atitle%3DIbudilast%252C%2520a%2520pharmacologic%2520phosphodiesterase%2520inhibitor%252C%2520prevents%2520human%2520immunodeficiency%2520virus-1%2520Tat-mediated%2520activation%2520of%2520microglial%2520cells%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De18633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Sui, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sniderhan, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schifitto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbard, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhurst, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggirwar, S. B.</span><span> </span><span class="NLM_article-title">Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implication in HIV type 1 dementia</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">3226</span><span class="NLM_x">–</span> <span class="NLM_lpage">3236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=3226-3236&author=Z.+Suiauthor=L.+F.+Sniderhanauthor=G.+Schifittoauthor=R.+P.+Phippsauthor=H.+A.+Gelbardauthor=S.+Dewhurstauthor=S.+B.+Maggirwar&title=Functional+synergy+between+CD40+ligand+and+HIV-1+Tat+contributes+to+inflammation%3A+implication+in+HIV+type+1+dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DSniderhan%26aufirst%3DL.%2BF.%26aulast%3DSchifitto%26aufirst%3DG.%26aulast%3DPhipps%26aufirst%3DR.%2BP.%26aulast%3DGelbard%26aufirst%3DH.%2BA.%26aulast%3DDewhurst%26aufirst%3DS.%26aulast%3DMaggirwar%26aufirst%3DS.%2BB.%26atitle%3DFunctional%2520synergy%2520between%2520CD40%2520ligand%2520and%2520HIV-1%2520Tat%2520contributes%2520to%2520inflammation%253A%2520implication%2520in%2520HIV%2520type%25201%2520dementia%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D3226%26epage%3D3236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DTC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3DTC','PDB','3DTC'); return false;">PDB: 3DTC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ETA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ETA','PDB','3ETA'); return false;">PDB: 3ETA</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i70"><a href="/doi/suppl/10.1021/jm401094t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40261"></div></div></div></div></div><hr /></hr><p class="last">Kinase inhibition profiles for 442 kinases for compound <b>1</b> and <b>2</b> performed by DiscoverRx; inhibition profile using radio ligand binding assay for 342 wild-type human kinases performed by Reaction Biology Corp for compound <b>1</b>.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401094t/suppl_file/jm401094t_si_001.pdf">jm401094t_si_001.pdf (209.29 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401094t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm401094t%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-20" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401094t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b477cc92c3d18","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
